<SEC-DOCUMENT>0001193125-20-126529.txt : 20200429
<SEC-HEADER>0001193125-20-126529.hdr.sgml : 20200429
<ACCEPTANCE-DATETIME>20200429171517
ACCESSION NUMBER:		0001193125-20-126529
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20200617
FILED AS OF DATE:		20200429
DATE AS OF CHANGE:		20200429
EFFECTIVENESS DATE:		20200429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MADRIGAL PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001157601
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33277
		FILM NUMBER:		20831680

	BUSINESS ADDRESS:	
		STREET 1:		200 BARR HARBOR DRIVE, SUITE 400
		CITY:			WEST CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428
		BUSINESS PHONE:		404-380-9263

	MAIL ADDRESS:	
		STREET 1:		200 BARR HARBOR DRIVE, SUITE 400
		CITY:			WEST CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNTA PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20010815
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d878734ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material under &#167;240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>MADRIGAL
PHARMACEUTICALS, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid: $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878734g16t43.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878734g63s72.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">May&nbsp;5, 2020 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9">DEAR STOCKHOLDERS: </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">I am pleased to invite you to attend the 2020 annual meeting of
stockholders of Madrigal Pharmaceuticals, Inc. (the &#147;Annual Meeting&#148;) on Wednesday, June&nbsp;17, 2020 at 9:00 a.m. Eastern Time. In light of recent COVID-19 health concerns and social distancing recommendations by governmental and health
authorities, Madrigal has decided to adopt a virtual format for our Annual Meeting. This virtual approach is designed to provide a consistent and convenient remote access and attendance experience for all stockholders, via internet, regardless of
location. You may attend the Annual Meeting virtually via the Internet at <U>www.proxydocs.com/MDGL</U>. In order to attend you must register in advance at <U>www.proxydocs.com/MDGL</U> prior to the deadline of June&nbsp;10, 2020 at 5:00 pm Eastern
Time. Upon completing your registration, you will receive further instructions via email, including your unique links that will permit you to submit questions in advance of the Annual Meeting and allow you access to the meeting. Please be sure to
follow instructions found on your Proxy Card and/or Voting Authorization Form and subsequent instructions that will be delivered to you via email. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Notice of
the 2020 Annual Meeting of Stockholders and the proxy statement contain details of the business to be conducted at the Annual Meeting, including the nominees for election as directors. Only stockholders of record at the close of business on
April&nbsp;24, 2020 will be entitled to notice of, and to vote at, the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Your vote is important. Regardless of whether you plan to participate in the
Annual Meeting, we hope that you will vote as soon as possible. You may vote by proxy over the Internet (as described below), by telephone, or by mail (if you received paper copies of the proxy materials) by following the instructions on the proxy
card or voting instruction card. Voting over the Internet or by telephone, written proxy or voting instruction card will ensure your representation at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Thank you for your ongoing support of Madrigal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:ARIAL">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:55%; text-indent:-2%">


<IMG SRC="g878734g75q32.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:ARIAL"><B>Paul A. Friedman </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:ARIAL">Chairman and Chief Executive Officer </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878734g97q10.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9">NOTICE OF 2020 ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT
 COLOR="#0075c9">TO BE HELD JUNE 17, 2020 </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>To the Stockholders of Madrigal Pharmaceuticals, Inc.: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">NOTICE IS HEREBY
GIVEN that the 2020 Annual Meeting of Stockholders of Madrigal Pharmaceuticals, Inc., a Delaware corporation, will be held on Wednesday, June&nbsp;17, 2020, at 9:00 a.m. Eastern Time for the following purposes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:ARIAL; " ALIGN="left">to elect three Class&nbsp;I director nominees named in the accompanying proxy statement to serve on the Board of
Directors for three-year terms expiring at the Annual Meeting of Stockholders to be held in 2023 or until their successors are duly elected and qualified; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:ARIAL; " ALIGN="left">to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the
fiscal year ending December&nbsp;31, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:ARIAL; " ALIGN="left">to approve, on an advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy
statement, pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:ARIAL; " ALIGN="left">to transact such other business that is properly presented at the meeting and any adjournments or postponements thereof.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The 2020 Annual Meeting of Stockholders will be a completely virtual meeting. There will be no physical meeting location. The meeting will only
be conducted via live webcast. To participate in the 2020 Annual Meeting virtually via the Internet, please visit <U>www.proxydocs.com/MDGL</U>. Through this webcast, stockholders and proxyholders will be deemed to be present in person for purposes
of conducting a vote at such meeting. <B>In order to attend this webcast, you must register in advance at <U>www.proxydocs.com/MDGL</U> prior to the deadline of June&nbsp;10, 2020 at 5:00 pm Eastern Time,</B> as more fully described in the
accompanying proxy statement and proxy card. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In accordance with rules established by the Securities and Exchange Commission, we are providing you access to our
proxy materials over the Internet. Accordingly, we plan to mail a Notice of Internet Availability of Proxy Materials, or the Notice, to our stockholders on or about May&nbsp;5, 2020. The Notice will describe how to access and review our proxy
materials, including our proxy statement, proxy card, and 2019 Annual Report on Form 10-K. The Notice, as well as our proxy card, will also describe how you may submit your proxy electronically. If you received just a Notice by mail and would like
to receive a printed copy of our proxy materials, you should follow the instructions for requesting such materials included in the accompanying proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Only stockholders of record at the close of business on April&nbsp;24, 2020, are entitled to notice of and to vote at the Annual Meeting. A list of stockholders
entitled to vote at the Annual Meeting will be available for inspection at our executive offices for the ten days prior to the Annual Meeting. All stockholders are cordially invited to attend the Annual Meeting via live webcast. Whether or not you
plan to attend the virtual Annual Meeting, please vote as soon as possible. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">BY ORDER OF THE BOARD OF DIRECTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g878734g41p15.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"><B>Brian J. Lynch</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">Senior Vice President and General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">West Conshohocken, Pennsylvania</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">May&nbsp;5, 2020</TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0075c9">YOUR VOTE IS IMPORTANT. PLEASE CAST YOUR VOTE PROMPTLY. </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc"></A>TABLE OF CONTENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">Page</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_1">QUESTIONS AND ANSWERS ABOUT
THESE PROXY MATERIALS AND VOTING</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">1</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_2">SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">7</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_3">MANAGEMENT AND CORPORATE
 GOVERNANCE</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">10</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_4">The Board of Directors</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">10</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_5">Director Independence</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">15</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_6">Committees of the Board of Directors and Meetings
</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">15</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_7">Board Leadership Structure</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">19</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_8">Our Board of Directors&#146; Role in Risk Oversight
</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">19</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_9">Stockholder Communications to the
Board</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">20</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_10">Information About Our Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">21</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_11">COMPENSATION
 DISCUSSION AND ANALYSIS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">22</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_12">Madrigal&#146;s Focus and its Achievements in 2019
</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">22</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_13">2019 Executive Compensation
Highlights</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">24</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_14">Overview of Our Executive Compensation Program
</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">24</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_15">Direct Compensation Components</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">26</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_16">Executive Compensation and
Risk-Taking</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">30</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_17">Advisory Vote on Executive
Compensation</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">30</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_18">EXECUTIVE
 OFFICER AND DIRECTOR COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">31</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_19">Summary Compensation Table</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">31</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_20">Grants of Plan-Based Awards</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">32</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_21">Outstanding Equity Awards at Fiscal Year
End</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">33</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_22">Pay Ratio</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">33</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_23">Option Exercises and Stock
Vested</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">34</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_24">Employment Agreements, Severance and Change in Control
 Arrangements</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">35</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_25">Potential Qualifying Separation and Change of Control
Payments</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">38</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_26">Director Compensation</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">39</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_27">Director Compensation Tables</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">40</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#toc878734_28">Report of the Compensation Committee of the Board
 of Directors</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">41</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_29">EQUITY
 COMPENSATION PLAN INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">42</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>

<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_30">DELINQUENT SECTION 16(a)
 REPORTS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">43</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_31">CERTAIN RELATIONSHIPS AND
 RELATED PARTY TRANSACTIONS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">43</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_32">PROPOSAL NO. 1: ELECTION
 OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">45</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_33">PROPOSAL NO. 2: RATIFICATION
 OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">46</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_34">PROPOSAL NO. 3: ADVISORY
 VOTE ON EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">49</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_35">CODE OF CONDUCT AND ETHICS
</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">50</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">TABLE OF CONTENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>

<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">Page</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_36">OTHER
MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">50</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">STOCKHOLDER PROPOSALS AT FUTURE ANNUAL
MEETINGS</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">50</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_38">HOUSEHOLDING OF PROXY MATERIALS
</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">51</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#toc878734_39">DISCLOSURE REGARDING FORWARD-LOOKING
STATEMENTS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">51</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:16.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>For the Stockholder Meeting to be Held on June&nbsp;17, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>at 9:00 a.m. Eastern Time </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>This year&#146;s
meeting is a virtual stockholders meeting at <U>www.proxydocs.com/MDGL</U>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>The Proxy Statement, Proxy Card and Annual Report on Form 10-K
for 2019 are available at: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B><I>www.proxydocs.com/MDGL </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>YOUR VOTE IS VERY IMPORTANT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>You are cordially invited to
attend the Annual Meeting, which will be a virtual meeting and therefore will not be held at a physical location. To participate in the 2020 Annual Meeting, virtually via the Internet, please visit <U>www.proxydocs.com/MDGL</U>. In order to attend,
you must register in advance at <U>www.proxydocs.com/MDGL</U> prior to the deadline of June&nbsp;10, 2020 at 5:00&nbsp;pm Eastern Time. Whether or not you expect to attend the Annual Meeting virtually, please vote over the telephone or the Internet,
or, if you receive a paper proxy card by mail, by completing, dating, signing and returning the proxy mailed to you, as promptly as possible in order to ensure your representation at the Annual Meeting. </B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">

<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878734g63s72.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:22pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We
prepared this proxy statement under the direction of our Board of Directors to solicit your proxy for use at our 2020 Annual Meeting of Stockholders to be held via internet webcast on Wednesday, June&nbsp;17, 2020, at 9:00&nbsp;a.m. Eastern
Time.&nbsp;As used in this proxy statement, the terms &#147;Madrigal,&#148; &#147;Public Madrigal,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;our&#148; and &#147;us&#148; refer to Madrigal Pharmaceuticals, Inc., a Delaware corporation that
has been publicly traded since July&nbsp;22, 2016. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">How do I attend the Annual Meeting? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The 2020 Annual Meeting will be a completely virtual meeting. There will be no physical meeting location. The meeting will only be conducted via live webcast. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">To participate in the 2020 Annual Meeting virtually, via the Internet, please visit <U>www.proxydocs.com/MDGL</U>. In order to attend, you must register in advance at
<U>www.proxydocs.com/MDGL</U> prior to the deadline of June&nbsp;10, 2020 at 5:00 pm Eastern Time. Upon completing your registration, you will receive further instructions via email, including your unique links that will allow you access to the
meeting and will permit you to submit questions. You will not be able to attend the 2020 Annual Meeting in person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Why did I receive a notice regarding the
availability of proxy materials on the Internet? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to rules adopted by the Securities and Exchange Commission, or the SEC, we have elected to provide access
to our proxy materials over the Internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials, or the Notice, because the Board of Directors is soliciting your proxy to vote at the Annual Meeting, including at any
adjournments or postponements of the Annual Meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to
access the proxy materials over the Internet or to request a printed copy may be found in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We intend to mail the Notice on or about May&nbsp;5, 2020 to
all stockholders of record entitled to vote at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Who can vote at the Annual Meeting? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Only stockholders of record at the close of business on April&nbsp;24, 2020 will be entitled to vote at the Annual Meeting. On this record date, there were 15,429,154
shares of common stock outstanding and entitled to vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Stockholder of Record: Shares Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If on April&nbsp;24, 2020, your shares were registered directly in your name with our transfer agent, then you are a stockholder of record. As a stockholder of record,
you may vote directly through any of the following means: (1)&nbsp;electronically over the Internet, (2)&nbsp;by telephone, or (3)&nbsp;by completing and returning a printed proxy card that you may request or that we may elect to deliver at a later
time, to ensure your vote is counted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Beneficial Owner: Shares Registered in the Name of a Broker or Bank </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If on
April&nbsp;24, 2020, your shares were held, not in your name, but rather in an account at a brokerage firm, bank or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and the Notice is being
forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other
agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting, on a virtual basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">What am I voting on? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">There are three matters scheduled for a vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">election of three Class I directors (Proposal No.&nbsp;1); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our
fiscal year ending December&nbsp;31, 2020 (Proposal No.&nbsp;2); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this proxy statement
pursuant to the compensation disclosure rules of the Securities and Exchange Commission, or SEC (Proposal No.&nbsp;3). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">What if another matter is
properly brought before the meeting? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">As of the date of this proxy statement, the Board of Directors knows of no other matters that will be presented for
consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">How do I vote? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">For each of Proposal Nos. 1, 2 and 3 to be voted on at the Annual
Meeting, including each nominee for director, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. See the table below for more details. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Stockholder of Record: Shares Registered in Your Name </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If you are a
stockholder of record, you may vote by proxy over the telephone, vote by proxy through the Internet or vote by proxy using a proxy card that you may request. Whether or not you plan to participate in the virtual Annual Meeting webcast, we urge you
to vote in advance by proxy by one of the foregoing means to ensure your vote is counted. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">To vote using the proxy card, simply complete, sign and date the proxy card that may be delivered and return it promptly in
the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">To vote over the telephone, dial toll-free 1-866-249-5094 using a touch-tone phone and follow the recorded instructions.
You will be asked to provide the company number and control number from the Notice. We recommend that you cast your telephone by 11:59 p.m. Eastern Time on June&nbsp;16, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">To vote through the Internet, go to www.proxypush.com/MDGL to complete an electronic proxy card. You will be asked to
provide the company number and control number from the Notice. We recommend that you cast your Internet vote by 11:59 p.m. Eastern Time on June&nbsp;16, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If you are
a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice containing voting instructions from that organization rather than from us. Simply follow the voting
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">instructions in the Notice to ensure that your vote is counted. Alternatively, you may vote by telephone or over the Internet as instructed by your broker or bank.
Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact that organization for assistance on how to vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">How
many votes do I have? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On each matter to be voted upon, you have one vote for each share of common stock you owned as of April&nbsp;24, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If you are a stockholder of record and do not vote through the Internet, by telephone, or by completing a proxy card that may be delivered to you, your shares will not
be voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, &#147;For&#148; each of the
proposals, including for each nominee for director. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If you are a beneficial owner of shares held in street name and you do not instruct your broker, bank or other agent how to vote your shares, your broker, bank or other
agent may still be able to vote your shares in its discretion. In this regard, under the rules of the New York Stock Exchange, or the NYSE, brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to
vote your &#147;uninstructed&#148; shares with respect to matters considered to be &#147;routine&#148; under NYSE rules, but not with respect to &#147;non-routine&#148; matters. In this regard, we believe that Proposals Nos.&nbsp;1 and 3 are
considered to be &#147;non-routine&#148; under NYSE rules meaning that your broker may not vote your shares on those proposals in the absence of your voting instructions. However, Proposal No.&nbsp;2 is considered a &#147;routine&#148; matter under
NYSE rules, meaning that if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposal No.&nbsp;2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>If you are a beneficial owner of shares held in street name, to ensure your shares are voted in the way you would prefer, you <U>must</U> provide voting
instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Who is paying
for this proxy solicitation? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also
solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of
forwarding proxy materials to beneficial owners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">What does it mean if I receive more than one Notice? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the Notices
to ensure that all of your shares are voted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Can I change my vote after submitting my proxy? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Stockholder of Record: Shares
Registered in Your Name </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Yes. You can revoke your proxy before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke
your proxy in any one of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">You may grant a subsequent proxy by telephone or through the Internet. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">You may submit another properly completed proxy card with a later date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">You may send a timely written notice that you are revoking your proxy to our Secretary at 200 Barr Harbor Drive, Suite 200,
West Conshohocken, Pennsylvania 19428. Such notice will be considered timely if it is received at the indicated address by the close of business on Tuesday, June&nbsp;16, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Your most current proxy card or most current vote via telephone or Internet proxy will be the vote that is counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If your
shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">How are votes counted? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Votes will be counted by the inspector of election appointed for the meeting, who will separately count votes in accordance with the requirements summarized in the table
within the section caption below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">What are &#147;broker non-votes?&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">When
a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be &#147;non-routine&#148; under NYSE
rules, the broker, bank or other such agent cannot vote the shares. These un-voted shares are counted as &#147;broker non-votes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>As a reminder, if you
are a beneficial owner of shares held in street name, to ensure your shares are voted in the way you would prefer, you<U> must</U> provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive
from your broker, bank or other agent. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">What Vote is Required to Approve Each Proposal and How Are Votes Counted? </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0075c9"><B>Proposal&nbsp;1:&nbsp;Election&nbsp;of&nbsp;Directors</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The nominees for director who receive the most votes (also known as a &#147;plurality&#148; of the votes cast)
will be elected. You may vote either FOR all of the nominees, WITHHOLD your vote from all of the nominees or WITHHOLD your vote from any one or more of the nominees. WITHHOLD votes will not be included in the vote tally for the election of the
directors. Brokerage firms do not have authority to vote customers&#146; unvoted shares held by the firms in street name for the election of directors. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker
non-votes will have no effect on the results of this vote.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #e5e5e5"><B>Proposal 2: Ratify Appointment of Independent Registered Public Accounting Firm</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The vote of a majority of the shares of our common stock cast affirmatively at the Annual Meeting is required to
ratify the appointment of our independent registered public accounting firm. Abstentions are not considered votes cast and will have no effect on the results of this vote. Brokerage firms have authority to vote customers&#146; unvoted shares held by
the firms in street name on this proposal. If a broker does not exercise this authority, such broker non-votes will have no effect on the results of this vote. We are not required to obtain the approval of our stockholders to select our independent
registered public accounting firm. However, if our stockholders do not ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2020 fiscal year, our Audit Committee will reconsider its
selection.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #e5e5e5; BORDER-BOTTOM:1px solid #0075c9"><B>Proposal 3: Approve an Advisory Vote on the Compensation of our Named Executive Officers</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #e5e5e5; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #e5e5e5; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The vote of a majority of the shares of our common stock cast affirmatively at
the Annual Meeting is required to approve on an advisory basis the compensation of our named executive officers, as described in this proxy statement. Abstentions are not considered votes cast and will have no effect on the results of this vote.
Brokerage firms do not have authority to vote customers&#146; unvoted shares held by the firms in street name on this proposal. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker non-votes will have no
effect on the results of this vote. Although the advisory vote is non-binding, the Compensation Committee and the Board of Directors will review the voting results and take them into consideration when making future decisions regarding executive
compensation.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following table summarizes the applicable vote required for approval of each item of business to be transacted at the Annual
Meeting, assuming there is a quorum. In addition, the table shows the effect on the outcome of the vote of: (i)&nbsp;abstentions (or, in the case of Proposal 1, WITHHOLD votes); (ii)&nbsp;&#147;broker non-votes&#148; or shares held by brokers when a
beneficial owner of shares held in &#147;street name&#148; does not provide voting instructions for non-routine matters and, as a result, the broker/nominee is prohibited from voting those shares); and (iii)&nbsp;signed but unmarked proxy cards.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Proposal</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">Vote Required for Approval</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Effect of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Abstentions/</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Withhold</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Votes</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP
STYLE="font-size:85%; vertical-align:top"> (1)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Uninstructed&nbsp;Shares/<BR>Effect&nbsp;of&nbsp;Broker</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Non-Votes</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top"> (1)</SUP></FONT></P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Signed but</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Unmarked</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Proxy&nbsp;Cards</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP
STYLE="font-size:85%; vertical-align:top"> (2)</SUP></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.70em; text-indent:-1.20em; font-size:10pt; font-family:ARIAL">1. Election of Directors</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">Plurality of Votes Cast</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">No effect</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Not&nbsp;voted&nbsp;/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">no effect</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Voted &#147;For&#148;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">each&nbsp;nominee</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.70em; text-indent:-1.20em; font-size:10pt; font-family:ARIAL">2. Ratification of selection of independent registered public accounting firm</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">The vote of a majority of the shares of
our common stock cast affirmatively or negatively</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">No&nbsp;effect</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Not</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">applicable&#151;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">discretionary</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">vote by</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">broker</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">Voted &#147;For&#148;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.70em; text-indent:-1.20em; font-size:10pt; font-family:ARIAL">3. Advisory Vote on Compensation of Our Named Executive Officers</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">The vote of a majority of the shares of
our common stock cast affirmatively or negatively</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">No&nbsp;effect</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Not voted /</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">no&nbsp;effect</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">Voted &#147;For&#148;</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Abstentions and broker non-votes are included for purposes of determining whether a quorum is present.
</P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">If you sign and return your proxy card properly, but do not provide instructions on your proxy card as to how to vote your
shares, your shares will be voted as shown in this column, and in accordance with the judgment of the individuals named as proxies on the proxy card as to any other matter properly brought before the Annual Meeting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Under the rules of the NASDAQ Stock Market, without voting instructions from beneficial owners, brokers will have discretion to vote on the ratification of the
appointment of the independent registered public accounting firm but not on the other proposals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Is Voting Confidential? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We will keep all the proxies and voting tabulations private. We only let our Inspector of Elections examine these documents. Management will not know how you voted on a
specific proposal unless it is necessary to meet legal requirements. We will, however, forward to management any written comments you make, on the proxy card or elsewhere. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Where Can I Find the Voting Results of the Annual Meeting? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The preliminary voting
results will be announced at the Annual Meeting, and we will publish preliminary, or final results if available, in a Current Report on Form 8-K within four business days of the Annual Meeting. If final results are unavailable at the time, we file
the Form 8-K, then we will file an amended report on Form 8-K to disclose the final voting results within four business days after the final voting results are known. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">What Constitutes a Quorum for the Meeting? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The presence, in person or by proxy, of
the holders of a majority of the voting power of all outstanding shares of our common stock entitled to vote at the meeting is necessary to constitute a quorum at the meeting. Votes of stockholders of record who are deemed present at the meeting in
person or by proxy, abstentions, and broker non-votes are counted for purposes of determining whether a quorum exists. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">6</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_2"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Except as otherwise noted, the following table sets forth certain information regarding the beneficial ownership of our common stock as of April&nbsp;1, 2020 by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">each of our executive officers listed in this proxy statement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">each of our directors and director nominees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">all of our current directors and executive officers as a group; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">each stockholder known by us to own beneficially more than 5% of our common stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Shares of common
stock that may be acquired by an individual or group within 60 days of April&nbsp;1, 2020 pursuant to the exercise of options or warrants, are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or
group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. Percentage of ownership is based on 15,429,154 shares of common stock outstanding on April&nbsp;1, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Except as indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of
common stock shown to be beneficially owned by them, based on information provided to us by such stockholders. Unless otherwise indicated, the address for each director and executive officer listed is: c/o Madrigal Pharmaceuticals, Inc., 200 Barr
Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD style="width:33pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:33pt"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD style="width:30pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:30pt"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Beneficial
Owner</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Beneficially&nbsp;Owned</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.75em; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Percentage&nbsp;of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.75em; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Common&nbsp;Stock</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.75em; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Beneficially&nbsp;Owned</FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL"><I>Directors and Executive
Officers</I></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Paul A. Friedman, M.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (1)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,845,303</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">11.67</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Rebecca Taub, M.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (2)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,845,303</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">11.67</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Marc R. Schneebaum<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (3)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">185,739</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1.19</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Brian J. Lynch<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (4)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">18,813</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Remy Sukhija</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Kenneth M. Bate<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (5)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">40,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Fred B. Craves, Ph.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (6)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">4,513,921</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">29.18</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">James M. Daly<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (7)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Keith R. Gollust<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (8)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">100,452</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Richard S. Levy, M.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (9)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">49,100</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">David Milligan Ph.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (10)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">10,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">*</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">All current executive officers
and directors as a group (11 persons)<SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (11)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">6,763,828</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">41.89</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL"><I>Five Percent
Stockholders</I></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Entities Affiliated with Bay
City Capital LLC<SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (12)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">4,177,854</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">27.08</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Entities Affiliated with
HealthCor Management, L.P.<SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (13)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,088,310</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">7.05</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Capital Research Global
Investors<SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (14)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,697,119</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">10.99</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Entities Affiliated with
Wellington Management Group LLP<SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (15)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">957,146</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">6.20</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Entities Affiliated with The
Vanguard Group<SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (16)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">785,441</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">5.09</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:14pt; font-size:10pt; font-family:ARIAL">Entities Affiliated with Baker
Bros. Advisors LP <SUP STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top">(17)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,169,278</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="right">7.58</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">%</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Represents beneficial ownership of less than 1% of the shares of common stock. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes: 384,081 shares of common stock issuable upon the exercise of Dr.&nbsp;Friedman&#146;s options that are
exercisable within sixty days of April&nbsp;1, 2020; 655,540 shares of common stock owned and held by SQN, LLC, or SQN; shares held of record or in street name by Dr.&nbsp;Friedman; 8,000 shares held in a grantor retained annuity trust (the
&#147;GRAT&#148;); and the deemed beneficial ownership of shares not reflected in the foregoing clauses that are beneficially owned by his spouse, Dr.&nbsp;Taub. See footnote 2 below for Dr.&nbsp;Taub&#146;s beneficial ownership information, but
note that the shares described therein should not be double-counted with Dr.&nbsp;Freidman&#146;s shares described herein. Dr.&nbsp;Friedman is a managing member of SQN and may be deemed to share voting and investment power over our common stock
that is owned and held by SQN. Dr.&nbsp;Friedman disclaims beneficial ownership of our common stock held by SQN and the GRAT and shares of our common stock beneficially owned by Dr.&nbsp;Taub, except to the extent of his pecuniary interest therein.
</P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes: 211,978 shares of common stock issuable upon the exercise of Dr.&nbsp;Taub&#146;s options that are exercisable
within sixty days of April&nbsp;1, 2020; 655,540 shares of common stock held by SQN; shares held of record or in street name by Dr.&nbsp;Taub; 8,000 shares held in the GRAT; and the deemed beneficial ownership of shares not reflected in the
foregoing clauses that are beneficially owned by her spouse, Dr.&nbsp;Friedman. See footnote 1 above for Dr.&nbsp;Freidman&#146;s beneficial ownership information, but note that the shares described therein should not be double-counted with
Dr.&nbsp;Taub&#146;s shares described herein. Dr.&nbsp;Taub is a managing member of SQN and may be deemed to share voting and investment power over our common stock that is owned and held by SQN. The 655,540 shares held by SQN and the 8,000 shares
held by the GRAT are the same shares of our common stock as are listed in footnote 1. Dr.&nbsp;Taub disclaims beneficial ownership of our common stock held by SQN and the GRAT and shares of our common stock beneficially owned by Dr.&nbsp;Friedman,
except to the extent of her pecuniary interest therein. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 144,072 shares of common stock issuable upon the exercise of options exercisable within sixty days of
April&nbsp;1, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 18,313 shares of common stock issuable upon the exercise of options exercisable within sixty days of April 1,
2020. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Consists of 40,000 shares of common stock issuable upon the exercise of options exercisable within sixty days of
April&nbsp;1, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 4,177,854 shares of common stock held by investment entities affiliated with Bay City Capital LLC, or BCC, as set
forth in footnote 12 below, and 40,000 shares of common stock issuable upon the exercise of options exercisable within sixty days of April&nbsp;1, 2020 issued to Dr. Craves, a director of the Issuer, in connection with his service as a director of
the Issuer. Dr. Craves is a party to an agreement whereby he must transfer such stock options to BCC upon receipt. Dr.&nbsp;Craves is a managing director of BCC and thus may be deemed to share voting and investment power and therefore beneficially
own shares held by the entities listed in footnote 12. Dr.&nbsp;Craves disclaims beneficial ownership of the shares beneficially owned by the entities listed in footnote 12 except to the extent of his pecuniary interest therein.
</P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 500 shares of common stock issuable upon the exercise of outstanding options exercisable within sixty days of
April 1, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 40,000 shares of common stock issuable upon the exercise of options exercisable within sixty days of April 1,
2020, 43,975 shares of common stock owned of record by Wyandanch Partners, L.P., 11,477 shares held directly and 5,000 shares of common stock owned of record by Keith R. Gollust Roth IRA. Mr.&nbsp;Gollust is the president and sole stockholder of
Gollust Management, Inc., which is the general partner of Wyandanch Partners, L.P. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 40,000 shares of common stock issuable upon the exercise of options exercisable within sixty days of
April&nbsp;1, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 10,000 shares of common stock issuable upon the exercise of options exercisable within sixty days of
April&nbsp;1, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Percentage calculation includes common stock issuable upon the exercise of options as set forth in footnotes 1 through 10.
Common stock beneficially owned by Drs. Friedman and Taub and referenced in footnotes 1 and 2 above have not been double-counted in the number of shares beneficially owned on this line. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Information in the table and this footnote is based on disclosures made in Schedule 13D, Amendment No. 2 filed with the
SEC on December&nbsp;13, 2019. Of the 4,177,854 shares listed above, 4,089,702 shares of common stock are held by Bay City Capital Fund IV, L.P., or Fund IV, and 88,152 shares of common stock are held by Bay City Capital Fund IV Co-Investment Fund,
L.P., or Co-Invest Fund. Bay City Capital Management IV LLC, or BCC Management IV, is the general partner of Fund IV and Co-Invest Fund. BCC Management IV holds no shares of common stock directly, but is deemed to have beneficial ownership of common
stock owned by Fund IV and Co-Invest Fund due to its role as general partner of such funds. Investment and voting decisions by BCC Management IV are exercised by BCC as manager. BCC holds no shares of common stock directly. Due to its role as
manager of BCC Management IV, BCC is deemed to have beneficial ownership of common stock deemed to be beneficially owned by BCC Management IV. Dr.&nbsp;Craves is a managing director of BCC and thus may be deemed to share investment and voting power
and therefore beneficially own shares held by these entities. Dr.&nbsp;Craves disclaims beneficial ownership of the shares beneficially owned by these entities except to the extent of his pecuniary interest therein. The address for BCC and the
entities affiliated with BCC is 750 Battery Street, Suite 400, San Francisco, California 94111. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Number of shares beneficially owned is based solely upon information disclosed by the entities listed above via Amendment
No.1 to Schedule 13G filed with the SEC on February&nbsp;14, 2020. The address for the entities listed above is 55 Hudson Yards, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor, New York, New York 10001. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Number of shares beneficially owned is based solely upon information disclosed via Amendment No.&nbsp;2 to Schedule 13G
filed with the SEC on February&nbsp;14, 2020. The address for the entities listed above is 333 South Hope Street, Los Angeles, CA 90071. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Number of shares beneficially owned is based solely upon information disclosed via Schedule 13G filed with the SEC on
January 28, 2020. The address for the entities listed above is c/o Wellington Management Company, 280 Congress Street, Boston, MA 02210. </P></TD></TR></TABLE> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">8</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Number of shares beneficially owned is based solely upon information disclosed via Schedule 13G filed with the SEC
February 11, 2020. The address for the entities listed above is 100 Vanguard Blvd., Malvern, PA 19355. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Based upon information disclosed via Schedule 13G filed with the SEC on February 13, 2019 (the &#147;Baker Bros.
13G&#148;), the number of shares in the table reflects common stock of Madrigal directly held by certain affiliated funds. The shares described in the table do not include 1,969,797 shares of Common Stock that may be acquired upon conversion of
convertible preferred stock of Madrigal, subject to the limitation on conversion described in the Baker Bros. 13G. Assuming Baker Bros. Advisors LP took action to remove such conversion limitation completely, Baker Bros. Advisors LP would be deemed
to beneficially own 3,139,075 shares, or 18.04%, of Madrigal common stock. The address for the entities listed above and additional reporting persons described in the Baker Bros. 13G is c/o Baker Bros. Advisors LP, 860 Washington Street, 3rd Floor,
New York, NY 10014. </P></TD></TR></TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_3"></A>MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_4"></A>The Board of Directors </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our restated certificate of incorporation and restated bylaws provide that our business is to be managed by or under the direction of our Board of Directors. Our Board
of Directors is divided into three classes for purposes of election. One class is elected at each Annual Meeting of Stockholders to serve for a three-year term. Our Board of Directors, which consists of eight members, is classified into three
classes as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the Class&nbsp;I directors are Paul A. Friedman, M.D., Kenneth M. Bate and James M. Daly, and their terms will expire at
the Annual Meeting of Stockholders to be held in 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the Class&nbsp;II directors are Rebecca Taub, M.D. and Fred B. Craves, Ph.D., and their terms will expire at the Annual
Meeting of Stockholders to be held in 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the Class&nbsp;III directors are Keith R. Gollust, David Milligan, Ph.D. and Richard S. Levy, M.D., and their terms are
scheduled to expire at the at the Annual Meeting of Stockholders to be held in 2022. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On March&nbsp;5, 2020, our Nominating and Governance
Committee nominated Paul A. Friedman, M.D., Kenneth M. Bate, and James M. Daly, for election at the Annual Meeting for a term of three years to serve until the 2023 Annual Meeting of Stockholders, and until their respective successors have been
elected and qualified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Set forth below are the names of the persons nominated as directors and directors, their ages, their offices in the company, if any, their
principal occupations or employment for at least the past five years, the length of their tenure as directors and the names of other public companies in which such persons hold or have held directorships during the past five years. Except as
otherwise specified, such information is reflected as of April&nbsp;1, 2020. As used in certain of the following biographical descriptions, the term &#147;Private Madrigal&#148; refers to Madrigal Pharmaceuticals, Inc., a privately-held Delaware
corporation focused on developing innovative therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases prior to the consummation of the Merger; the term &#147;Merger&#148; means the July&nbsp;22, 2016 business
combination transaction and name change which involved the merger of Private Madrigal and a subsidiary of Synta and resulted in the establishment of Public Madrigal; and the term &#147;Synta&#148; refers to Synta Pharmaceuticals Corp., a publicly
traded Delaware corporation prior to the consummation of the Merger. Additionally, information is set forth below about the specific experience, qualifications, attributes or skills relevant to service on our Board of Directors. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Name</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Age</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Position</FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Kenneth M. Bate<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (1)(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">69</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Class&nbsp;I Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Fred B. Craves, Ph.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (2)(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">74</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Lead Director and Class&nbsp;II Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">James M. Daly<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (1)(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">58</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Class I Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">77</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Chairman of the Board of Directors, Chief Executive Officer and Class&nbsp;I
Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Keith R. Gollust<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (1)(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">74</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Class&nbsp;III Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Richard S. Levy, M.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (2)(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">62</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Class&nbsp;III Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">David Milligan, Ph.D.<SUP
STYLE="font-size:85%; line-height:11.0pt ; vertical-align:top"> (1)(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">79</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Class&nbsp;III Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">68</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">President, Research&nbsp;&amp; Development, Chief Medical Officer and Class&nbsp;II
Director</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Member of our Audit Committee. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Member of our Compensation Committee. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Member of our Nominating and Governance Committee. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">10</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In addition to the information presented below regarding each of our director&#146;s specific experience, qualifications, attributes and skills that led our Board to the
conclusion that he or she should serve as a director, we also believe that all of our directors have a reputation for integrity, honesty and adherence to high ethical standards. They each have demonstrated business acumen and an ability to exercise
sound judgment, as well as a commitment of service to our company and our Board of Directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Kenneth&nbsp;M.&nbsp;Bate</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 69</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Mr.&nbsp;Bate
currently works as an independent consultant. Previously, Mr.&nbsp;Bate was the President and Chief Executive Officer of Archemix Corp., a privately-held biopharmaceutical company, a position he held from April 2009 through December 2011. From 2006
to April 2009, he served in various positions at NitroMed, Inc., a publicly-held pharmaceutical company, most recently as President and Chief Executive Officer. From 2002 to 2005, Mr.&nbsp;Bate served as Head of Commercial Operations and Chief
Financial Officer at Millennium Pharmaceuticals, Inc., a biopharmaceutical company. Prior to joining Millennium Pharmaceuticals, Mr.&nbsp;Bate co-founded JSB Partners, LLC, a banking and advisory services firm for biopharmaceutical and life sciences
companies. From 1990 to 1996, Mr.&nbsp;Bate was employed with Biogen, Inc., a publicly-held biotechnology company, first as its Chief Financial Officer and then as head of the commercial organization responsible for launching its multiple sclerosis
business. Mr.&nbsp;Bate currently serves as chairman of the board of directors of the following publicly-held biopharmaceutical companies: AVEO Pharmaceuticals, Inc., Genocea Biosciences, Inc. and Catabasis Pharmaceuticals, Inc. In addition,
Mr.&nbsp;Bate currently serves on the board of directors of Epizyme, Inc., a publicly-held biopharmaceutical company. During the last five years, Mr.&nbsp;Bate also served as chairman of the board of directors of Cubist Pharmaceuticals, Inc. and as
a director of BioMarin Pharmaceuticals, Inc. and Vanda Pharmaceuticals Inc., each a publicly-held biopharmaceutical company. Mr.&nbsp;Bate holds a B.A. in Chemistry from Williams College and an M.B.A. from The Wharton School of the University of
Pennsylvania.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Mr.&nbsp;Bate&#146;s qualifications to serve on our board of directors include his operating, finance, commercial, transactional and
senior management experience in the industry, such as his experience as chief executive officer of Archemix and NitroMed, as head of commercial operations and chief financial officer at Millennium Pharmaceuticals, and as chief financial officer and
vice president of sales and marketing at Biogen, as well as his experience serving on the board of directors of other public companies in the life sciences industry.</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Fred&nbsp;B.&nbsp;Craves,&nbsp;Ph.D.</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 74</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Craves co-founded and served as Chairman of the Board of Private Madrigal, a privately-held biopharmaceutical company, from its inception in September 2011
through the Merger involving Synta, in July of 2016. Dr.&nbsp;Craves is a Managing Director and co-founder of Bay City Capital. In the course of his career, Dr.&nbsp;Craves has founded and managed several biotechnology companies. Dr.&nbsp;Craves
previously served on the boards of directors of several privately-held and publicly-held companies. Dr.&nbsp;Craves currently serves as a member of the board of directors of Synchronicity Pharma, Inc., Imidomics, Inc., and KBP Pharmaceuticals, Inc.,
each a privately-held life science company. During the past five years, Dr. Craves served as a member of the board of directors of Dermira, Inc. and Twist Bioscience, Inc., each a publicly-held life science company. Dr.&nbsp;Craves earned a B.S.
degree in biology from Georgetown University, an M.S. in biochemical pharmacology from Wayne State University and a Ph.D. in pharmacology and experimental toxicology from the University of California, San Francisco.</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Dr.&nbsp;Craves is qualified to serve on our board of directors due to his extensive experience with founding, managing and serving
on the boards of directors of life sciences companies, both public and private, and his extensive knowledge of the life sciences industry.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">James M. Daly</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 58</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">On June 27,
2019, our Board of Directors appointed James M. Daly as a member of our Board of Directors. Mr. Daly has over 30 years of experience leading U.S. and global businesses in the biopharmaceutical industry and also currently serves as a Director of
Acadia Pharmaceuticals, argenx SE, Bellicum Pharmaceuticals, and Halozyme Therapeutics. He previously served on the board of directors of Chimerix, Inc. Most recently, Mr. Daly served as Executive Vice President and Chief Commercial Officer at
Incyte Corporation from 2012 to 2015. Previously, Mr. Daly worked for Amgen, Inc. and held various leadership positions over a 10-year period, including his last role as Senior Vice President, North America Commercial Operations, Global Marketing
and Commercial Development. Earlier in his career, he spent over 16 years with Glaxo Wellcome/GlaxoSmithKline (GSK), where he held roles of increasing responsibility, including his last role as Senior Vice President, General Manager of the
Respiratory and Anti-Infective Business Unit. He earned a B.S. in Pharmacy and an M.B.A. from the University at Buffalo, The State University of New York.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Mr.&nbsp;Daly is qualified to serve as a member of our board of directors due to his extensive experience as a pharmaceutical
executive heading up major commercialization programs and given his extensive experience as a director with public biopharmaceutical companies.</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman, M.D.</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 77</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Dr. Friedman
has served as our Chairman and Chief Executive Officer since July 22, 2016. Dr.&nbsp;Friedman served as the Chief Executive Officer of Incyte Corporation, a publicly-held biopharmaceutical company, or Incyte, from November 2001 until his retirement
in January 2014 and has continuously served on the Incyte board since November 2001. Dr. Friedman also serves on the Board at Alexion Pharmaceuticals, a public company. Dr.&nbsp;Friedman served from 1994 to 1998, as President of Research&nbsp;&amp;
Development for the DuPont-Merck Pharmaceutical Company and from 1998 to 2001 as President of DuPont Pharmaceuticals Research Laboratories, a wholly-owned subsidiary of the DuPont Company. From 1991 to 1994, he served as Senior Vice President at
Merck Research Laboratories. Prior to his tenures at Merck and DuPont, Dr.&nbsp;Friedman was an Associate Professor of Medicine and Pharmacology at Harvard Medical School. Dr.&nbsp;Friedman is a diplomat of the American Board of Internal Medicine
and a member of the American Society of Clinical Investigation. He previously served on the board of directors of the following publicly-held pharmaceutical companies in the last five years: Cerulean Pharma Inc. (now Dar&eacute; Bioscience, Inc.)
(through January of 2017); Synta Pharmaceuticals Corp. (through April of 2016); and Verastem, Inc. (through April of 2017). Dr.&nbsp;Friedman received his A.B. in Biology from Princeton University and his M.D. from Harvard Medical School.
Dr.&nbsp;Friedman and Dr.&nbsp;Taub, our Chief Medical Officer, President, Research&nbsp;&amp; Development, and a director, are married.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Dr.&nbsp;Friedman is qualified to serve as Chief Executive Officer and as Chairman of our board of directors due to his: more than 40
years of experience in the biopharmaceutical industry; deep experience in research and both early and late stage clinical development; extensive experience building and leading R&amp;D organizations, expanding company pipelines of assets, and
overseeing the commercial development of innovative therapeutic products across a range of areas; and valuable perspectives to the Board as Madrigal&#146;s Chief Executive Officer.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">12</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Keith R. Gollust</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 74</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Mr.&nbsp;Gollust served on our Board since July of 2016, on the board of directors of Synta from July 2002 through the Merger in July 2016 and as Chairman of the Synta
board of directors from September 2002 through the Merger in July 2016. Mr.&nbsp;Gollust is a private investor and President of Gollust Management, Inc., the general partner of Wyandanch Partners, an investment partnership. In the past,
Mr.&nbsp;Gollust has is served as a director of numerous public and private companies, and he currently serves on the board of VINDEX, LLC, a private company. Mr.&nbsp;Gollust received a B.A. from Princeton University and an M.S.I.A. from Carnegie
Mellon University.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Mr.&nbsp;Gollust is qualified to serve as a member of our board of directors due to his experience as managing general partner of
various investment partnerships which have given him the responsibility for investing over $1&nbsp;billion as a fiduciary.</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Richard S. Levy, M.D.</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 62</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;August&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Dr. Levy has
served on Madrigal&#146;s board of directors since August of 2016. Dr.&nbsp;Levy also serves on the board of directors of Artara Therapeutics, Inc., Kodiak Sciences Inc., and Kiniksa Pharmaceuticals, Ltd., each a publicly-held pharmaceutical
company. Dr. Levy previously served on the board of Aquinox Pharmaceuticals, Inc. Previously, from December 2016 to May 2019, Dr.&nbsp;Levy was a part-time Senior Advisor for Baker Bros. Advisors, L.P., a firm that primarily manages long-term
investment funds focused on publicly traded life sciences companies. Dr.&nbsp;Levy served as Executive Vice President and Chief Drug Development Officer at Incyte from January 2009 until his retirement in April 2016, and as Senior Vice President of
Drug Development at Incyte from August 2003 to January 2009. Prior to joining Incyte, Dr.&nbsp;Levy served as Vice President, Biologic Therapies, at Celgene Corporation, a publicly-held biopharmaceutical company, from 2002 to 2003. From 1997 to
2002, Dr.&nbsp;Levy served in various executive positions with DuPont Pharmaceuticals Company, first as Vice President, Regulatory Affairs and Pharmacovigilence, and thereafter as Vice President, Medical and Commercial Strategy. Dr.&nbsp;Levy served
at Novartis, and its predecessor company Sandoz, from 1991 to 1997 in positions of increasing responsibility in clinical research and regulatory affairs. Dr.&nbsp;Levy has more than 25 years&#146; experience in the pharmaceutical and biotechnology
industries through his prior positions at Incyte, Celgene, DuPont Pharmaceuticals and Novartis, has extensive clinical research, regulatory and product development skills and has worked in multiple therapeutic areas. Prior to joining the
pharmaceutical industry, Dr.&nbsp;Levy served as an Assistant Professor of Medicine at the UCLA School of Medicine. Dr.&nbsp;Levy is Board Certified in Internal Medicine and Gastroenterology and received his A.B. in Biology from Brown University,
his M.D. from the University of Pennsylvania School of Medicine, and completed his training in Internal Medicine at the Hospital of the University of Pennsylvania and a fellowship in Gastroenterology and Hepatology at UCLA.</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Dr.&nbsp;Levy is qualified to serve on our board of directors due to his extensive and diverse experience in the pharmaceutical and
biotechnology industries.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">David Milligan, Ph.D.</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 79</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Milligan currently works as an independent consultant. Previously, Dr.&nbsp;Milligan was a partner at Bay City Capital LLC, a life sciences investment firm, a
position he held from 1997 through 2013. From 1979 to 1996, Dr.&nbsp;Milligan served in a variety of roles retiring as Senior Vice President and Chief Scientific Officer at Abbott Laboratories, a publicly-held healthcare products company.
Dr.&nbsp;Milligan currently serves as a director of Inspirotech and Minute Molecular Diagnostics, which are privately-held life sciences companies. He is also on the Board of Xoult, a life sciences software company, as well as Ekatra Inc., a company
utilizing information technology to monitor and protect valuable assets. From 2016 to 2018 he was a board member for WebLoq Inc, a privately-held information technology security company that is no longer in business. Starting in 1995,
Dr.&nbsp;Milligan served as a director of Caliper Life Sciences, a publicly-held pharmaceutical and biotechnology company that was acquired by PerkinElmer Company in 2011, as well as ICOS, a publicly-held pharmaceutical company where he was a board
member and later lead director before it was acquired by Eli Lilly in 2008. Dr.&nbsp;Milligan also served as Chairman and a director at Vicuron Pharmaceuticals, Inc., a privately-held biopharmaceutical company from 1997 to 2005 when it was acquired
by Pfizer. He was also a director of Reliant Pharmaceuticals, Inc., a privately-held pharmaceutical company from 1999 until acquired by GlaxoSmithKline, in 2007. In addition, he was a director of Pathway Diagnostics Corporation, a privately-held
diagnostics company acquired by Quest Diagnostics, Inc., and a director of Maxia Pharmaceuticals, Inc., a privately-held pharmaceutical company acquired by Incyte Corporation, from 1999 to 2003. Dr.&nbsp;Milligan received an A.B. in Chemistry from
Princeton University and an M.S. and Ph.D. in Organic Chemistry from the University of Illinois.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Dr.&nbsp;Milligan&#146;s qualifications to serve on our board of directors include his operating, finance, commercial, transactional
and senior management experience in the life sciences industry, as well as his experience serving on the boards of directors of publicly- and privately-held companies in the life sciences industry.</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub, M.D.</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Age: 68</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL">Director&nbsp;Since:&nbsp;July&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Biographical Information</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Taub
has been a member of our Board of Directors since July 2016 and has served as our President, Research &amp; Development since June 2019 and our Chief Medical Officer since July 2016. She also served as Executive Vice President, Research &amp;
Development, from July 2016 through June 2019. Dr. Taub served on the board of directors of Private Madrigal and as Chief Executive Officer of Private Madrigal from its inception in September 2011 through the Merger in July 2016. Prior to joining
Private Madrigal, Dr.&nbsp;Taub served as Senior Vice President, Research and Development of VIA Pharmaceuticals from 2008 to 2011 and as Vice President, Research, Metabolic Diseases at Hoffmann-La Roche from 2004 to 2008. In those positions,
Dr.&nbsp;Taub oversaw clinical development and drug discovery programs in cardiovascular and metabolic diseases including the conduct of a series of Phase I and II proof of conduct clinical trials. Dr.&nbsp;Taub led drug discovery including target
identification, lead optimization and advancement of preclinical candidates into clinical development. From 2000 through 2003, Dr.&nbsp;Taub worked at Bristol-Myers Squibb Co. and DuPont Pharmaceutical Company, in a variety of positions, including
Executive Director of CNS and metabolic diseases research. Before becoming a pharmaceutical executive, Dr.&nbsp;Taub was a tenured Professor of Genetics and Medicine at the University of Pennsylvania, and remains an adjunct professor. Dr.&nbsp;Taub
is the author of more than 120 research articles. Before joining the faculty of the University of Pennsylvania, Dr.&nbsp;Taub served as an Assistant Professor at the Joslin Diabetes Center of Harvard Medical School, Harvard University and an
associate investigator with the Howard Hughes Medical Institute. Dr.&nbsp;Taub received her M.D. from Yale University School of Medicine and B.A. from Yale College. Dr.&nbsp;Taub and Dr.&nbsp;Friedman, our Chief Executive Officer and Chairman of the
Board of Directors, are married.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER:1px solid #e5e5e5; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-right:0.60em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Qualifications</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-right:0.67em; font-size:9pt; font-family:ARIAL">We believe that Dr.&nbsp;Taub is qualified to serve as Chief Medical Officer, President, Research and Development and a member of our board of
directors due to her extensive experience as a pharmaceutical executive heading up major development programs in non-alcoholic steatohepatitis, or NASH.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">14</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_5"></A>Director Independence </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of Directors has reviewed
the materiality of any relationship that each of our directors has with our company, either directly or indirectly. Based on this review, our Board of Directors has determined that each of its current and nominated directors is independent under
applicable listing standards of the NASDAQ Stock Market LLC, or NASDAQ, other than Dr.&nbsp;Friedman, who is our Chief Executive Officer, and Dr.&nbsp;Taub, who is our Chief Medical Officer and President, Research&nbsp;&amp; Development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_6"></A>Committees of the Board of Directors and Meetings </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Meeting Attendance </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of Directors held four meetings and acted
one time by unanimous written consent in lieu of a meeting during 2019. Our Board of Directors has an Audit Committee, a Compensation Committee, and a Nominating and Governance Committee. Each director attended or participated in 75% or more of the
aggregate of (i)&nbsp;the total number of meetings of the Board of Directors and (ii)&nbsp;the total number of meetings held by all committees of the Board of Directors on which he or she served during 2019. The Board of Directors has adopted a
policy under which each member of the Board of Directors is encouraged, but not required, to attend each Annual Meeting of Stockholders. Each member of our Board of Directors at the time of our 2019 Annual Meeting of Stockholders attended such
Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Audit Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Audit Committee is composed of
Messrs. Bate (chairman), Daly and Gollust and Dr.&nbsp;Milligan. Our Audit Committee held four meetings during 2019. Our Board of Directors has determined that each member of the Audit Committee is independent under SEC rules and the applicable
listing standards of NASDAQ, as such rules and standards apply specifically to members of audit committees. Our Board of Directors has determined that Mr.&nbsp;Bate is an &#147;audit committee financial expert,&#148; as the SEC has defined that
term, and has the requisite financial sophistication in accordance with applicable NASDAQ listing standards. Please also see the report of the Audit Committee set forth elsewhere in this proxy statement. Our Audit Committee&#146;s role and
responsibilities are set forth in the Audit Committee&#146;s written charter and include the authority to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">approve and retain the independent auditors to conduct the annual audit of our consolidated financial statements;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">review the proposed scope and results of the audit; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">review and pre-approve the independent auditor&#146;s audit and non-audit services rendered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">approve the audit fees to be paid; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">review accounting and financial controls with the independent auditors and our financial and accounting staff;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">review and approve transactions between us and our directors, officers and affiliates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">recognize and prevent prohibited non-audit services; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">establish procedures for complaints received by us regarding accounting matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">oversee internal audit functions, if any; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">prepare the report of the Audit Committee that the rules of the SEC require to be included in our Annual Meeting proxy
statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">A copy of the Audit Committee&#146;s written charter is publicly available through the &#147;Investors&#151;Corporate Governance&#148;
section of our website at<I> www.madrigalpharma.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Compensation Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Compensation Committee is composed of
Mr.&nbsp;Bate and Drs. Craves, Levy (chairman) and Milligan. Our Compensation Committee held three meetings and acted one time by unanimous written consent in lieu of a meeting during 2019. Our Board of Directors has determined that each member of
the Compensation Committee is independent under SEC rules and the applicable listing standards of NASDAQ. Our Compensation Committee&#146;s role and responsibilities are set forth in the Compensation Committee&#146;s written charter and include the
authority to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">review and establish the compensation arrangements for management, including the compensation for our Chief Executive
Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">establish and review general compensation policies with the objective to attract and retain superior talent, to reward
individual performance and to achieve our financial goals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">administer our stock incentive plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">review the Compensation Discussion and Analysis, or CD&amp;A, discuss the CD&amp;A with management and, based on such
review and discussions, recommend to our Board of Directors that the CD&amp;A be included in our Annual Report on Form 10-K, Annual Meeting proxy statement, or any other applicable filing as required by the SEC; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">prepare the report of the Compensation Committee that SEC rules require to be included in our Annual Meeting proxy
statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Compensation Committee is charged with establishing a compensation policy for our executives and directors that is designed to
attract and retain the best possible executive talent, to motivate them to achieve corporate objectives, and reward them for superior performance. Our Compensation Committee is also responsible for establishing and administering our executive
compensation policies and equity compensation plans. The Compensation Committee meets at least twice per year and more often as necessary to review and make decisions with regard to executive compensation matters. As part of its review of executive
compensation matters, the Compensation Committee may delegate any of the powers given to it to a subcommittee of the committee consisting of one or more members of the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Compensation Committee has the authority to directly retain the services of independent consultants and other experts to assist in fulfilling its responsibilities.
In October 2016, the Compensation Committee engaged Compensia, Inc., or Compensia, as its independent compensation consultant, continuing through to the present. Compensia was engaged to review all aspects of our executive compensation programs. As
described in the CD&amp;A, Compensia assists the Compensation Committee in defining the appropriate peer companies for executive compensation and practices and in benchmarking our executive compensation program against the peer group. The
Compensation Committee also uses information obtained from Compensia for evaluating our executive compensation practices, including measuring the competitiveness of our practices, and to review our cash bonus policy, equity awards, and base salary
benchmarks across all levels of the Company. The Compensation Committee has assessed the independence of Compensia pursuant to SEC rules and the corporate governance rules of NASDAQ and concluded that no conflict of interest exists that would
prevent Compensia from independently representing the Compensation Committee. In compliance with SEC rules and the corporate governance rules of NASDAQ, Compensia provided the Compensation Committee with a letter addressing each of the six
independence factors. Their responses affirm the independence of Compensia and the partners, consultants, and employees who service the Compensation Committee on executive compensation matters and governance issues. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Please also see the CD&amp;A and the report of the Compensation Committee set forth elsewhere in this proxy statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">A copy of the Compensation Committee&#146;s written charter is publicly available through the &#147;Investors&#151;Corporate Governance&#148; section of our website
at<I> www.madrigalpharma.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">16</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Nominating and Governance Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Nominating and Governance
Committee is composed of Drs. Craves and Levy and Messrs.&nbsp;Daly and Gollust (chairman). Our Nominating and Governance Committee held one meeting during 2019. Our Board of Directors has determined that each member of the Nominating and Governance
Committee is independent under SEC rules and the applicable listing standards of NASDAQ. Our Nominating and Governance Committee&#146;s role and responsibilities are set forth in the Nominating and Governance Committee&#146;s written charter and
include the authority to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">identify and nominate members of the Board of Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">develop and recommend to the Board of Directors a set of corporate governance principles applicable to our company; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">oversee the evaluation of the Board of Directors and management. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In future annual meetings, if a stockholder wishes to propose to nominate a director for election and include such candidate proposal in our proxy statement, in order
to be properly considered by our Nominating and Governance Committee, such proposal must follow the procedures described below as well as under our bylaws, as summarized under &#147;Stockholder Proposals at Future Annual Meetings&#148; at the end of
this proxy statement (our &#147;Bylaw Provisions Related to Stockholder Nominations of Director Candidates&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Nominating and Governance Committee may
consider candidates recommended by stockholders as well as from other sources such as other directors or officers, third-party search firms or other appropriate sources. For all potential candidates, our Nominating and Governance Committee may
consider all factors it deems relevant, such as a candidate&#146;s personal integrity and sound judgment, business and professional skills and experience, independence, knowledge of the industry in which we operate, possible conflicts of interest,
diversity, the extent to which the candidate would fill a present need on the Board of Directors, and concern for the long-term interests of the stockholders. Director candidates nominated by stockholders for election at an Annual Meeting must be
made in accordance with our Bylaw Provisions Related to Stockholder Nominations of Director Candidates, and are subject to the following requirements and/or considerations. Our Nominating and Governance Committee will consider a recommended nominee
from any stockholder or group of affiliated stockholders, and such recommending stockholder or group must have held at least 5% of our common stock for at least one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Additionally, stockholder recommendations for proposed director nominees must be in writing to the Nominating and Governance Committee, care of our Secretary at 200
Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428. The recommendation must be accompanied by the following information concerning the recommending stockholder: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">name, address and telephone number of the recommending stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the number of shares of our common stock owned by the recommending stockholder and the time period for which such shares
have been held; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">if the recommending stockholder is not a stockholder of record, a statement from the record holder verifying the holdings
of the recommending stockholder and a statement from the recommending stockholder of the length of time such shares have been held (alternatively the recommending stockholder may furnish a current Schedule 13D, Schedule 13G, Form 3, Form 4 or Form 5
filed with the SEC, together with a statement of the length of time that the shares have been held); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a statement from the recommending stockholder as to a good faith intention to continue to hold such shares through the date
of the next Annual Meeting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The recommendation must also be accompanied by the following information concerning the proposed director nominee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the information required by Items 401, 403 and 404 of Regulation S-K under the Securities Act of 1933, as amended, or the
Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a description of all relationships between the proposed nominee and the recommending stockholder, including any agreements
or understandings regarding the nomination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a description of all relationships between the proposed nominee and any of our competitors, customers, suppliers, labor
unions or other persons with special interests regarding our company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the contact information of the proposed nominee. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The recommending stockholder must also furnish a statement supporting a view that the proposed nominee possesses the minimum qualifications as set forth below for
director nominees and describing the contributions that the proposed nominee would be expected to make to the Board of Directors and to the governance of our company and must state whether, in its view, the proposed nominee, if elected, would
represent all stockholders and not serve for the purpose of advancing or favoring any particular stockholder or other constituency of our company. The recommendation must also be accompanied by the written consent of the proposed nominee (1)&nbsp;to
be considered by the Nominating and Governance Committee and interviewed if the committee chooses to do so in its discretion, and (2)&nbsp;if nominated and elected, to serve as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">For all potential candidates, the Nominating and Governance Committee may consider all factors it deems relevant, including the following threshold criteria: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">candidates should possess the highest personal and professional standards of integrity and ethical values;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">candidates must be committed to promoting and enhancing the long-term value of our company for our stockholders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">candidates must be able to represent fairly and equally all stockholders without favoring or advancing any particular
stockholder or other constituency of our company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">candidates must have demonstrated achievement in one or more fields of business, professional, governmental, community,
scientific or educational endeavor, and possess mature and objective business judgment and expertise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">candidates are expected to have sound judgment, derived from management or policy making experience that demonstrates an
ability to function effectively in an oversight role; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">candidates must have, and be prepared to devote, adequate time to the Board of Directors and its committees.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Nominating and Governance Committee considers diversity of experience as one of the factors it considers in conducting its assessment of
director nominees, along with such other factors as it deems appropriate given the then current needs of the Board and the company, to maintain a balance of knowledge, experience and capability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In addition, the Nominating and Governance Committee will also take into account the extent to which the candidate would fill a present need on the Board of Directors,
including the extent to which a candidate meets the independence and experience standards promulgated by the SEC and by NASDAQ. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">A copy of the Nominating and
Governance Committee&#146;s written charter is publicly available through the &#147;Investors&#151;Corporate Governance&#148; section of our website at<I> www.madrigalpharma.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">18</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Compensation Committee Interlocks and Insider Participation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our
Compensation Committee is composed of Mr.&nbsp;Bate and Drs. Craves, Levy and Milligan. No member of our Compensation Committee has at any time been an employee of our company. None of our executive officers serve as a member of the board of
directors or compensation committee of any entity that has one or more executive officers serving as a member of our Board of Directors or Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_7">
</A>Board Leadership Structure </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Currently, our Chief Executive Officer, Dr.&nbsp;Friedman, serves as Chairman of our Board of Directors. Our Board of Directors
believes that Dr.&nbsp;Friedman is the director best situated to identify strategic opportunities for our company and to focus the activities of our Board of Directors due to his full-time commitment to our business operations. Our Board of
Directors also believes that Dr.&nbsp;Friedman&#146;s dual roles as Chairman of the Board and Chief Executive Officer promotes effective execution of our business strategy and facilitates information flow between management and our Board of
Directors. Our Board of Directors has appointed Fred Craves as lead independent director to enhance the independence of our Board leadership function. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of
Directors has determined that maintaining the independence of a majority of our directors helps maintain the Board&#146;s independent oversight of management and ensures that the appropriate level of independence is applied to all Board decisions.
Moreover, in addition to feedback provided during the course of Board meetings, the independent directors conduct regular executive sessions without the presence of Dr.&nbsp;Friedman, Dr.&nbsp;Taub or any other members of management. Our Audit,
Compensation, and Nominating and Governance Committees, each consisting of independent directors, oversee critical matters such as our accounting policies, financial reporting processes, internal control assessment over financial reporting,
executive compensation program, and selection and evaluation of our directors and director nominees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_8"></A>Our Board of Directors&#146; Role in
Risk Oversight </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of Directors has overall responsibility for risk oversight, including, as part of regular Board and committee meetings, general oversight
of our executive officers&#146; management of risks relevant to us. A fundamental part of risk oversight is not only understanding the material risks our company faces and the steps management is taking to manage those risks, but also understanding
what level of risk is appropriate for us. The involvement of our Board of Directors in reviewing our business strategy is an integral aspect of its assessment of our management&#146;s tolerance for risk and also its determination of what constitutes
an appropriate level of risk for us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">While it has overall responsibility for risk oversight, our Board of Directors has delegated oversight responsibility related
to certain risks to committees of the Board. Our Audit Committee is responsible for reviewing our policies with respect to risk assessment and risk management, as well as coordinating our internal control over financial reporting, disclosure
controls and procedures and code of conduct. Our Audit Committee receives regular reports from officers responsible for oversight of particular risks within our company at its regularly scheduled meetings and other reports as requested by our Audit
Committee from time to time. The Nominating and Governance Committee reviews our risks associated with governance matters and non-compensation related human resources matters. In addition, our Compensation Committee has authority to oversee risks as
to our compensation programs and discusses with management its annual assessment of our employee compensation policies and programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of Directors
satisfies its overall responsibility through full reports by each committee chair regarding the committee&#146;s considerations and actions, as well as through regular reports directly from relevant officers within our company. Our Board of
Directors believes that full and open communication between management and the board is essential for effective risk management and oversight. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_9"></A>Stockholder Communications to the Board </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Generally,
stockholders who have questions or concerns should contact our Investor Relations department at<I> ir@madrigalpharma.com</I>. However, any stockholders who wish to address questions regarding our business directly with the Board of Directors, or any
individual director, must prepare the communication in written form and mail or hand deliver the same to the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>ATTN: SECURITY HOLDER
COMMUNICATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Madrigal Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">200 Barr Harbor Drive, Suite 200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">West Conshohocken, PA 19428 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Such communications should not exceed 500 words in length and must be accompanied by the following information: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a statement of the type and amount of the securities of our company that the person holds; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">any special interest, meaning an interest not in the capacity as a stockholder of our company, that the person has in the
subject matter of the communication; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the address, telephone number and e-mail address, if any, of the person submitting the communication.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following types of communications are not appropriate for delivery to directors under these procedures: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">communications regarding individual grievances or other interests that are personal to the party submitting the
communication and could not reasonably be construed to be of concern to security holders or other constituencies of our company (such as employees, members of the communities in which we operate our businesses, customers and suppliers) generally;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">communications that advocate engaging in illegal activities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">communications that, under community standards, contain offensive, scurrilous or abusive content; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">communications that have no rational relevance to the business or operations of our company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Communications will be distributed to the Board of Directors, or to any individual director or directors as appropriate, depending on the facts and circumstances
outlined in the communications. Items that are unrelated to the duties and responsibilities of the Board of Directors may be excluded, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">junk mail and mass mailings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">r&eacute;sum&eacute;s and other forms of job inquiries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">surveys; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">solicitations or advertisements. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In addition, any material that is unduly hostile, threatening, or illegal in nature may be excluded, provided that any communication that is filtered out will be made
available to any outside director upon request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">20</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">MANAGEMENT AND CORPORATE GOVERNANCE </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_10"></A>Information About Our Executive Officers </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following
table sets forth certain information regarding our executive officers as of April&nbsp;1, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Name</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Age</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Position</FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">77</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Chairman of the Board and Chief Executive Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub,
M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">68</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">President, Research&nbsp;&amp; Development, and Chief Medical Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Remy Sukhija</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">48</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Senior Vice President, Chief Commercial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Marc R.
Schneebaum</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">65</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Senior Vice President, Chief Financial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; line-height:14pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Brian J. Lynch</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL" ALIGN="center">58</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:10pt; font-family:ARIAL">Senior Vice President and General Counsel</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Paul A. Friedman, M.D.</I> Dr.&nbsp;Friedman&#146;s biographical information is set forth above under &#147;Management and Corporate
Governance&#151;The Board of Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Rebecca Taub, M.D.</I> Dr.&nbsp;Taub&#146;s biographical information is set forth above under &#147;Management and
Corporate Governance&#151;The Board of Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Remy Sukhija</I>, who joined Madrigal as Senior Vice President, Chief Commercial Officer, on
April&nbsp;1, 2020, has over 25 years of commercial experience with large pharmaceutical and biopharmaceutical companies. Before joining Madrigal, from January of 2017 to March of 2020, Mr.&nbsp;Sukhija served as Senior Vice President, US
Commercial, for Otsuka Pharmaceutical, and also as CEO of Otsuka Digital Health, Inc. from June of 2018 to June of 2019. From May of 2015 to December of 2016, Remy was Chief Operating Officer for Merganser Biotech, Inc. From April 2010 to April
2015, Mr.&nbsp;Sukhija served as Vice President and Business Unit Head for Biogen. While at Biogen, Remy was responsible for building a commercial organization in support of the launch of two rare disease therapies (ALPROLIX and ELOCTATE), and he
was a member of the U.S. leadership team responsible for the $5 billion per year U.S. affiliate and launch of Tecfidera<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Plegridy<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
for multiple sclerosis. Earlier in his career, he held positions of increasing responsibility for Pfizer and GlaxoSmithKline. Mr.&nbsp;Sukhija earned his degree in business from The University of Akron. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Marc R. Schneebaum</I> joined us as our Senior Vice President and Chief Financial Officer in July 2016. Mr.&nbsp;Schneebaum served as Synta&#146;s Senior Vice
President and Chief Financial Officer from December 2014 through the Merger in July 2016. Mr.&nbsp;Schneebaum has over 25 years of experience in the biotechnology and healthcare sector. Prior to joining Synta, Mr.&nbsp;Schneebaum served as a
consultant in the healthcare industry. From 2011 to 2013, Mr.&nbsp;Schneebaum served as President, Chief Executive Officer and a director of Predictive BioSciences, Inc., a commercial stage cancer diagnostics company. From 1997 to 2010, he served as
President, Chief Executive Officer, and a director of Sensors for Medicine and Science, Inc., an emerging medical technology company. From 1991 to 1997, he served as Senior Vice President, Finance, Business Development and Administration, and Chief
Financial Officer of Genetic Therapy, Inc., a biotechnology company (acquired by Sandoz/Novartis). From 1987 to 1991, Mr.&nbsp;Schneebaum was a Vice President at Alex. Brown&nbsp;&amp; Sons Incorporated, a leading investment banking firm, where he
participated in a variety of finance and strategic assignments. Mr.&nbsp;Schneebaum began his career in the accounting and auditing group at KPMG LLP, advancing to Senior Manager in the management consulting group. Mr.&nbsp;Schneebaum served as a
director of GenVec, Inc., a publicly-held biopharmaceutical company acquired by Intrexon Corporation, from 2007 to 2017. Mr.&nbsp;Schneebaum earned his B.S. in Business Administration, Accounting from the University of Maryland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Brian J. Lynch</I> has served as our Senior Vice President and General Counsel since February of 2019. Brian has over 33 years of legal experience, including over 28
years in private practice. Brian has served as a Partner in leading law firms headquartered in Philadelphia (Morgan, Lewis&nbsp;&amp; Bockius and Drinker Biddle&nbsp;&amp; Reath), Washington, DC (Hogan Lovells) and Silicon Valley (Cooley), and a
significant portion of his private practice experience was focused on serving life sciences companies. In addition to his law firm experience, Mr.&nbsp;Lynch served as our Consulting General Counsel (from July of 2018 through February of 2019) and
in public service in Washington, DC (from 1987 -1990) in the Division of Corporation Finance at the Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_11"></A><A NAME="tx878734_1"></A>COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Table of Contents </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#ffffff">Page</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A HREF="#tx878734_1">COMPENSATION DISCUSSION AND
 ANALYSIS</A></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">22</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#tx878734_2">Madrigal&#146;s Focus and its Achievements in 2019
</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">22</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#tx878734_3">2019 Executive Compensation
Highlights</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">24</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#tx878734_4">Overview of Our Executive Compensation
Program</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">24</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#tx878734_5">Direct Compensation Components</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">26</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#tx878734_6">Executive Compensation and
Risk-Taking</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">30</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL"><A HREF="#tx878734_7">Advisory Vote on Executive
Compensation</A></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">30</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">This Compensation Discussion and Analysis, or CD&amp;A, explains the policies and objectives underlying our executive compensation
program as it relates to the following &#147;named executive officers&#148; whose compensation information is presented in the tables following this discussion under &#147;Executive Officer and Director Compensation&#148; in accordance with SEC
rules: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="74%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12.0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;&nbsp;Name</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12.0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Position</FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Paul A. Friedman, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Chief Executive Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Rebecca Taub, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">President, Research&nbsp;&amp; Development, and Chief Medical Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Marc R. Schneebaum</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Senior Vice President, Chief Financial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Brian J. Lynch</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Senior Vice President and General Counsel</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_12"></A><A NAME="tx878734_2"></A>Madrigal&#146;s Focus and its Achievements in 2019 </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><I>Our Focus</I>. We are a clinical-stage biopharmaceutical company focused on the development and commercialization of
innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Our lead product candidate, resmetirom, is a proprietary, liver-directed, selective thyroid hormone receptor-&szlig;, or THR-&szlig;, agonist being
developed as a once-daily oral pill that can potentially be used to treat a number of disease states with high unmet medical need, including non-alcoholic steatohepatitis, or NASH. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><I>Our Patient Market Opportunity. </I>NASH is a serious inflammatory form of nonalcoholic fatty liver disease, or NAFLD.
NAFLD has become the most common liver disease in the United States and other developed countries and is characterized by an accumulation of fat in the liver with no other apparent causes. NASH can progress to cirrhosis or liver failure, require
liver transplantation and can also result in liver cancer. Progression of NASH to end stage liver disease will soon surpass all other causes of liver failure requiring liver transplantation. Importantly, beyond these critical conditions, NASH and
NAFLD patients additionally suffer heightened cardiovascular risk and, in fact, die more frequently from cardiovascular events than from liver disease. NASH and NAFLD have grown as a consequence of rising worldwide obesity-related disorders. In the
United States alone, NAFLD is estimated to affect approximately 27% to 34% of the population, or an estimated 86 million to 108 million people, and approximately 10% to 20% of this population is projected to progress from NAFLD to NASH. Current
estimates place NASH prevalence at approximately nine million to 15 million people in the United States, or three percent to five percent of the population, with similar prevalence in Europe and Asia. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><I>Our Completed Studies</I>. For NASH, we enrolled 125 patients in a Phase 2 clinical trial with resmetirom. We achieved
the 12-week primary endpoint for this Phase 2 clinical trial and reported the results in December 2017, and we reported positive topline 36-week results at the conclusion of the Phase 2 clinical trial in May 2018. We
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">22</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD VALIGN="top">have completed treatment in a 36-week, open-label extension study in 31 participating NASH patients from our Phase 2 clinical trial, which includes 14 patients who received placebo in the main study. We also completed a 116 patient
Phase 2 clinical trial and announced results in February 2018 for the use of resmetirom in patients with heterozygous familial hypercholesterolemia. In addition to the foregoing clinical trials, resmetirom has also been studied in eight completed
Phase 1 trials in a total of 219 subjects. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><I>Our MAESTRO-NASH Phase 3 Clinical Trial</I>. On March&nbsp;28, 2019, the Company announced that it had initiated
MAESTRO-NASH, a Phase 3 trial in NASH with its once daily, oral thyroid hormone receptor beta selective agonist, resmetirom. This double-blind, placebo-controlled study will be conducted at more than 150 sites in the United States and the rest of
the world. Patients with liver biopsy confirmed NASH with stage 2 or 3 fibrosis will be randomized 1:1:1 to receive a single oral daily dose of placebo, resmetirom 80 mg or resmetirom 100 mg. A second liver biopsy at week 52 in the first 900
patients will be the basis of filing for subpart H-accelerated approval; the primary endpoint will be the percent of patients treated with either dose of resmetirom as compared with placebo who achieve NASH resolution on the week 52 liver biopsy,
defined as the absence of hepatocyte ballooning (score=0), and minimal lobular inflammation (score 0-1), associated with at least a 2-point reduction in NAS, and no worsening of fibrosis stage. Two key secondary endpoints are reduction in
LDL-cholesterol and a 1-point or more improvement in fibrosis stage on the week 52 biopsy with no worsening of NASH. Patients will continue in the study for a total of approximately 54 months, and will be evaluated for a composite clinical outcome
including cirrhosis on liver biopsy, or a liver related event such a hepatic decompensation. The total anticipated enrollment is approximately 2,000 patients, and will include up to 15% high risk F1 fibrosis stage NASH patients whose efficacy
responses will be evaluated as exploratory endpoints. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><I>FDA Track designation for resmetirom in NASH</I>.&nbsp;In October 2019, FDA granted Fast Track designation to resmetirom
for NASH. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><I>Our MAESTRO-NAFLD-1 Phase 3 Clinical Trial</I>. On December&nbsp;10, 2019 the Company announced it had opened for
enrollment MAESTRO-NAFLD-1, a 52-week, double-blind, placebo controlled Phase 3 clinical study in 700 patients with biopsy-confirmed or presumed NASH recruited from sites in the U.S. Key endpoints are safety, including safety biomarkers, LDL
cholesterol, lipid biomarkers, and fibrosis biomarkers. Except for serial liver biopsies, the study protocol is similar to the MAESTRO-NASH study with resmetirom doses of 80 mg or 100 mg or placebo and includes key secondary lipid, MRI-PDFF and NASH
biomarker endpoints. MAESTRO-NAFLD-1 also includes a 100 mg resmetirom open label arm in up to 100 patients. Unlike MAESTRO-NASH, MAESTRO-NAFLD-1 is a non-biopsy study and represents a &#147;real-life&#148;&nbsp;NASH&nbsp;study.&nbsp;NASH&nbsp;or
presumed&nbsp;NASH&nbsp;is documented using historical liver biopsy or non-invasive techniques including fibroscan and MRI-PDFF. Using non-invasive measures, MAESTRO-NAFLD-1 is designed to provide incremental safety information to support
the&nbsp;NASH&nbsp;indication as well as provide additional data regarding clinically relevant key secondary efficacy endpoints to better characterize the potential clinical benefits of resmetirom on cardiovascular and liver related endpoints. These
key secondary endpoints include LDL-cholesterol, apolipoprotein B and triglyceride (TG) lowering; reduction of liver fat as determined by magnetic resonance imaging, proton density fat fraction (MRI-PDFF); and reduction of PRO-C3,
a&nbsp;NASH&nbsp;fibrosis biomarker. Additional secondary and exploratory endpoints will be assessed including reduction in liver enzymes, fibroscan scores and other fibrosis and inflammatory biomarkers.&nbsp;The MAESTRO-NAFLD-1 study will help
support the adequacy of the safety database at the time of NDA submission for subpart H approval for treatment of NASH in patients with F2 or F3 fibrosis (MAESTRO-NASH, NASH resolution surrogate endpoint). </P></TD></TR></TABLE>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_13"></A><A NAME="tx878734_3"></A>2019 Executive Compensation Highlights </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">As discussed in this CD&amp;A, the Compensation Committee strives to create a positive relationship between our compensation program and our operational performance and
stockholder return. The Compensation Committee established our 2019 compensation program and the associated corporate goals in accordance with this philosophy based on our business plans and objectives. Our compensation practices keep the best
interests of our stockholders in mind. Below is a summary of the best practices that we have implemented: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">In order to assure that the compensation programs for our executive officers remain competitive with peer companies,
accomplish our pay-for-performance objectives, and create rewards for the realization of our long-term strategic objectives, the Compensation Committee works with a compensation consultant, Compensia, to obtain the advice and market data needed to
structure compensation programs consistent with these goals. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">The Compensation Committee approved an increase in base salaries for executive officers in 2019 to bring executive salaries
in line with peer companies; as discussed in greater detail below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">The Compensation Committee continued the Company&#146;s cash bonus program in 2019 to provide our executive officers with a
direct financial incentive in the form of a cash bonus award tied to our achievement of pre-established objectives, including clinical, research and development, business, finance and investor relations, commercial and hiring objectives for the 2019
year. The performance goals had to be attained at a minimum threshold of 75% in order for a bonus to be paid. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">We do not offer a defined benefit pension plan, deferred compensation plan or supplemental executive retirement plan.
Instead, in 2019 we relied on equity compensation in the form of stock options in order to attract and retain key employees, align the interests of our executive officers with those of our stockholders and to provide our executive officers and other
employees with the opportunity to accumulate retirement income. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">The Compensation Committee annually assesses whether our compensation programs have potential risks that are reasonably
likely to have a material adverse effect on the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">We do not offer any significant perquisites or personal benefits to our executive officers. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_14"></A><A NAME="tx878734_4"></A>Overview of Our Executive Compensation Program </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Corporate Governance and the Role of the Compensation Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The
Compensation Committee assists the Board of Directors in fulfilling its fiduciary responsibilities with respect to the oversight of our compensation plans, policies and programs, especially those regarding executive compensation and employee
benefits. The Compensation Committee&#146;s responsibilities include reviewing and establishing the compensation arrangements for management, including the compensation for our Chief Executive Officer, and establishing and reviewing general
compensation policies with the objective to attract and retain industry-leading talent, to reward individual performance and to achieve our financial goals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Objectives of the Company&#146;s Compensation Program </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We are focused on
developing and commercializing innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. To achieve this objective, we have recruited executives with significant industry or scientific experience,
including in the areas of commercialization, development and research. The biotechnology industry is very competitive and our success depends upon our ability to attract and retain qualified executives through competitive compensation packages. The
Compensation Committee administers the compensation programs for our executive&nbsp;officers with this competitive environment in mind. The Compensation Committee believes our compensation program must balance (1)&nbsp;long-term incentives that
create rewards for the realization of our long-term strategic objectives and (2)&nbsp;near-term compensation that rewards our executives for the achievement of annual goals. We believe this approach motivates the attainment of our long-term
objectives and aligns the interests of our executives with those of our stockholders. At the same time, our compensation programs have to be designed to serve as an important retention tool. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">24</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">To this end, the primary objectives of our compensation program are to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Enable us to attract and retain highly qualified executives with extensive industry or scientific experience by providing a
competitive compensation package that includes long-term incentives that provide significant retentive value; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Reward our executives for our success in achieving significant operational goals; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Align the interests of our executives with those of our stockholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Executive Compensation Determination Procedures and Policies </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The
Compensation Committee reviews executive compensation annually. As part of this process, our Chief Executive Officer makes recommendations to the Compensation Committee with respect to the compensation levels for individual executives other than
himself. The Compensation Committee reviews this information and adjusts or approves the recommendations as appropriate. In making its determination for each named executive officer, the Compensation Committee considers our performance against
established performance objectives and market data regarding executive compensation at comparable companies. In the case of our Chief Executive Officer, the Compensation Committee evaluates his performance against our established performance
objectives and market data regarding executive compensation at comparable companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In October 2016, the Compensation Committee initially retained the services of
Compensia to review all aspects of our executive compensation. Since then we have continued to work with Compensia, which assists the Compensation Committee in defining the appropriate peer companies for executive compensation and practices and in
benchmarking our executive compensation program against the peer group. The Compensation Committee uses the information obtained from Compensia primarily for evaluating our executive compensation practices, including measuring the competitiveness of
our practices. The Compensation Committee also uses information obtained from Compensia to review our cash bonus policy, equity awards, and base salary benchmarks across all levels of the company. The Compensation Committee determined that Compensia
was independent pursuant to SEC rules and the corporate governance rules of NASDAQ and concluded that no conflict of interest exists that would prevent Compensia from independently representing the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Comparative Analysis </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">For purposes of measuring the competitive positioning
of our compensation packages, peer companies are generally selected by the Compensation Committee with input from Compensia, primarily using the following criteria: (i)&nbsp;publicly-held pre-commercial U.S. biotechnology companies, and
(ii)&nbsp;companies that fall within a specific market capitalization range relative to our market capitalization at the time of the peer evaluation. Because the biotechnology industry is a dynamic industry, the comparator group used by the
Compensation Committee to measure the competitive positioning of our compensation packages is periodically updated to ensure that companies continue to meet the established criteria. During the 2019 year, adjustments to peer group composition were
made for a number of factors, including adjustments associated with market capitalization alignment between Madrigal and the peer group of companies, phase of development alignment between Madrigal and the peer group of companies and the occurrence
of acquisitions of peer companies, each of which occurred subsequent to the 2018 determination of our peer group. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The selected comparable companies for purposes of measuring the competitive positioning of the base salary, cash incentive bonus and equity compensation elements of the
compensation packages in 2019 were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">Arqule*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Global Blood Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Provention Bio*</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">Axsome Therapeutics*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Immunomedics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Reata Pharmaceuticals</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">Blueprint Medicines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Insmed</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">REGENXBIO</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">Eidos Therapeutics*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intra-Cellular Therapies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rhythm Pharmaceuticals*</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">Epizyme</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Karyopharm Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tricida*</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">FibroGen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">MyoKardia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Reflects new additions to peer group for 2019. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_15"></A><A NAME="tx878734_5"></A>Direct Compensation Components </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The components of our direct compensation package are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="57%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT STYLE="font-size:7pt" COLOR="#ffffff">&nbsp;&nbsp;</FONT><FONT COLOR="#ffffff">Element</FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Fixed or</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Variable</FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Compensation Objective</FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; font-size:10pt; font-family:ARIAL">Base Salary</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Fixed</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">To attract and retain executives by offering fixed compensation that is competitive with market opportunities and that recognizes each executive&#146;s position, role, responsibility and
experience.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; font-size:10pt; font-family:ARIAL">Annual Cash Incentive Bonus</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Variable</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">To motivate and reward the achievement of annual individual performance objectives and corporate goals.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; font-size:10pt; font-family:ARIAL">Equity Awards</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9">Variable</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">To align our executives&#146; interests with the interests of stockholders and to promote the long-term retention of our executives and all employees through equity-based compensation in the
form of stock options and/or restricted stock.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Base Salary </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Compensation Committee
reviews base salaries for our named executive officers on an annual basis as part of our compensation program and, in general, may adjust base salaries for a variety of reasons, such as: an executive officer&#146;s success in meeting or exceeding
individual performance objectives established by our Compensation Committee; the collective achievement of significant corporate goals, as established by our Compensation Committee; or other factors warranted throughout the year, including for
changes in the scope or breadth of an executive officer&#146;s role or responsibilities. Our Compensation Committee will also evaluate an executive officer&#146;s base salary together with other components of the executive officer&#146;s
compensation to ensure that the executive officer&#146;s total compensation is in line with our overall compensation philosophy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Compensation Committee will
also realign base salaries with market levels for the same positions if our Compensation Committee, with input from Compensia, identifies significant disparities in peer pay or market changes in its data analysis, or if a change is needed to align
our pay practices so we can attract and retain top talent necessary to advance our strategic and operational goals. In light of significant disparities between Madrigal and peer executive salaries and the Compensation Committee&#146;s desire to
align our pay practices in order for Madrigal to attract and retain top talent necessary to advance our strategic and operational goals, executive base salaries were materially adjusted. For instance, Dr.&nbsp;Friedman&#146;s salary for 2018 was
approximately $100,000 less than the lowest CEO salary paid in 2018 within our peer group, which consisted of 18 companies at such time. In </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">26</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">January 2019, our Compensation Committee, after consultation with Compensia, determined to increase Dr.&nbsp;Friedman&#146;s salary to an amount that ranked at
approximately the 50th percentile for 2018 peer group CEO salaries. The Compensation Committee determined to take this action in order to establish a company-wide salary structure that is designed to attract and retain the best industry talent and
enable us to better achieve our strategic and operational goals. This change was implemented by the Compensation Committee after considering (i)&nbsp;a substantial improvement in our long-term liquidity and capital resources during 2018, when we
completed a successful equity capital raise which yielded net proceeds to the Company of $312 million, and (ii)&nbsp;our long-term plans to build out our work force to advance our strategic and operational goals as our clinical programs advance. The
Compensation Committee also approved salary increases for our other named executive officers to align their salary levels at approximately the 50th percentile of the peer group levels. As a result, in the first quarter of 2019, the Compensation
Committee increased established the annual salary of each of our named executive officers as set forth in the table below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4" STYLE="BORDER-LEFT:1px solid #0075c9; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff; padding-left:8pt"><FONT COLOR="#ffffff">Name</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"><FONT COLOR="#ffffff">2019<BR>Base&nbsp;Salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">2018</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Base&nbsp;Salary</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Percent&nbsp;&nbsp;</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Increase&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Paul A. Friedman, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">584,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)&nbsp;</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">420,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">39.0%</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Rebecca Taub, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">454,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">389,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">16.7%</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Marc R. Schneebaum</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">421,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">383,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">9.9%</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Brian J. Lynch</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">$</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Effective as of January&nbsp;1, 2019. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Represents annual salary rate. The actual salary amount paid in 2019, as disclosed in the Summary Compensation Table, was
prorated from the February 19, 2019 hire date: </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">In July of 2019, Dr. Taub was promoted to President, R&amp;D, and she retained the position of Chief Medical Officer. In
connection with such promotion, her annual salary rate increased from $454,000 to $475,000. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Annual Cash Incentive Bonus </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In addition to base salaries, our named executive officers are eligible to receive annual cash incentive bonuses. The annual cash incentive bonus each named executive
officer is eligible to receive is based on the individual&#146;s target bonus, as a percentage of base salary, and an assessment of individual performance and achievement of pre-established objectives, including clinical, research and development,
business, finance and investor relations, commercial and hiring objectives for the 2019 year. The Compensation Committee determined the size of potential cash bonuses by reference to target bonus amounts, based on market data from the peer group and
the terms of each named executive officer&#146;s employment agreement. The specified percentages are intended to make our total cash compensation competitive when compared to the peer companies. It is also designed to allocate a significant portion
of each executive&#146;s cash compensation opportunity to be contingent on goal achievement and create a significant performance-based component of each executive&#146;s total compensation. Our annual cash incentive bonuses are disclosed in the
Summary Compensation Table in this proxy statement under the column &#147;Non-Equity Incentive Plan Compensation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In the first quarter of 2019, the target
cash bonus percentage for each of our named executive officers was maintained at 2018 levels, with Dr.&nbsp;Friedman, at 50% of base salary, Dr.&nbsp;Taub at 40% of base salary, and Mr.&nbsp;Schneebaum at 40% of base salary. Mr.&nbsp;Lynch&#146;s
target bonus was established at 40% of base salary. In connection with the July 2019 promotion of Dr.&nbsp;Taub to President, R&amp;D, a pro rata adjustment for her target cash bonus for the remainder of the year was set at 50% of her adjusted
annual salary rate of $475,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">For 2019, the Compensation Committee assigned points to each objective based on its determination, with input from our senior
management team, of the value of the objective in light of our overall corporate goals and objectives for 2019. The Compensation Committee also assigned bonus points for certain ancillary performance objectives within each primary group of
performance objectives. If we achieved a performance objective at the target level, 100% of the available points for such objective would be assigned. If we achieved a performance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">objective above the target level, up to 163% of the available points for such objective would be assigned. If we achieved a performance objective at less than 75% of the
target level, zero points for such objective would be assigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The performance objectives and associated allocation goal percentage at target for 2019 may be
summarized as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="22%"></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff">&nbsp;</TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.33em; font-size:12pt; font-family:ARIAL"><FONT COLOR="#ffffff">2019 Corporate Performance Objectives</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #ffffff; BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"><FONT COLOR="#ffffff">Percentage&nbsp;of&nbsp;Overall&nbsp;Objectives&nbsp;at&nbsp;Target&nbsp;&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Research and Development Objectives</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9">72.5%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Includes Goals Based on Clinical Objectives, such as:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Phase 3 NASH clinical trial initiation, site activation and patient randomization goals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Phase 3 NAFLD FDA interaction and study initiation goals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Achievement of peer-reviewed publication objectives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Advancement of preclinical and clinical pharmacology studies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Achievement of manufacturing and supply inventory development goals concerning drug product for Phase 3
clinical trials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:ARIAL">Submission of study plans to FDA</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #ffffff; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Finance and Investor Relations Objectives</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9">7.5%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Includes Goals Based on Finance and Investor Relations Objectives, such as:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Achievement of expenditure control objectives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Completion of objectives relating to investor and analyst meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:ARIAL">Achievement of objectives relating to website content update</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #ffffff; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Commercial Objectives</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9">10%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Includes Goals Based on Commercial Objectives, such as:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Developing dynamic market model for multiple commercialization opportunities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.40em; font-size:10pt; font-family:ARIAL">Advancing health economics planning for future market access for resmetirom</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #ffffff; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0075c9">Hiring Plan Objectives for 2019</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #0075c9">10%</TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:12pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.33em; font-size:12pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">100%</FONT></B></FONT> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">28</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On March&nbsp;5, 2020, the Compensation Committee, with input from our senior management team, assessed our achievement of the performance objectives set forth above.
Based on its assessment, the Compensation Committee determined that we outperformed and achieved bonus point performance in a number of categories established previously by the Compensation Committee, such that overall performance was achieved at
132.6% of the target level (out of a maximum 163% objective opportunity). As a result, in March of 2020, the Compensation Committee awarded the following cash bonuses in respect of such 2019 performance to our named executives based upon 132.6% of
his or her stated target bonus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4" STYLE="BORDER-LEFT:1px solid #0075c9; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff; padding-left:8pt"><FONT COLOR="#ffffff">Name</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"><FONT COLOR="#ffffff">Target<BR>Award</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Actual</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Award</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Paul A. Friedman, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">292,000</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">387,192</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Rebecca Taub, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">237,500</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">274,775</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Marc R. Schneebaum</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">168,400</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">223,298</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:9pt; font-family:ARIAL">Brian J. Lynch</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">$</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">145,250</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">$</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">192,602</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Reflects pro rata bonus target and payment, respectively, for applicable salary and target amounts before and after July
2019 promotion to President, R&amp;D. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Reflects pro rata bonus target and payment, respectively, from February 2019 hire date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Long-Term Incentives </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We believe that long-term incentives in the form of
equity-based awards are critical to meeting the following objectives: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">focus all employees, including our named executive officers, on our long-term performance by aligning their interests with
those of our stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">retain our key employees and executives and maintain management continuity through longer-term vesting of our equity-based
awards; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">promote an ownership culture through participation in equity-based compensation programs. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our 2015 Stock Plan allows the grant of stock options, restricted stock, and other equity-based awards to employees, consultants and directors. We typically make an
initial equity award of stock options to new employees, including our executive officers, and annual equity grants as part of our overall compensation program. Our Compensation Committee authorized Dr.&nbsp;Friedman to make new hire stock option
grants to our employees, except for our executive officers, within certain parameters, beyond which approval of our Compensation Committee is required. Dr.&nbsp;Friedman may award new hire stock option grants as of the employee&#146;s initial
commencement of employment with an exercise price equal to the closing price of our common stock on the date of grant, in accordance with our 2015 Stock Plan. Mr.&nbsp;Lynch received stock options associated with his commencement of employment in
2019, as discussed under &#147;&#150;Employment Agreements, Severance and Change of Control Arrangements.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Annual grants of options to all of our employees
and equity awards to our executive officers are approved by our Compensation Committee, the timing of which we intend to be consistent each year with a regularly scheduled meeting of our Compensation Committee and is not coordinated with the public
release of nonpublic material information. In March 2019, at a regularly scheduled meeting, the Compensation Committee granted stock options concerning 50,000 shares to Dr.&nbsp;Friedman, 38,000 shares to Dr.&nbsp;Taub, and 28,000 shares to
Mr.&nbsp;Schneebaum. Each of these options vests as follows: 25% on the first anniversary of the grant date, and 6.25% each quarter thereafter until fully-vested. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">COMPENSATION DISCUSSION AND ANALYSIS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Other Benefits </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We maintain broad-based benefits that are provided to all
employees, including health insurance, life and disability insurance, dental insurance, and a 401(k) plan with a matching company contribution. Our named executive officers participate in the benefits programs generally on the same basis as all
employees, except that Drs. Friedman and Taub have elected to forego group life and disability insurance and 401(k) plan participation and Dr.&nbsp;Friedman has elected to forego health and dental insurance plan participation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Employment Agreements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We have entered into agreements with each of our named
executive officers, which agreements provide financial protection against the potential loss of employment in designated circumstances, and which the Compensation Committee believes will allow the executives to focus attention on the best interests
of the stockholders, without undue concern as to the executive&#146;s own financial situation. None of these agreements contains a tax gross-up provision. A summary of the material terms of the employment agreements may be found in this proxy
statement under the section entitled &#147;- Employment Agreements, Severance and Change in Control Arrangements&#148; and &#147;-; Potential Qualifying Separation and Change of Control Payments.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_16"></A><A NAME="tx878734_6"></A>Executive Compensation and Risk-Taking </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We have sought to align the equity and cash components of our executive compensation program with industry peers in order to offer compensation packages that enable us
to attract and retain talented executive officers. The Compensation Committee continues to evaluate the relative importance of equity and cash components of total compensation. We do not believe that our executive compensation program encourages
excessive risk-taking by our executive officers. For example, long-term equity awards tied to the value of our common stock represent a significant component of an executive officer&#146;s total direct compensation, as evidenced by the compensation
breakdown contained in the Summary Compensation Table that follows. Those awards promote a commonality of interest between our executive officers and our stockholders in sustaining and increasing stockholder value. Because the equity awards are
typically made on an annual basis to our executive officers, vested and unvested awards that are outstanding can decrease in value or have no value in the event of stock price declines, whether due to market factors or whether our business is not
managed to achieve its long-term goals. Thus, our executive compensation program is not heavily weighted toward short-term incentives, and we have taken what we believe are reasonable steps to protect against the potential of disproportionately
large short-term incentives that might encourage excessive risk taking. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_17"></A><A NAME="tx878734_7"></A>Advisory Vote on Executive Compensation
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">At our 2019 Annual Meeting of Stockholder we conducted an advisory vote on executive compensation. At such meeting, approximately 98.4% of the votes cast on the
advisory vote proposal were in favor of our named executive officer compensation as disclosed in last year&#146;s proxy statement. The Board of Directors and Compensation Committee reviews the advisory vote results in the context of our overall
compensation philosophy and programs and other relevant competitive, incentive and market developments affecting executive officer compensation in order to assess the need for changes to our executive compensation programs and policies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">30</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_18"></A>EXECUTIVE OFFICER AND DIRECTOR COMPENSATION </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_19"></A>Summary Compensation Table </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following table shows for
the fiscal years ended December&nbsp;31, 2019, 2018, and 2017, the compensation awarded to or earned by our principal executive officer and our three other most highly compensated executive officers who were serving as executive officers as of
December&nbsp;31, 2019. The persons listed in the following table are referred to herein as the &#147;named executive officers.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt"><FONT COLOR="#ffffff">Name and Principal Position</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">Year</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Salary</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Option</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Awards</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Non-Equity</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Incentive Plan</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Compensation</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">All
Other</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Compensation</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Total</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman, M.D.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.75em; text-indent:-1.00em; font-size:8pt; font-family:ARIAL">Chairman and Chief Executive Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">584,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,122,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">387,192</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,093,192</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">416,666</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">4,907,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">304,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,628,666</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2017</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">400,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">629,424</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">335,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">558</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,364,982</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3" STYLE="BORDER-TOP:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub,
M.D.</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:ARIAL">President, Research&nbsp;&amp; Development<SUP STYLE="font-size:85%; vertical-align:top"> </SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.63em; font-size:8pt; font-family:ARIAL">and Chief Medical Officer,</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">463,948</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">4,531,120</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">274,775</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,269,843</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">385,416</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,729,700</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">225,330</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">4,340,446</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2017</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">370,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">473,337</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">247,900</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">558</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,091,795</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3" STYLE="BORDER-TOP:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Marc R.
Schneebaum</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:ARIAL">Senior Vice President,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.63em; font-size:8pt; font-family:ARIAL">Chief Financial Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">421,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,868,320</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">223,298</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">20,034</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP
STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(2)</SUP>&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,532,652</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">380,250</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,748,200</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">222,314</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,336</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,366,100</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2017</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">365,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">346,437</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">244,550</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">14,307</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">970,294</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Brian J Lynch</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.63em; font-size:8pt; font-family:ARIAL">Senior Vice President and General Counsel <SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2019</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">358,602</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,506,859</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">192,602</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">10,574</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP
STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(2)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">4,068,568</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">These amounts represent the aggregate grant date fair value of option awards, granted in each year presented calculated in
accordance with Financial Accounting Standards Board Accounting Standards Codification, or FASB ASC, Topic 718,<I> Compensation&#151;Stock Compensation</I>. See our discussion of &#147;Stock-Based Compensation&#148; under Notes 2, 3 and 9 to our
audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2019 filed on February&nbsp;26, 2020 or the Annual Report, for a discussion of all assumptions made by us in determining
the grant date fair values of our equity awards. See also our discussion of stock-based compensation under Item&nbsp;7 &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Critical Accounting Policies
and Estimates&#148; of the Annual Report. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">All Other Compensation for Mr.&nbsp;Schneebaum in 2019 includes $11,933 in life and disability insurance premiums paid,
and matching contributions of $8,100 made under our 401(k) plan. For Mr.&nbsp;Lynch All Other Compensation for 2019 includes $2,474 in life insurance premiums paid, and matching contributions of $8,100 made under our 401(k) plan.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Mr.&nbsp;Lynch became an employee and was appointed our Senior Vice President and General Counsel on February&nbsp;19,
2019, and salary bonus data in the table reflect pro rata amounts for the year, as paid from February&nbsp;19, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">EXECUTIVE OFFICER AND DIRECTOR COMPENSATION </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_20"></A>Grants of Plan-Based Awards </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following table shows
information regarding grants of plan-based awards during the fiscal year end December&nbsp;31, 2019 to our named executive officers.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">Name&nbsp;and<BR>principal&nbsp;position</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">Grant&nbsp;date</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="padding-bottom:3pt ;" BGCOLOR="#0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">Estimated&nbsp;future&nbsp;payouts&nbsp;under&nbsp;non-</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">equity incentive plan awards target</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">All&nbsp;other</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">stock</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">awards:</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">Number</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">of&nbsp;shares</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">of stock</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">or units</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">(#)</FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">All other</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">stock and</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">option</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">awards:</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">Number&nbsp;of</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">securities</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">underlying</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">options (#)</FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">Exercise&nbsp;or</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">base price</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">of stock</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">and option</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">awards</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">($/share)<SUP STYLE="font-size:85%; vertical-align:top"><BR>(2)</SUP></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">Grant date</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">fair value of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">stock and</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#FFFFFF">option</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF">award<SUP STYLE="font-size:85%; vertical-align:top"> (3)</SUP></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt" BGCOLOR="#0075c9">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" BGCOLOR="#0075c9" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">Threshold</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">Target</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">Maximum</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9" BGCOLOR="#0075c9">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT
 COLOR="#0075c9">Paul A. Friedman, M.D.</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chairman and Chief</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Executive Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">March&nbsp;7,&nbsp;2019</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">219,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">292,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">475,960</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">50,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">$127.96</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,122,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT
 COLOR="#0075c9">Rebecca Taub, M.D.</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chief Medical Officer, President, R&amp;D</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">March&nbsp;7,&nbsp;2019</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">July&nbsp;10,&nbsp;2019</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">156,750</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(4)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">209,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(4)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">340,670</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9">
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(4)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">38,000</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">8,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">$127.96</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">$101.30</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,892,728</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">638,392</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE="margin-bottom:0pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Marc R. Schneebaum</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Senior Vice President,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chief Financial
Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">March&nbsp;7, 2019</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">126,300</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">168,400</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">274,429</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">28,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">$127.96</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,868,320</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Brian J. Lynch</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Senior Vice President,</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">And General Counsel</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">February&nbsp;5,&nbsp;2019</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">February&nbsp;19,&nbsp;2019</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">124,500</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(5)&nbsp;</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">143,440</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(5)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">233,742</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(5)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">16,000</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">18,000</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">$114.27</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">$134.25</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,464,503</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,042,356</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The material terms of the 2019 non-equity incentive awards are described above in the Compensation Discussion and Analysis
in the section entitled &#147;Annual Cash Incentive Bonus.&#148; The threshold value above represents performance at 75% of target without achievement of bonus points or outperformance objectives. The target value above represents performance at
100% of target without achievement of bonus points or outperformance objectives. If bonus points or outperformance objectives are earned, the threshold and target amounts could increase. The maximum value above represents performance at 163% of
target, including full achievement of bonus points and/or outperformance objectives. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The exercise price of these stock options is determined by the Company based on the closing price of its common stock on
the Nasdaq Stock Market on the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Amounts represent the grant date fair value of the executive officer&#146;s stock options and awards, calculated in
accordance with FASB ASC Topic 718, using a Black-Scholes valuation model for stock options. See Note 1 under &#147;&#151;Summary Compensation Table&#148; for a discussion of the assumptions made by the Company in determining the grant date fair
value of our option awards for the fiscal year ended December&nbsp;31, 2019. Option awarded with time-based vesting criteria established by the Compensation Committee and described in Compensation Discussion and Analysis above.
</P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes mean values for estimated payments based on pro rata adjustment to salary and target bonuses established for July
2019 promotion to President, R&amp;D. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Represents pro rata value derived from February 19, 2019 hire date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">32</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">EXECUTIVE OFFICER AND DIRECTOR COMPENSATION </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_21"></A>Outstanding Equity Awards at Fiscal Year End </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The
following table shows stock options and shares of unvested stock held by each of our named executive officers as of December&nbsp;31, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-TOP:2.00pt solid #0075c9; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" NOWRAP ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9;border-bottom:1.00px solid #ffffff"><FONT COLOR="#ffffff">Option Awards</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt"><FONT COLOR="#ffffff">Name</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Date of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Grant</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Number of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Securities</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Underlying</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Unexercised</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Options (#)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Exercisable</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Number of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Securities</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Underlying</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Unexercised</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Options (#)</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Unexercisable</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Option</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Exercise</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Price ($)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Option</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Expiration</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Date</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="4" STYLE="BORDER-TOP:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.78em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman, M.D.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.88em; font-size:8pt; font-family:ARIAL">Chief Executive Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/7/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">50,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP
STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">127.96</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/7/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/1/2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">21,875</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">28,125</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP></P>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">124.45</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/1/2028</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/2/2017</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">34,100</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP></P>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15.80</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/2/2027</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/22/2016</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">306,256</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">9.45</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/22/2026</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="5" STYLE="BORDER-TOP:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.78em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub, M.D.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.88em; font-size:8pt; font-family:ARIAL">President, Research&nbsp;&amp; Development, Chief Medical Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/10/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">8,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP
STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">101.30</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/10/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/7/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">38,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">127.96</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/7/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/1/2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">16,625</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">21,375</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP></P>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">124.45</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/1/2028</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/2/2017</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">25,644</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">11,656</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP></P>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15.80</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/2/2027</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/22/2016</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">153,128</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">9.45</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/22/2026</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="6" STYLE="BORDER-TOP:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.78em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Marc R. Schneebaum</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.88em; font-size:8pt; font-family:ARIAL">Senior Vice President, Chief Financial Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/7/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">28,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP
STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">127.96</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/7/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/1/2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">12,250</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,750</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP></P>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">124.45</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/1/2028</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/2/2017</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">18,769</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">8,531</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP></P>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15.80</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3/2/2027</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/22/2016</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">98,002</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">9.45</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/22/2026</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">10/2/2015</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,640</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">61.60</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">10/2/2025</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">12/8/2014</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,205</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">99.75</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">12/8/2024</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="4" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.78em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Brian J.
Lynch</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.88em; font-size:8pt; font-family:ARIAL">Senior Vice President and General Counsel</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2/19/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">19,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP
STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">$</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">134.25</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2/19/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0075c9; BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2/5/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">-0-</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">16,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL"><SUP STYLE="font-size:85%; line-height:12.0pt ; vertical-align:top">(1)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">114.27</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2/5/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/14/2019</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,250</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">750</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">114.55</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/14/2029</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/1/2018</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,125</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,875</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">279.69</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7/1/2028</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">These stock options vest as to 25% of the underlying shares on the first anniversary of the grant date and, thereafter, as
to 6.25% of the underlying shares on the last day of each successive three-month period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_22"></A>Pay Ratio </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following is a reasonable estimate, prepared under applicable SEC rules, of the ratio of the annual total compensation of our Chief Executive Officer to the median
of the annual total compensation of our other employees. We calculated this ratio after examining the total compensation amounts for all of our employees for the 2019 fiscal year, which included the following elements: base salary (annualized where
applicable for those who commenced employment during 2019); bonus payments made in respect of the 2019 fiscal year (also annualized where applicable); the grant date value of equity awards; and 401(k) plan matching contributions. We calculated the
median total compensation of this employee population of (25 all of whom were employed in the U.S.) and selected the median-compensated employee from within that group as our median employee. This median employee&#146;s total compensation for 2019
was $791,000, calculated in the same manner as our Chief Executive Officer&#146;s total compensation for 2019, as disclosed in the Summary Compensation Table. The Chief Executive Officer&#146;s total compensation for 2019 was $6,093,000, as
disclosed in the Summary Compensation Table. Therefore, our estimate of the ratio of Chief Executive Officer pay to median employee pay is 8:1. Given the different methodologies that various public companies will use to determine an estimate of
their pay ratio, the ratio reported above should not be used as a basis for comparison between companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">EXECUTIVE OFFICER AND DIRECTOR COMPENSATION </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_23"></A>Option Exercises and Stock Vested </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following table
shows the number of shares acquired upon exercise of stock options and the number of shares that vested under restricted stock awards held by each of our named executive officers during the fiscal year ended December&nbsp;31, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD></TR>


<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:8pt; font-family:ARIAL"><FONT
 COLOR="#ffffff">Name</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9" ALIGN="center"><FONT COLOR="#ffffff">Option&nbsp;awards</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">number&nbsp;of&nbsp;shares</FONT></P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">acquired on</FONT></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">exercise (#)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9" ALIGN="center"><FONT COLOR="#ffffff">Option&nbsp;awards</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">value&nbsp;realized&nbsp;on</FONT></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">exercise ($)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9" ALIGN="center"><FONT COLOR="#ffffff">Stock&nbsp;awards</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">number&nbsp;of&nbsp;shares</FONT></P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">acquired on</FONT></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">vesting (#)</FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top"><BR></SUP></FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9" ALIGN="center"><FONT COLOR="#ffffff">Stock awards</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">value realized</FONT></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">on vesting ($)</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top"><BR>(1)</SUP></FONT></P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt"><FONT COLOR="#ffffff">&nbsp;</FONT><BR>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">&nbsp;</FONT></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:ARIAL"><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP
STYLE="font-size:85%; vertical-align:top">&nbsp;<BR></SUP></FONT><FONT COLOR="#ffffff">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman,
M.D.</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chief Executive Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">38,282</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">3,409,778</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub, M.D.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chief Medical Officer and President,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Research&nbsp;&amp; Development</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">7,656</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">681,920</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Marc R. Schneebaum</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Senior Vice President, Chief Financial Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">6,125</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">545,554</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0075c9"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#e5e5e5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0075c9">Brian J. Lynch</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Senior Vice President and General Counsel</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right"><FONT STYLE="font-size:9pt">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9"></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Represents value realized solely for SEC disclosure requirements based upon fair market value per share ($89.07) of
restricted stock vesting on the applicable vesting date (July 22, 2019). In fact, no value was actually realized by each named executive officer on such vesting date or during 2019 either (a)&nbsp;for tax purposes, as Internal Revenue Code
Section&nbsp;83(b) elections previously were taken by each named executive officer, or (b)&nbsp;for financial purposes, since such shares continued to be owned as of December&nbsp;31, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">34</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_24"></A>EMPLOYMENT AGREEMENTS, SEVERANCE AND CHANGE IN CONTROL ARRANGEMENTS </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Paul A. Friedman, M.D. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On April&nbsp;13, 2016, Private Madrigal
entered into an agreement, or the Friedman Letter Agreement, with Dr.&nbsp;Friedman, for the position of Chairman and Chief Executive Officer of our company following the completion of the Merger. We assumed the Friedman Letter Agreement upon
completion of the Merger. Under the terms of the Friedman Letter Agreement, Dr.&nbsp;Friedman is entitled to an annual base salary of $400,000 (subject to adjustment by the Compensation Committee) and an annual target bonus of 50% of his base salary
(subject to adjustment by the Compensation Committee). In addition, upon the consummation of the Merger, Dr.&nbsp;Friedman received equity awards, including stock options to purchase 306,256 shares of our common stock and a restricted stock award
representing 153,128 shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The foregoing stock options vested as to 25% of the shares on the grant date and the remainder vested in equal
annual installments on the first, second and third anniversaries of the grant date. The repurchase right relating to the foregoing restricted stock award lapsed as to 25% of the shares on the grant date and the repurchase right on the remaining
shares lapsed in equal annual installments on the first, second and third anniversaries of the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Friedman is also entitled to severance benefits
if we terminate his employment without &#147;Cause&#148; (as defined) or if Dr.&nbsp;Friedman voluntarily resigns for &#147;Good Reason&#148; (as defined), which we refer to herein collectively as a &#147;Qualifying Separation,&#148; consisting of:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a severance payment equal to 12 months of Dr.&nbsp;Friedman&#146;s then-current base salary and target bonus, payable
(i)&nbsp;in a lump sum for a Qualifying Separation, if such Qualifying Separation occurs following a change of control of our company and (ii)&nbsp;in 12 equal monthly payments if such Qualifying Separation does not occur following a change of
control of our company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">full vesting of restricted stock and stock options held by Dr.&nbsp;Friedman if a Qualifying Separation occurs following a
change of control of our company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">reimbursement of continuation of medical benefits for 12 months following a Qualifying Separation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Friedman has also entered into a customary indemnification agreement with us with respect to his service as an officer and director of our company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Rebecca Taub, M.D. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On April&nbsp;13, 2016, Private Madrigal entered
into an agreement, or the Taub Letter Agreement, with Rebecca Taub, M.D. for the position of Chief Medical Officer and Executive Vice President, Research&nbsp;&amp; Development, of our company following the completion of the Merger. We assumed the
Taub Letter Agreement upon completion of the Merger. Under the terms of the Taub Letter Agreement, Dr.&nbsp;Taub is entitled to an annual base salary of $370,000 (subject to adjustment by the Compensation Committee) and an annual target bonus of 40%
of her base salary (subject to adjustment by the Compensation Committee). In addition, upon the consummation of the Merger, Dr.&nbsp;Taub received equity awards, including stock options to purchase 153,128 shares of our common stock and a restricted
stock award representing 30,626 shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The foregoing stock options vested as to 25% of the shares on the grant date and the remainder vested
in equal annual installments on the first, second and third anniversaries of the grant date. The repurchase right relating to the foregoing restricted stock award lapsed as to 25% of the shares on the grant date and the repurchase right on the
remaining shares lapsed in equal annual installments on the first, second and third anniversaries of the grant date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">EMPLOYMENT AGREEMENTS, SEVERANCE AND CHANGE IN CONTROL ARRANGEMENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Taub is also entitled to severance benefits upon a Qualifying Separation consisting of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a severance payment equal to 12 months of Dr.&nbsp;Taub&#146;s then-current base salary and target bonus, payable
(i)&nbsp;in a lump sum for a Qualifying Separation, if such Qualifying Separation occurs following a change of control of our company and (ii)&nbsp;in 12 equal monthly payments if such Qualifying Separation does not occur following a change of
control of our company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">full vesting of restricted stock and stock options held by Dr.&nbsp;Taub if a Qualifying Separation occurs following a
change of control of our company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">reimbursement of continuation of medical benefits for 12 months following a Qualifying Separation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Taub has also entered into a customary indemnification agreement with us with respect to her service as an officer and director of our company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Marc R. Schneebaum </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to a letter agreement dated
November&nbsp;24, 2014, with Mr.&nbsp;Schneebaum, Mr.&nbsp;Schneebaum is entitled to receive an annual base salary of $365,000 (subject to adjustment by the Compensation Committee). Under our bonus policy, Mr.&nbsp;Schneebaum is eligible to receive
an annual performance-based bonus with a target at 40% of his base salary (subject to adjustment by the Compensation Committee). In addition, upon the consummation of the Merger, Mr.&nbsp;Schneebaum received equity awards, including stock options to
purchase 98,002 shares of our common stock and a restricted stock award representing 24,501 shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The foregoing stock options vested as to
25% of the shares on the grant date and the remainder vested in equal annual installments on the first, second and third anniversaries of the grant date. The repurchase right relating to the foregoing restricted stock award lapsed as to 25% of the
shares on the grant date and the repurchase right on the remaining shares lapsed in equal annual installments on the first, second and third anniversaries of the grant date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to the terms of a severance and change of control agreement entered into with Mr.&nbsp;Schneebaum, he is also entitled to severance benefits upon a Qualifying
Separation consisting of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a severance payment equal to 12 months of Mr.&nbsp;Schneebaum&#146;s then-current base salary and target bonus, payable
(i)&nbsp;in a lump sum if such Qualifying Separation occurs following a change of control of our company, and (ii)&nbsp;in 12 equal monthly payments if such Qualifying Separation does not occur following a change of control of our company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">(i)&nbsp;full vesting of restricted stock and stock options held by Mr.&nbsp;Schneebaum upon a Qualifying Separation, if
such Qualifying Separation occurs following a change in control of our company, and (ii)&nbsp;six months&#146; vesting of restricted stock and stock options held by Mr.&nbsp;Schneebaum upon a Qualifying Separation, if such Qualifying Separation does
not occur following a change of control of our company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">reimbursement of continuation of medical benefits for 12 months following a Qualifying Separation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Schneebaum has also entered into a customary indemnification agreement with us with respect to his service as an officer of our company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Brian J. Lynch </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to a letter agreement dated February&nbsp;19,
2019, with Mr.&nbsp;Lynch, Mr.&nbsp;Lynch is entitled to receive an annual base salary of $415,000 (subject to adjustment by the Compensation Committee). Under our bonus policy, Mr.&nbsp;Lynch is eligible to receive an annual performance-based bonus
with a target at 40% of his base salary (subject to adjustment by the Compensation Committee). In addition, in connection the signing of the letter agreement, Mr.&nbsp;Lynch was granted stock options to purchase 15,000 and 18,000 shares of our
common stock at exercise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">36</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">EMPLOYMENT AGREEMENTS, SEVERANCE AND CHANGE IN CONTROL ARRANGEMENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">prices of $114.27 and $134.25, per share respectively. The foregoing stock options vest as to 25% of the shares on the first anniversary of the grant date as to 6.25% of
the shares on each quarterly anniversary after the first anniversary of the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to the terms of a severance and change of control agreement
entered into with Mr.&nbsp;Lynch, he is also entitled to severance benefits upon a Qualifying Separation consisting of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a severance payment equal to 12 months of Mr.&nbsp;Lynch&#146;s then-current base salary and target bonus, payable
(i)&nbsp;in a lump sum if such Qualifying Separation occurs following a change of control of our company, and (ii)&nbsp;in 12 equal monthly payments if such Qualifying Separation does not occur following a change of control of our company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">(i)&nbsp;full vesting of restricted stock, if any, and stock options held by Mr.&nbsp;Lynch upon a Qualifying Separation,
if such Qualifying Separation occurs following a change in control of our company, and (ii)&nbsp;six months&#146; vesting of restricted stock and stock options held by Mr.&nbsp;Lynch upon a Qualifying Separation, if such Qualifying Separation does
not occur following a change of control of our company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">reimbursement of continuation of medical benefits for 12 months following a Qualifying Separation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Lynch has also entered into a customary indemnification agreement with us with respect to his service as an officer of our company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Remy Sukhija </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to a letter agreement dated April&nbsp;1, 2020,
with Mr.&nbsp;Sukhija, Mr.&nbsp;Sukhija is entitled to receive an annual base salary of $450,000 (subject to adjustment by the Compensation Committee). Under our bonus policy, Mr.&nbsp;Sukhija is eligible to receive an annual performance-based bonus
with a target at 40% of his base salary (subject to adjustment by the Compensation Committee). In addition, in connection with the signing of the letter agreement, Mr.&nbsp;Sukhija (1)&nbsp;became eligible to receive a signing bonus of $100,000
(which is subject to repayment equal to $50,000 in the event his employment with the Company ceases before his first start date anniversary, subject to certain exceptions including events that would constitute a Qualified Separation) and
(2)&nbsp;was granted stock options to purchase 60,000 shares of our common stock at an exercise price of $60.26 per share. The foregoing stock options vest as to 25% of the shares on the first anniversary of the grant date and as to 6.25% of the
shares on each quarterly anniversary after the first anniversary of the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to the terms of a severance and change of control agreement entered
into with Mr.&nbsp;Sukhija, he is also entitled to severance benefits upon a Qualifying Separation consisting of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">a severance payment equal to 12 months of Mr.&nbsp;Sukhija&#146;s then-current base salary and target bonus, payable
(i)&nbsp;in a lump sum if such Qualifying Separation occurs following a change of control of our company, and (ii)&nbsp;in 12 equal monthly payments if such Qualifying Separation does not occur following a change of control of our company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">(i)&nbsp;full vesting of restricted stock, if any, and stock options held by Mr.&nbsp;Sukhija upon a Qualifying Separation,
if such Qualifying Separation occurs following a change in control of our company, and (ii)&nbsp;six months&#146; vesting of restricted stock and stock options held by Mr.&nbsp;Sukhija upon a Qualifying Separation, if such Qualifying Separation does
not occur following a change of control of our company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">reimbursement of continuation of medical benefits for 12 months following a Qualifying Separation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Sukhija has also entered into a customary indemnification agreement with us with respect to his service as an officer of our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">EMPLOYMENT AGREEMENTS, SEVERANCE AND CHANGE IN CONTROL ARRANGEMENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_25"></A>Potential Qualifying Separation and Change of Control Payments </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Potential Qualifying Separation without change of control payments and Qualifying Separation with change of control payments pursuant to the employment agreements
assuming termination event occurred on December&nbsp;31, 2019 are set forth in the table below using our common stock price of $91.11, the closing price of our common stock on the Nasdaq Stock Market on December&nbsp;31, 2019. In addition to the
amounts shown in the table below, each executive would receive payments for base salary and vacation time accrued through the date of termination and payment for any reimbursable business expenses incurred. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="padding-bottom:3pt ;"><FONT COLOR="#ffffff">Triggering event</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt"><FONT COLOR="#ffffff">Name</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">Benefit</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Qualifying</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Separation&nbsp;Only</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #ffffff; BORDER-BOTTOM:2.00pt solid #0075c9">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Qualifying</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Separation</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">within 12 months</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">after&nbsp;a&nbsp;Change&nbsp;of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Control</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #ffffff; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Paul A. Friedman,
M.D.</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chairman and Chief Executive Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><FONT STYLE="white-space:nowrap">Salary-based&nbsp;Severance</FONT></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">$584,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></FONT>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">$584,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></FONT>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Bonus-based Severance</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">292,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">292,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Continuation of Benefits</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">-0-</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">-0-</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #0075c9">Market Value of Vesting</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">1,167,305</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">1,167,305</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Rebecca Taub,
M.D.</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Chief Medical Officer,&nbsp;President, R&nbsp;&amp; D,</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">Salary-based Severance</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">$475,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></FONT>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">475,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></FONT>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Bonus-based Severance</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">237,500</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">237,500</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Continuation of Benefits</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">17,700</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">17,700</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #0075c9">Market Value of Vesting</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">877,813</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">877,813</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Marc R.
Schneebaum</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Senior Vice President, Chief Financial Officer</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">Salary-based Severance</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">$421,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></FONT>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">421,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></FONT>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Bonus-based Severance</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">168,400</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">168,400</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Continuation of Benefits</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">33,300</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">33,300</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #0075c9">Market Value of Vesting</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">256,958</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">642,470</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#0075c9">Brian J.
Lynch</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:ARIAL">Senior Vice President and General Counsel</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">Salary-based Severance</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">$415,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></FONT>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right"><FONT STYLE="font-size:10pt">415,000</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT STYLE="font-size:10pt"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></FONT>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Bonus-based Severance</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">166,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">166,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #e5e5e5">Continuation of Benefits</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">29,800</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(4)&nbsp;</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">29,800</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #0075c9">Market Value of Vesting</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">-0-</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" ALIGN="right">-0-</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Upon such Qualifying Separation, each named executive officer is entitled to 12 months&#146; base salary and target bonus,
payable over 12 months. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Upon such Qualifying Separation, each named executive officer is entitled to 12 months&#146; base salary and target bonus,
payable in a lump sum. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Represents value associated with an acceleration and cancellation of unvested stock option awards assuming cancellation
occurred at December&nbsp;31, 2019 and involved a payment equal to the difference between the closing price on such date ($91.11) and the exercise price of all unvested in-the-money stock options. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Upon Qualifying Separation, such named executive officer is eligible for the Company to continue to pay the employer-paid
portion of health benefits for 12 months. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">38</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_26"></A>DIRECTOR COMPENSATION </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Non-Employee Director Compensation Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">A non-employee director is a director who is not employed by us and who does not receive compensation from us through any business relationship with us that is
inconsistent with applicable Nasdaq or SEC independence rules. Our Board of Directors approves the form and amount of non-employee director compensation. Our Compensation Committee makes recommendations on the form and amount of non-employee
director compensation. In July 2016, we adopted a non-employee director compensation program that became effective upon its adoption. The terms of our non-employee director compensation program are described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Initial Stock Option Grant Upon Appointment or Election </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Each new
non-employee director automatically receives a stock option to purchase 20,000 shares of our common stock upon his or her initial appointment or election to our Board of Directors, to be granted on or as soon as reasonably practicable after the date
of such non-employee director&#146;s initial appointment or election, as applicable. Each such stock option has an exercise price equal to the fair market value of our common stock on the date of grant and vests as to 50% of the underlying shares on
the first anniversary of the grant date and as to an additional 12.5% of the underlying shares on the last day of each successive quarterly period thereafter for four successive quarterly periods, subject to the non-employee director&#146;s
continued service as a director. Effective in 2019, each such stock option will terminate on the earlier of five years from the date of grant and three months after the recipient ceases to serve as a director, except in the case of death or
disability, in which event the option will terminate one year from the date of the non-employee director&#146;s death or disability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Annual Stock Option Awards
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Each non-employee director automatically receives an annual stock option on the date of each annual meeting of our stockholders, or the Annual Grant Date, to
purchase 10,000 shares of our common stock. Each such stock option has an exercise price equal to the fair market value of our common stock on the Annual Grant Date and vests in full on the first anniversary of the Annual Grant Date, subject to the
non-employee director&#146;s continued service as a director on such date. Effective in 2019, each such stock option will terminate on the earlier of five years from the date of grant and three months after the recipient ceases to serve as a
director, except in the case of death or disability, in which event the option will terminate one year from the date of the non-employee director&#146;s death or disability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Annual Cash Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In addition to stock options, each non-employee
director is eligible to receive for his or her service on our Board of Directors or committees thereof annual cash retainers (payable quarterly, in arrears), as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12.0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Position</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12.0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Retainer&nbsp;($)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Board Member</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">40,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Audit Committee Chair</P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">20,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Compensation Committee
Chair</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">12,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Nominating and Governance
Committee Chair</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">12,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Audit Committee
Member</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">7,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Compensation Committee
Member</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">7,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Nominating and Governance
Committee Member</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">7,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">DIRECTOR COMPENSATION </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Expenses </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Finally, we reimburse our non-employee directors for their
reasonable out-of-pocket expenses incurred in attending meetings of our Board of Directors and committee meetings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_27"></A>Director Compensation
Tables </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following tables set forth information about the compensation paid to the non-employee members of our Board of Directors who served as a director during
the year ended December&nbsp;31, 2019. Other than as set forth in the tables and described more fully below, during the year ended December&nbsp;31, 2019, we did not pay any fees to, make any equity awards to or pay any other compensation to the
non-employee members of our Board of Directors. The stock options granted in 2019 and disclosed in the table below were granted under our 2015 Stock Plan. Neither Dr.&nbsp;Friedman, our Chief Executive Officer and Chairman of our Board of Directors,
nor Dr.&nbsp;Taub, our President, Research&nbsp;&amp; Development, and Chief Medical Officer, and a director, received any compensation from us in 2019 for service as a director and they are not included in the table below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:22pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:22pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:13pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:13pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:24pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:24pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:14pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:14pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4" STYLE="BORDER-LEFT:1px solid #0075c9; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="5"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff; padding-left:8pt"><FONT COLOR="#ffffff">Name</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Fees</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Earned&nbsp;or</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Paid&nbsp;in&nbsp;Cash</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP
STYLE="font-size:85%; vertical-align:top"> (1)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Option</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Awards</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">($)</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top"> (2)(3)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">All Other</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Compensation</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">($)</FONT><FONT STYLE="font-size:5pt" COLOR="#ffffff"><SUP STYLE="font-size:85%; vertical-align:top"> (4)</SUP></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"><FONT COLOR="#ffffff">Total ($)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD COLSPAN="4" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Kenneth M. Bate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">67,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">602,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">670,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">James M. Daly</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">20,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,289,495</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">1,309,495</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Fred B. Craves, Ph.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">55,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">602,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">657,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Keith R. Gollust</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">60,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">602,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">662,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">Richard S. Levy, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">60,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">602,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">750</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">663,250</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.30em; line-height:15.0pt; font-size:10pt; font-family:ARIAL">David Milligan, Ph.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">55,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">602,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">657,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:10pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Consists of the annual retainer fee for service as a member of the Board of Directors or any Board committee. For further
information concerning such fees, see the section above entitled &#147;&#151;Annual Cash Compensation.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Mr.&nbsp;Bate, Dr.&nbsp;Craves, Mr.&nbsp;Gollust, Dr.&nbsp;Levy, and Dr.&nbsp;Milligan each received an option to purchase
10,000 shares of common stock with an exercise price per share of $100.45 at our 2019 Annual Meeting of Stockholders and Mr.&nbsp;Daly received an option grant for 20,000 shares upon his election to the Board on the same date. The amounts in this
column represent the aggregate grant date fair value of the option awards granted to applicable director in our fiscal year 2019 computed in accordance with FASB ASC Topic 718. See our discussion of &#147;Stock-Based Compensation&#148; under Notes 2
and 9 to our audited consolidated financial statements included in the Annual Report for a discussion of all assumptions made by us in determining the grant date fair values of our equity awards. See also our discussion of stock-based compensation
under Item&nbsp;7 &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Critical Accounting Policies and Estimates&#148; of the Annual Report. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD style="width:32pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:32pt"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD style="width:32pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:32pt"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #0075c9">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="10"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#ffffff">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"><FONT COLOR="#ffffff">The following table shows the total<BR>number&nbsp;of&nbsp;outstanding&nbsp;and&nbsp;vested&nbsp;stock<BR>options as of December&nbsp;31,
2019, the<BR>last day of our fiscal year, that have<BR>been&nbsp;issued&nbsp;as&nbsp;director&nbsp;compensation&nbsp;to<BR>our non-employee directors.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="4" VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0075c9">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #0075c9">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="5"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD>
<TD HEIGHT="4" COLSPAN="5"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #0075c9; BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff"><FONT COLOR="#ffffff">Name</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">#&nbsp;of&nbsp;Stock&nbsp;Options</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Outstanding</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">#&nbsp;of&nbsp;Stock&nbsp;Options</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Vested</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD COLSPAN="4" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #ffffff">&nbsp;&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#ffffff"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">Kenneth M. Bate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">50,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">40,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#ffffff"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">Fred B. Craves, Ph.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">50,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">40,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#ffffff"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">James M. Daly</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">20,500</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#ffffff"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">Keith R. Gollust</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">50,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">40,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#ffffff"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">Richard S. Levy, M.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">50,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">40,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#ffffff"></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">David Milligan, Ph.D.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">20,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">10,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15.0pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The amount listed in this column reflects fees in respect of consultations concerning drug development and regulatory
matters. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">40</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">DIRECTOR COMPENSATION </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><A NAME="toc878734_28"></A>Report of the Compensation Committee of the Board of Directors </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Compensation Committee of our Board of Directors has reviewed and discussed the Compensation Discussion and Analysis required by Item&nbsp;402(b) of Regulation S-K,
which appears elsewhere in this proxy statement, with our management. Based on this review and discussion, the Compensation Committee has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in our proxy
statement and incorporated by reference in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">MEMBERS OF THE COMPENSATION COMMITTEE: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Richard S. Levy, M.D. (Chairman) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Kenneth M. Bate </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Fred B. Craves, Ph.D. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">David Milligan, Ph.D. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_29"></A>EQUITY COMPENSATION PLAN INFORMATION </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following table provides certain aggregate information with
respect to all of our equity compensation plans in effect as of December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD style="width:46pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:46pt"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD style="width:37pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:37pt"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD style="width:46pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:46pt"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD style="width:0pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:0pt"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff">Plan Category</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">(a)</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Securities&nbsp;to&nbsp;be</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Issued Upon Exercise of</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Outstanding Options,</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Warrants and Rights</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">(b)</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Weighted&nbsp;Average</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Exercise Price of</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Outstanding&nbsp;Options,</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Warrants and Rights</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">(c)</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Securities</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Remaining&nbsp;Available&nbsp;for</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">Future Issuance Under</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">Equity&nbsp;Compensation&nbsp;Plans</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">(excluding securities</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff">reflected</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff">in column (a))</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="4" VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Equity Compensation Plans Approved by Security Holders<SUP
STYLE="font-size:85%; vertical-align:top"> (1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">1,461,987</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">$64.67</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">1,351,345</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#ffffff">Total</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT COLOR="#ffffff">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT COLOR="#ffffff">1,461,987</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT COLOR="#ffffff">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT COLOR="#ffffff">$64.67</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT COLOR="#ffffff">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT COLOR="#ffffff">1,351,345</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">These shares relate to those authorized under our Amended 2015 Stock Plan, as amended at the 2019 Annual Meeting of
Stockholders. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">42</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_30"></A>DELINQUENT SECTION 16(a) REPORTS </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The members of our Board of Directors, our executive officers,
and persons who beneficially own more than ten percent of our outstanding common stock are subject to the reporting requirements of Section&nbsp;16 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which require them to file
reports with respect to their beneficial ownership of our common stock and their transactions in our common stock. Based upon (i)&nbsp;the copies of Section&nbsp;16 reports which we received from such persons for their 2019 year transactions in our
common stock and their common stock holdings, and (ii)&nbsp;written representation that no other reports were required, we believe that all reporting requirements under Section&nbsp;16 for such year were met in a timely manner by our directors,
executive officers and greater than ten percent beneficial owners, with the exception of two transactions that were not timely filed in two Form 4 reports by our Director, David Milligan. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_31"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Other than the compensation amounts or arrangements for our
named executive officers and directors already disclosed under &#147;Executive Officer and Director Compensation,&#148; herein, and except as disclosed below, there have been no transaction or series of similar transactions, since January&nbsp;1,
2019, to which we were a party or will be a party, in which: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the amounts involved exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets at
year-end; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate
family of the foregoing persons, had or will have a direct or indirect material interest. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Brian Lynch and James Daly served as consultants to
Madrigal prior to their appointment as an executive officer and director, respectively, of Madrigal. With regard to consulting services rendered in respect of 2019 services, Mr.&nbsp;Lynch received a stock option to purchase 3,000 shares of common
stock at an exercise price of $114.50 per share and cash compensation of $151,203. In respect of 2019 consulting services, Mr.&nbsp;Daly received stock options to purchase 500 shares of common stock at an exercise price of $112.94 per share and cash
compensation of $28,500.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Indemnification Agreements </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We have entered into
indemnification agreements with each of our directors and executive officers and certain other key employees. The indemnification agreements provide that we will indemnify each of our directors, executive officers and such other key employees
against any and all expenses incurred by that director, executive officer, or other key employee because of his or her status as one of our directors, executive officers, or other key employees, to the fullest extent permitted by Delaware law, our
restated certificate of incorporation and our amended and restated bylaws. In addition, the indemnification agreements provide that, to the fullest extent permitted by Delaware law, we will advance all expenses incurred by our directors, executive
officers and other key employees in connection with a legal proceeding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Policy for Approval of Related Person Transactions </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to the written charter
of our Audit Committee, the Audit Committee is responsible for reviewing and approving, prior to our entry into any such transaction, all transactions in which we are a participant and in which any of the following persons has or will have a direct
or indirect material interest: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">our executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">our directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the beneficial owners of more than 5% of our securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">the immediate family members of any of the foregoing persons; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">any other persons whom the Board of Directors determines may be considered related persons. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">For purposes of these procedures, &#147;immediate family members&#148; means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and any person (other than a tenant or employee) sharing the household with the executive officer, director or 5% beneficial owner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">In reviewing and approving such transactions, the Audit Committee shall obtain, or shall direct our management to obtain on its behalf, all information that the
committee believes to be relevant and important to a review of the transaction prior to its approval. Following receipt of the necessary information, a discussion shall be held of the relevant factors if deemed to be necessary by the committee prior
to approval. If a discussion is not deemed to be necessary, approval may be given by written consent of the committee. This approval authority may also be delegated to the chairman of the Audit Committee in some circumstances. No related person
transaction shall be entered into prior to the completion of these procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Audit Committee or its chairman, as the case may be, shall approve only those
related person transactions that are determined to be in, or not inconsistent with, the best interests of the Company and our stockholders, taking into account all available facts and circumstances as the committee or the chairman determines in good
faith to be necessary. These facts and circumstances will typically include, but not be limited to, the benefits of the transaction to our company; the impact on a director&#146;s independence in the event that the related person is a director, an
immediate family member of a director or an entity in which a director is a partner, stockholder or executive officer; the availability of other sources for comparable products or services; the terms of the transaction; and the terms of comparable
transactions that would be available to unrelated third parties or to employees generally. No member of the Audit Committee shall participate in any review, consideration or approval of any related person transaction with respect to which the member
or any of his or her immediate family members is the related person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">44</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_32"></A>PROPOSAL NO. 1: ELECTION OF DIRECTORS </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Summary </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of Directors currently consists of eight members, classified into three classes as follows: Paul A. Friedman, M.D., Kenneth M. Bate and James M. Daly are the
Class&nbsp;I directors with a term ending at the 2020 Annual Meeting of Stockholders; Rebecca Taub, M.D. and Fred B. Craves, Ph.D. are the Class&nbsp;II directors with a term ending at the 2021 Annual Meeting of Stockholders; and Keith R. Gollust,
David Milligan, Ph.D. and Richard S. Levy, M.D. are the Class&nbsp;III directors with a term ending at the 2022 Annual Meeting of Stockholders. At each Annual Meeting of Stockholders, directors are elected for a full term of three years to succeed
those directors whose terms are expiring. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On March&nbsp;5, 2020, our Nominating and Governance Committee nominated Paul A. Friedman, M.D., Kenneth M. Bate and
James M. Daly as Class&nbsp;I directors for election at the Annual Meeting for a term of three years to serve until the 2023 Annual Meeting of Stockholders, and until their respective successors have been elected and qualified, or until their
earlier death, resignation, retirement or removal. Unless authority to vote for any of these nominees is withheld, the shares represented by a validly executed proxy will be voted FOR the election of Paul A. Friedman, M.D., Kenneth M. Bate and James
M. Daly as directors. In the event that either nominee should become unable or unwilling to serve, the shares represented by a validly executed proxy will be voted for the election of such other person as the Board of Directors may recommend in his
or her place, as the case may be, unless the Board of Directors chooses to reduce the number of directors serving on the Board of Directors. We have no reason to believe that any nominee will be unable or unwilling to serve as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Vote Required </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Directors are elected by a plurality of the affirmative votes cast by
those shares deemed present in person or represented by proxy and entitled to vote at the Annual Meeting. The three nominees for director receiving the highest number of affirmative votes will be elected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Recommendation of the Board of Directors </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>THE BOARD OF DIRECTORS UNANIMOUSLY
RECOMMENDS THAT OUR STOCKHOLDERS VOTE &#147;FOR&#148; THE ELECTION OF PAUL A. FRIEDMAN, M.D., KENNETH M. BATE AND JAMES M. DALY AS DIRECTORS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN ACCORDANCE WITH THE BOARD&#146;S RECOMMENDATION UNLESS
A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_33"></A>PROPOSAL NO. 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Summary </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Audit Committee has appointed PricewaterhouseCoopers LLP, independent
registered public accounting firm, to audit our financial statements for the fiscal year ending December&nbsp;31, 2020. PricewaterhouseCoopers LLP audited our financial statements for the fiscal year ended December&nbsp;31, 2019. The Board of
Directors proposes that our stockholders ratify this appointment. In the event our stockholders do not ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm, the Audit Committee will reconsider its
appointment. We do not expect a representative of PricewaterhouseCoopers LLP to be present at the Annual Meeting or to otherwise be available to make a statement or respond to questions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Accounting Fees and Services </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The following table summarizes the aggregate fees for
professional services rendered (1)&nbsp;to us by PricewaterhouseCoopers LLP for the years ended December&nbsp;31, 2019 and December&nbsp;31, 2018, and (2)&nbsp;to Private Madrigal by Friedman LLP, independent accounting firm, in 2018 for consents
and comfort letter services rendered during such period. The Audit Committee pre-approved all services fees described below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR BGCOLOR="#0075c9" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0075c9; BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">2019</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9"><FONT COLOR="#ffffff">2018</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0075c9; BORDER-RIGHT:1px solid #0075c9; BORDER-BOTTOM:2.00pt solid #0075c9; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Audit fees</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">526,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(1)&nbsp;</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">540,300</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Audit-related fees</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Tax fees</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#e5e5e5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">All other fees</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">2,862</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5" ALIGN="right">2,900</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #e5e5e5">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL"><FONT COLOR="#FFFFFF">Total</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9" ALIGN="right"><FONT COLOR="#FFFFFF">553,862</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#0075c9" STYLE=" BORDER-BOTTOM:1px solid #0075c9">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9" ALIGN="right"><FONT COLOR="#FFFFFF">568,200</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0075c9" BGCOLOR="#0075c9"><FONT COLOR="#FFFFFF">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Fees in this column consist of fees for professional services rendered to us by PricewaterhouseCoopers LLP.
</P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Audit fees for this year consist of $533&nbsp;thousand of fees for professional services rendered to us by
PricewaterhouseCoopers LLP and seven&nbsp;thousand of fees for professional services rendered by Friedman, LLP. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Audit Fees </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Audit services consist of fees and expenses for the audit of our annual financial statements included in our Forms&nbsp;10-K, and the related audit of internal control
over financial reporting included in our Annual Report on Form&nbsp;10-K, review of interim financial statements included in our Forms 10-Q, consultations regarding accounting and auditing matters, and fees in connection with our underwritten public
offering of shares of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Tax Fees </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Tax fees consist of
fees billed for professional services for tax compliance, tax planning, and tax advice. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-audit
Services of Independent Auditors </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Consistent with policies of the SEC regarding auditor independence, the Audit Committee has responsibility for appointing, setting
compensation and overseeing the work of our independent registered public accounting firm. In recognition of this responsibility, the Audit Committee has established a policy to pre-approve all audit and permissible non-audit services provided by
our independent registered public accounting firm. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">46</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">PROPOSAL NO. 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM </FONT></P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Prior to engagement of an independent registered public accounting firm for the next year&#146;s audit, management will submit an aggregate of services expected to be
rendered during that year for each of four categories of services to the Audit Committee for approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">1.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Audit</I></B> services
include audit work performed in the preparation of financial statements, as well as work that generally only an independent registered public accounting firm can reasonably be expected to provide, including comfort letters, statutory audits, and
attest services and consultation regarding financial accounting and/or reporting standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">2.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Audit-Related</I></B> services are for
assurance and related services that are traditionally performed by an independent registered public accounting firm, including due diligence services, employee benefit plan audits, and special procedures required to meet certain regulatory
requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">3.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Tax</I></B> services include all services performed by an independent registered public accounting firm&#146;s tax
personnel except those services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">4.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Other Fees</I></B> are those associated with services not captured in the other categories. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Prior to engagement, the Audit Committee pre-approves these services by category of service. The fees are budgeted and the Audit Committee requires our independent
registered public accounting firm and management to report actual fees versus the budget periodically throughout the year by category of service. During the year, circumstances may arise when it may become necessary to engage our independent
registered public accounting firm for additional services not contemplated in the original pre-approval. In those instances, the Audit Committee requires specific pre-approval before engaging our independent registered public accounting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Audit Committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated must report, for informational
purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Report of the Audit Committee of the Board of Directors </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The information contained in this &#147;Report of the Audit Committee of the Board of Directors&#148; shall not be: deemed to be &#147;soliciting material&#148; or to be
&#147;filed&#148; with the SEC, nor shall such information be incorporated by reference into any of our filings with the SEC, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing; or
subject to the liabilities of Section&nbsp;18 of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Audit Committee, which consists entirely of directors who meet the independence and
experience requirements of The Nasdaq Stock Market, has furnished the following report: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Audit Committee assists the Board of Directors in overseeing and
monitoring the integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of internal and external audit processes. The Audit Committee&#146;s role and responsibilities are set forth in a charter
adopted by the Board of Directors, which is publicly available through the &#147;Investors&#151;Corporate Governance&#148; section of our website at<I> www.madrigalpharma.com</I>. The Audit Committee reviews and reassesses its charter annually and
recommends any changes to the Board of Directors for approval. The Audit Committee is responsible for overseeing our overall financial reporting process, and for the appointment, compensation, retention, and oversight of the work of our independent
registered public accounting firm. In fulfilling its responsibilities for the financial statements for the fiscal year ended December&nbsp;31, 2019, the Audit Committee took the following actions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Reviewed and discussed the audited financial statements for the fiscal year ended December&nbsp;31, 2019 with management
and PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited our financial statements for the fiscal year ended December&nbsp;31, 2019; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">PROPOSAL NO. 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</FONT></P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Discussed with PricewaterhouseCoopers LLP the applicable requirements of the Public Company Accounting Oversight Board, or
PCAOB; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Received written disclosures and the letter from PricewaterhouseCoopers LLP regarding its independence as required by the
applicable requirements of the PCAOB regarding PricewaterhouseCoopers LLP&#146;s communications with the Audit Committee and the Audit Committee further discussed with PricewaterhouseCoopers LLP their independence. The Audit Committee also
considered the status of taxation matters and other areas of oversight relating to the financial reporting and audit process that the committee determined appropriate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Based on the Audit Committee&#146;s review of the audited financial statements and discussions with management and PricewaterhouseCoopers LLP, the Audit Committee
recommended to the Board that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2019 in our filing with the SEC. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">MEMBERS OF THE AUDIT COMMITTEE:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Kenneth M. Bate (Chairman)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Keith R. Gollust</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">David Milligan, Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; ">
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The material in this Report of the Audit Committee is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with
the SEC and is not to be incorporated by reference into any filing of Madrigal Pharmaceuticals, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in
any such filing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Vote Required </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The vote of a majority of the votes cast
affirmatively at the Annual Meeting on the proposal is required to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If our stockholders ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm, the Audit Committee may still, in its
discretion, decide to appoint a different independent registered public accounting firm at any time during the year ending December&nbsp;31, 2020, if it concludes that such a change would be in the best interests of our company and our stockholders.
If our stockholders fail to ratify the appointment, the Audit Committee will reconsider, but not necessarily rescind, the appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Recommendation of the Board
of Directors </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT OUR STOCKHOLDERS VOTE &#147;FOR&#148; RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS
LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN ACCORDANCE WITH THE BOARD&#146;S RECOMMENDATION UNLESS A STOCKHOLDER INDICATES OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">48</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_34"></A>PROPOSAL NO. 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">General </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Pursuant to Section&nbsp;14A(a)(1) of the Exchange Act, we are providing
our stockholders with an opportunity to approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with the compensation disclosure rules of the SEC (commonly
referred to as a &#147;say-on-pay&#148; vote). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Prior to casting your vote on this proposal, you are encouraged to read the proxy statement sections entitled
&#147;Compensation Discussion and Analysis&#148; and &#147;Executive Officer and Director Compensation&#148; for a detailed discussion of our policies and practices relating to the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Compensation Committee believes that the objectives of our executive compensation program, as it relates to our named executive officers, are appropriate for a
company of our size and stage of development and that our compensation policies and practices help meet those objectives. In addition, our Compensation Committee believes that our executive compensation program, as it relates to our named executive
officers, achieves an appropriate balance between fixed compensation and variable incentive compensation, pays for performance and promotes an alignment between the interests of our named executive officers and our stockholders. Accordingly, we are
asking our stockholders to approve the compensation of our named executive officers. This advisory vote is not intended to be limited or specific to any particular element of compensation, but rather to cover the overall compensation of our named
executive officers and the compensation policies and practices described in this proxy statement as it relates to our named executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Resolution </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Our Board of Directors is asking our stockholders to indicate their support for the compensation of our named executive officers, as described in this proxy statement,
by casting a non-binding advisory vote &#147;FOR&#148; the following resolution: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>&#147;RESOLVED, that the compensation paid to the named executive officers of
Madrigal Pharmaceuticals, Inc., as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables and the related material disclosed in
this proxy statement, is hereby APPROVED.&#148; </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Vote Required </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The
foregoing resolution will be approved on an advisory basis by the affirmative vote of a majority of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote on the proposal. Because this proposal is advisory,
the results of the vote will not be binding on us, our Board of Directors or our Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Recommendation of the Board of Directors </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT OUR STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL ON AN ADVISORY BASIS OF THE COMPENSATION OF OUR NAMED EXECUTIVE
OFFICERS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN ACCORDANCE WITH THE BOARD&#146;S RECOMMENDATION UNLESS A STOCKHOLDER INDICATES OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_35"></A>CODE OF CONDUCT AND ETHICS </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We have adopted a code of conduct and ethics that applies to
all of our directors and employees, including our chief executive officer and chief financial and accounting officer. The text of the code of conduct and ethics is posted on the &#147;Investors&#151;Corporate Governance&#148; section of our website
at<I><U> www.madrigalpharma.com</U></I>. Disclosure regarding any amendments to, or waivers from, provisions of the code of conduct and ethics that apply to our directors or principal executive and financial officers will be included in a Current
Report on Form 8-K within four business days following the date of the amendment or waiver, unless website posting or the issuance of a press release of such amendments or waivers is then permitted by the rules of NASDAQ. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_36"></A>OTHER MATTERS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Board of Directors knows of no other business which will be
presented at the Annual Meeting. If any other business is properly brought before the Annual Meeting, proxies in the enclosed form will be voted in accordance with the judgment of the persons named therein. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_37"></A>STOCKHOLDER PROPOSALS AT FUTURE ANNUAL MEETINGS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">To be considered for inclusion in the proxy statement relating
to our 2021 Annual Meeting of Stockholders, we must receive stockholder proposals subject to Rule 14a-8 under the Exchange Act no later than February 12, 2021; provided, however, that in the event that the date of the 2021 Annual Meeting is more
than thirty (30)&nbsp;days before or more than thirty (30)&nbsp;days after the anniversary date of the preceding year&#146;s Annual Meeting, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the
ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> ) day prior to such Annual Meeting and not later than the close of business on the later of the sixtieth (60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> ) day prior to
such Annual Meeting or the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> ) day following the day on which we make a public announcement of the date of such meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">A stockholder&#146;s nomination of persons for election to the Board of Directors (a &#147;Director Nomination Proposal&#148;) or for the proposal of business to be
considered by the stockholders (a &#147;Business Proposal&#148;) may be made at an annual meeting of stockholders if certain requirements are met including the following procedural requirements: (1) the stockholder must have given timely notice
thereof in writing to the Secretary of the Corporation (as described in greater detail below), (2) such other business must otherwise be a proper matter for stockholder action under the Delaware General Corporation Law, and (3) if the stockholder
intends to deliver a proxy statement and form of proxy to stockholders of, in the case of a proposal, at least the percentage of the Corporation&#146;s voting shares required under applicable law to carry the proposal or, in the case of a nomination
or nominations, a sufficient number of holders of the Corporation&#146;s voting shares to elect such nominee or nominees, the stockholder shall have satisfied applicable proxy statement and form of proxy notice and delivery requirements sufficient
to carry the applicable Director Nomination Proposal or Business Proposal under applicable law or satisfied solicitation requirements, in each case, as set forth in our Bylaws. To be timely, a stockholder&#146;s notice concerning the foregoing
matters pertaining to an annual meeting shall be delivered to the Secretary at the principal executive offices of the Corporation not less than forty-five (45) or more than seventy-five (75) days prior to the first anniversary of the date on which
the Corporation first mailed its proxy materials for the preceding year&#146;s annual meeting; <U>provided</U>, <U>however</U>, that in the event that the date of the annual meeting is more than thirty (30) days before or more than thirty (30) days
after the anniversary date of the preceding year&#146;s annual meeting, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the ninetieth (90) day prior to such annual meeting and not later than the
close of business on the later of the sixtieth (60th) day prior to such annual meeting or the close of business on the tenth (10th) day following the day on which public announcement of the date of such meeting is first made by the Corporation
(collectively, the &#147;Meeting Matter Notice Requirement&#148;). The submission window to meet the Meeting Matter Notice Requirement for the 2021 Annual Meeting of Stockholders runs from April 2, 2021 to May 2, 2021. In addition, such
stockholder&#146;s notice for an annual meeting shall set forth: (a) as to each person whom the stockholder proposes in a Director Nomination Proposal all information relating to such person that is required to be disclosed in solicitations of
proxies for election of directors, or is otherwise required, in each case, pursuant to Regulation 14A under the Exchange Act (including such person&#146;s written consent to being named in the proxy statement as a nominee and to serving as a
director if elected); (b) as to any Business Proposal a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest in such business of such
stockholder and the beneficial owner, if any, on whose behalf the proposal is made; and (c) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such
stockholder, as they appear on the Corporation&#146;s books, and of such beneficial owner, (ii) the class and number of shares of the Corporation that are owned beneficially and held of record by such stockholder and such beneficial owner, and (iii)
whether either such stockholder or beneficial owner intends to deliver a proxy statement and form of proxy to holders at least the percentage of the Corporation&#146;s voting shares required under applicable law to carry the proposal or, in the case
of a nomination or nominations, a sufficient number of holders of the Corporation&#146;s voting shares to elect such nominee or nominees as described above. The foregoing Bylaw provisions related to a Director Nomination Proposal are referenced to
elsewhere in this proxy statement as Bylaw Provisions Related to Stockholder Nominations of Director Candidates and such nominations are subject to additional requirements as set forth in this proxy statement. See &#147;Management and Corporate
Governance &#151; Committees of the Board of Directors and Meetings; Nominating and Governance Committee.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Proposals that are not a proper subject for
consideration or that are not received in a timely manner will not be voted on at the 2021 Annual Meeting. If a proposal is proper and received on time, the proxies that management solicits for the meeting may still exercise discretionary voting
authority on the proposal under circumstances consistent with the proxy rules of the SEC. All stockholder proposals should be marked for the attention of Corporate Secretary, Madrigal Pharmaceuticals, Inc., 200 Barr Harbor Drive, Suite 200, West
Conshohocken, Pennsylvania 19428. </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_38"></A>HOUSEHOLDING OF PROXY MATERIALS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The SEC has adopted rules that permit companies and
intermediaries to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet
Availability of Proxy Materials or other Annual Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for
companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">50</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0075c9">HOUSEHOLDING OF PROXY MATERIALS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">This year, a number of brokers with account holders who are our stockholders will be &#147;householding&#148; our proxy materials. A single Notice of Internet
Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be
&#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#147;householding&#148; and
would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or us. Direct your written request to Madrigal Pharmaceuticals, Inc., Corporate Secretary, 200 Barr Harbor Drive, Suite 200, West
Conshohocken, Pennsylvania 19428. Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#147;householding&#148; of their communications should
contact their brokers. In addition, we will promptly deliver, upon written request to the address above, a separate copy of the Notice of Internet Availability of Proxy Materials or the full set of proxy materials, as applicable, to a stockholder at
a shared address to which a single copy of the documents was delivered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Our Annual Report on Form 10-K for the year ended December&nbsp;31, 2019 is available
without charge upon written request to: Madrigal Pharmaceuticals, Inc., Corporate Secretary, 200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428. Our Annual Report on Form 10-K is not incorporated into this Proxy Statement and is
not considered proxy soliciting material. </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9"><A NAME="toc878734_39"></A>DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">This proxy statement contains &#147;forward-looking
statements&#148; made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, that are based on our beliefs and assumptions and on information currently available to us, but are subject to factors beyond our
control. Forward-looking statements include but are not limited to statements or references concerning: our clinical trials, research and development activities, and the timing and results associated with the future development of our lead product
candidate, resmetirom; our primary and secondary study endpoints for resmetirom and the potential for achieving such endpoints and projections; optimal dosing levels for resmetirom; projections regarding potential future NASH resolution, safety,
fibrosis treatment, cardiovascular effects, lipid treatment or biomarker effects with resmetirom; the predictive power of liver fat reduction on NASH resolution with fibrosis reduction; the achievement of enrollment objectives concerning patient
number, safety database and/or timing for our studies; potential NASH or NAFLD patient risk profile benefits with resmetirom; and our possible or assumed future results of operations and expenses, business strategies and plans, capital needs and
financing plans, trends, market sizing, competitive position, industry environment and potential growth opportunities, among other things. Forward-looking statements: reflect management&#146;s current knowledge, assumptions, judgment and
expectations regarding future performance or events; include all statements that are not historical facts; and can be identified by terms such as &#147;anticipates,&#148; &#147;be,&#148; &#147;believes,&#148; &#147;continue,&#148; &#147;could,&#148;
&#147;demonstrates,&#148; &#147;design,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;forecasts,&#148; &#147;future,&#148; &#147;goal,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plans,&#148; &#147;potential,&#148;
&#147;predicts,&#148; &#147;predictive,&#148; &#147;projects,&#148; &#147;seeks,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would&#148; or similar expressions and the negatives of those terms.&nbsp;Although management presently believes that
the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the
forward-looking statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to: our clinical development
of resmetirom: enrollment uncertainties, generally and in relation to COVID-19 mandatory lock-down measures and individual precautionary measures that may be implemented for an uncertain period of time; outcomes or trends from competitive studies;
the risks of achieving potential benefits in studies that includes substantially more patients than our prior studies; the timing and outcomes of clinical studies of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center">2020&nbsp;<FONT COLOR="#0075c9">PROXY&nbsp;STATEMENT</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="middle">&nbsp;</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0075c9">DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS </FONT></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #e5e5e5">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">resmetirom; and the uncertainties inherent in clinical testing. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they
are made. Madrigal undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events. Please refer to
Madrigal&#146;s filings with the U.S. Securities and Exchange Commission for more detailed information regarding these risks and uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. We
specifically discuss these risks and uncertainties in greater detail in the section entitled &#147;Risk Factors&#148; in Part I, Item&nbsp;1A of our Annual Report on Form 10-K for the year ended December&nbsp;31, 2019, as well as in our other
filings with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time and it is not possible for our
management to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual future results to be materially different from those
expressed or implied by any forward-looking statements. Except as required by applicable law or the rules of the NASDAQ Stock Market, or NASDAQ, we assume no obligation to update any forward-looking statements publicly, or to update the reasons
actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. We qualify all of our forward-looking statements by these cautionary statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9">MADRIGAL PHARMACEUTICALS, INC. </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9">200 BARR HARBOR DRIVE, SUITE 200 </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT COLOR="#0075c9">WEST CONSHOHOCKEN, PENNSYLVANIA 19428 </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:ARIAL"><FONT
 COLOR="#0075c9">(267) 824-2827 </FONT></P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">West Conshohocken, Pennsylvania </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">May&nbsp;5, 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"><FONT STYLE="font-size:10pt">52</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g878734g44q12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #e5e5e5">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="15"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878734mm.jpg" ALT="LOGO">
</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>ANNUAL MEETING OF MADRIGAL
PHARMACEUTICALS, INC.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="13"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="13"><FONT STYLE="font-size:8pt"><B>Date:</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;June 17, 2020</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" ROWSPAN="19">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="19"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">&nbsp;&nbsp;


<IMG SRC="g878734pc01a.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="13"><FONT STYLE="font-size:8pt"><B>Time:</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9:00 a.m. Eastern Time</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="15"><FONT STYLE="font-size:8pt"><B>Virtual Meeting Address:</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>www.proxydocs.com/MDGL</U></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="13"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Please make your marks like
this:&nbsp;</B>&#9746;<B></B><B>&nbsp;Use dark black pencil or pen only</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="13"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Board of Directors Recommends a Vote <B>FOR</B> proposals
1, 2, and 3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>1:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="9"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Election of Class I Directors</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Directors</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Recommend</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="FONT-FAMILY:'WINGDINGS 3'">&#228;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-size:8pt"><B>For</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-size:8pt"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">01&nbsp;Paul&nbsp;A.&nbsp;Friedman,&nbsp;M.D.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>For</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">02&nbsp;Kenneth&nbsp;M.&nbsp;Bate&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>For</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">03&nbsp;James&nbsp;M.&nbsp;Daly</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>For</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>2:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31,
2020.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Against</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstain</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>3:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Advisory vote on compensation of named executive
officers.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>4:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">In their discretion, the proxies are authorized to vote and
act upon any other matters which may properly come before the meeting or any adjournment or postponement thereof.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>&#9744;<B></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>&#9744;<B></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>&#9744;<B></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="9"> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Authorized Signatures - This section must be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>completed for your Instructions to be executed.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:7pt; font-family:Times New Roman"><FONT STYLE="font-size:12pt"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman"><FONT STYLE="font-size:12pt"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">Please Sign Here</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7" ALIGN="center"><FONT STYLE="font-size:8pt">Please Date Above</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:7pt; font-family:Times New Roman"><FONT STYLE="font-size:12pt"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman"><FONT STYLE="font-size:12pt"> &nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">Please Sign Here</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7" ALIGN="center"><FONT STYLE="font-size:8pt">Please Date Above</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="11"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Please sign exactly as your name(s) appears on your stock
certificate. If held in joint tenancy, all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the proxy.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> </DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="52%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g878734mm.jpg" ALT="LOGO">
</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of
Madrigal Pharmaceuticals, Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be held at 9:00 a.m. on Wednesday, June 17, 2020</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>for Holders as of April 24, 2020</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is being solicited on behalf of the Board of Directors</B></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>


<IMG SRC="g878734pc01b.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>INTERNET</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" align="left">Go To</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>www.proxypush.com/MDGL </B>to<B></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;<U>VOTE&nbsp;BY:</U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g878734pc01c.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>TELEPHONE</U></B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;866-249-5094</B></P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">&#149;&nbsp;&nbsp;Cast&nbsp;your&nbsp;vote&nbsp;online.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OR</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#149;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Use any touch-tone telephone.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="5">&#149;&nbsp;&nbsp;View&nbsp;Meeting&nbsp;Documents.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#149;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Have your Proxy Card/Voting Instruction Form ready.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g878734pc01d.jpg" ALT="LOGO">
&nbsp;<U><B>MAIL</B></U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#149;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Follow the simple recorded instructions.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>OR</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#149;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Mark, sign and date your Proxy Card/Voting Instruction Form.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#149;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Detach your Proxy Card/Voting Instruction Form.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#149;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Return your Proxy Card/Voting Instruction Form in the postage-paid envelope provided.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="9"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">The undersigned hereby appoints Paul A. Friedman, M.D.,
Marc R. Schneebaum and Brian J. Lynch, and each or either of them, as the true and lawful proxies of the undersigned, with full power of substitution and revocation, and authorizes them, and each of them, to vote all the shares of capital stock of
Madrigal Pharmaceuticals, Inc. which the undersigned is entitled to vote at said meeting and any adjournment or postponement thereof upon the matters specified and upon such other matters as may be properly brought before the meeting or any
adjournment or postponement thereof, conferring authority upon such true and lawful proxies to vote in their discretion on such other matters as may properly come before the meeting and revoking any proxy heretofore given.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="9"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS
DIRECTED OR, IF NO DIRECTION IS GIVEN, SHARES WILL BE VOTED FOR THE ELECTION OF THE DIRECTORS IN PROPOSAL 1, AND FOR PROPOSALS 2 AND 3 AND AUTHORITY WILL BE DEEMED GRANTED CONCERNING PROPOSAL&nbsp;4.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="9"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>
</TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman"><B>PROXY TABULATOR FOR</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman"><B>MADRIGAL PHARMACEUTICALS, INC.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>P.O. BOX 8016</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>CARY, NC 27512-9903</B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt" BGCOLOR="#bfbfbf">&nbsp;</TD>
<TD HEIGHT="10" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000" BGCOLOR="#bfbfbf">&nbsp;</TD>
<TD HEIGHT="10" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000" BGCOLOR="#bfbfbf">&nbsp;</TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>

<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt" BGCOLOR="#bfbfbf">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#bfbfbf" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" BGCOLOR="#bfbfbf"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> </P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#bfbfbf" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#bfbfbf">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1.00pt solid #000000; BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:1.00pt solid #000000; BORDER-RIGHT:1.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:1.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.00pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.00pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 </DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Proxy &#151; Madrigal Pharmaceuticals, Inc.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Annual Meeting of Stockholders</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>June 17, 2020 9:00 a.m. (Eastern Time)</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This Proxy is Solicited on Behalf of the Board of Directors</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g878734pc02.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned appoints Paul A. Friedman, M.D., Marc R. Schneebaum and Brian J. Lynch, (the &#147;Named Proxies&#148;) and each of them as
proxies for the undersigned, with full power of substitution, to vote the shares of common stock of Madrigal Pharmaceuticals, Inc., a Delaware corporation (&#147;the Company&#148;) that the undersigned is entitled to vote at the Annual Meeting of
Stockholders of the Company to be held via webcast at <U>www.proxydocs.com/MDGL</U>, on Wednesday, June 17, 2020 at 9:00 a.m. Eastern Time and all adjournments and postponements thereof.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of the Annual Meeting is to take action on the following:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1.&#8195;&#8201;To elect three Class I
directors;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2.&#8195;&#8201;To ratify the
appointment of our independent registered public accounting firm;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3.&#8195;&#8201;To approve, on an advisory basis, the compensation of our named executive officers; and</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">4.&#8195;&#8201;To transact such other business
properly presented at the meeting and any adjournments or postponements.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class
I directors up for election are Paul&nbsp;A. Friedman, M.D., Kenneth&nbsp;M. Bate and James&nbsp;M. Daly.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors of the Company recommends a vote &#147;FOR&#148; all nominees for director, and &#147;FOR&#148; proposals 2 and 3.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This proxy, when properly executed, will be voted in the manner directed herein. If
no direction is made, this proxy will be voted &#147;FOR&#148; all nominees for director, and &#147;FOR&#148; proposals 2 and 3. In their discretion, the Named Proxies are authorized to vote upon such other matters that may properly come before the
Annual Meeting or any adjournment or postponement thereof.</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You are
encouraged to specify your choice by marking the appropriate box (SEE REVERSE SIDE) but you need not mark any box if you wish to vote in accordance with the Board of Directors&#146; recommendation. The Named Proxies cannot vote your shares unless
you sign and return this card.</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>To&nbsp;attend&nbsp;the&nbsp;meeting via webcast,</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&#9744;<B></B><B></B></TD>
<TD VALIGN="bottom" ALIGN="right"><B></B><B></B><B></B></TD>
<TD NOWRAP VALIGN="bottom"><B></B><B></B><B></B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>please mark this box.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g878734g16t43.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734g16t43.jpg
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M #\ O\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M^1Z<MX3Z/*\_4;\D:DK
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MLLJRV<=%=PUE7.5SFNQMZQ#6:YRJJJJX]:;_ %]?I<?#A5DS(C)K
M             ,&=H/Y:>P_]AG+7^ =@-BU#^UNK_P Q83^IU35]X_L7M_\
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M !Z?^GS%B/8Z_M=MO\N0?U.N6]RCIT'
M                   . VK:]:T?7;?;=PO:O6M9H(3MC<WMU,9@5E=#9\O6
M_*E2%H;;QE64MMH\\N//+;890X\XA"O+=NT\;4L7K]F&G3JQNEL6;$C8H88V
M_%SY'JC43E41$YY<Y4:U%<J(OMQV.OY>]5QN+IV+^0NRM@J4ZD3YK$\K_@R.
M-B*YR\(KG+QPUJ.>Y4:U52NMV_\ &#VG9Y%IH?5E+^HZPE3T*7RM9PTXVZ\1
MYJ:<<U2JF-K:U:N>3Z\L6=@P_LKK;C,AAG69C*D+J=OW7RY<=/C-*1]&GRZ.
M3.31\7K*>K56A!(BI2A<G*MFF:ZXJ*US64Y&JBWCZ8>R_CL>RMF>HBLR>05&
MRQ:W7E5<947T<U,E9B5'Y&=J\(^O ]E!CFO8]^0B>BMTAZ!\?W?8?NGQBO:Y
MMIM'U3L3O*>[7-Y-E7$^='TI*;N.]<S9SLB5/3:[$S14TE<IUS+J;+"75*1G
M.,QQTNQ=G;.HF&6]+/=\%IV;R-BS(^Q+(W'(EACIY)'/?(DUMM:N]7N7E)O5
M53T)<ZT9NIH_2C8$QT-?'>\T6ZYB:M2*.K#"_+*M21E2&%L<<*UJ+[EJ-(FM
M[5@Y:B*G)8<\3_FG'#G43?FX4OX;8^3\Q^+-?PA?I>RC:&I*MG>3A.<.I2SI
MT*_;1(1Z<,39$'S6E3B,*M;UFV']']#RB1O[+>9[<)5X7AW%YK_?')Q]).W'
MQVD1R?LR.CY5%5.:0>SYJGZ4]3<*LL7DHZ_W[%=Y3EJ+CG1ICVJJIVJKLI+2
M56+RKXF3<(J-<J4\2@AU# !8J\%SK1FMI=I[0;17^F7?XF:-QC\2W\VZ6')1
MC<-DC87A2<_6-K&9UN%);RV^RBGV*.KU1[#&56S]GG3O!6N[G=BXDMI)C<-W
MI\*T;T]_MLY]/UT[&U(WIPYJ5[3?5DOK1KVK=^]XMX[I[CY^8J7BR^P>-WHZ
MW+&JXNA)PJ+^HK2.ORQN[F/6U1>G#X/3Z/&9[3?4]#2=6M0LO39;(W!VWE1R
M*[]^+K\>1B1JNK/Y1E6$N7-C&QL-C'7[3[4&LHU9PY#N5I5^O:#W5*]6MI="
M;]=<2.]FE8[UCJ,=WTJ3E3X.L2M]ZE8O:YL4-?GF.PO/X]E;IW[U=M]1,G!S
M!0=-C-=;(WTDNR1]F1R+$<B<MJP2>XP/3N8Z:Q<3Z,M5%2NU6V=E36$.VI["
M;56E=(:F5]E6RWX-A!EL+PXQ*AS(KC4B+(97C"VGV'$.MKQA2%8SC&2IT,TU
M>6.>O+)!/$]LD4T,CHI8GM7EKXY&*U['M7U:YJHJ+ZHI>*Q7@MP2UK4$-FM.
MQT4]>Q&R:":-Z</CEBD:Z.1CD54<Q[5:Y/145"PMX8??GL)RYR%6\ \C5,CE
M6L;I+*U_>8XZW$VC3JFHCX],K;Y>6_AMGK94UROIHTR0F/L6;.S8<E6%QASV
MV;6=&NJ&U9[*PZOEX'9N%M::?Y85R1W:$$#4X???PC+D3Y'15V2.1MOS3-62
M2QSPRD?M!=&-)UG"3[I@K+-<L.MP5OT?:UTF/REFR]>8\7'SY,?/'$V:U)$Q
M7T4KUWMBAJ\<OGU+0%,0       4N_I!O(O[4]SM3T2-(]</B_AG6H,J-ZLJ
MPQL.V7.P;1/<\O/R1E^@EZKC*?+U9PRE>592I"4WZ]F+%>YZ%>R+V\29?/VY
M&.XX[JM*O5IQI_'MLLN>OP^EQQRB\\W?:WS'OW4?'XICE6/!ZW2BD9SRC;=^
MS;O2N1/J[ZDE!.%]?H\_!4-%O#*YY_T=>[G ^]S)GP>M6VUL\>;HMQSVHF-6
MY$0K5)LV>KS3YPZ";95^T+QC/GAVC95A+GI]M<B]7=;_ $IZ>['CHX_);@I.
MRF/1$[G^^8M??8XXD]?UEF.*6FG\+#DY3GE(NZ)[5^A_4W5<K)+XJ5B^W$9)
M554C2CET6A))+PJ<QU9)H;J_'AU9J\.XX7T+3F =<P  #IO(N\T?&/'^\\D[
M,]\/KO'^H;)NM\]ZDHRW3ZO3S+NQ4E2_NX7B)">]'G_%?IQY9\_(]^+QUC+Y
M/'8JHWNM9.]4Q]9O"KS/<GCKQ(J)Z\>21O/\#'9C*5<)B<GF;KNRGB<?<R5I
MW*)VUZ->2S,J*OISXXG<?QX/-"Y$WB[Y-W_>.2-E>^(V+?\ ;]DW2^>]2E8=
MN-HN)EW9+3E7WLHS,G/>CS_@GRQY8\O(ZU8O'5\1C,=BJC>VKC*-3'UF\(G$
M%.".O$BHGISXXV\_Q.+.7R=K-9;)YFZ[ON9;(7,E;?ZKW6;UB2S.J<\KPLDK
MN.?J+5_T<CDSZTX:[#\0O2/4YI?(^L\@0F'%^:\1.0]<=H96(^%?/V&)7'+;
MCR&_N-/S\+5A*Y7FY3+VJ<1X<_J^<:WA,ABK>,D<B>G?B[:66*[C^\YF55&J
MOJYL?">C/2]_L=9KSZYM^O.=R[&YFEEHVJOKX\O3=5?V?7VL?AT5R)Z-=*BK
MPK_6R 53+D                     &#.T'\M/8?^PSEK_ .P&Q:A_:W5_Y
MBPG]3JFK[Q_8O;_Y7V#^DVSS4CK,<7RZ+]'G_D?WC^\GO7^7G$Q07VH/WAX[
M^4\=_5,V=(_9%_=CE/YSRG](P!.V5Q+2@          J]^)CX*W+?*G-NW=@
M>JO[/;&CDVT?V3>N,;N\@:O;5VYS\X=N[W6;>Z<BT-A5[)-]^YLX5K:UDZNN
M9DM4)5A F-,5-P.DG7_"8;7Z.L;G[U5^2(6U,;EZ]>2Y#+0CY2O6N05T?9BE
MJ1]L$,D$,T<M>-B2)%)&KIZ/]:O9KV#.[+D-MT-*=Q,U.^YE,)9M14;$62F7
MNLVJ-BRL=26"Y)W6)X[%B"6&S)(L:S12(V#Y_#6\%#EKC3FS4>>^UZ-<UZ-Q
MC;P]HT?C*EOH&T6]KNM4\F50W>S6E*N705]/KD]$>YKX=9;64ZSN(<1,W$"N
MC/,VGZZL^T#A,OK][6M+6U:=EX)*>1R]BM)3@AQ\S599KU(;",LRSVHE?7ED
MF@BCA@D>L:R2O:Z'\=%_9IS^%V7'[7OJ4Z;,)8CO8S"5K45ZQ/DH'))4M79Z
MKI*D5>G,C+,44,\\L]B.-)?%"QS9[1A3TO&
M#S@^\G\ZW<'^])V!_P V=M.J_3O]W^B_R=K']$HG'#J?^\OJ'_/.V_U_($PO
MT<G^8?L!_8Q6?XXIB"O:I_LQK'^/3_T^8L1['7]KMM_ER#^IURWN4=.@X
M                                           .J[QN^J<;:CL.^;Q=
MPM<U/5JR1;WES/7E$>'"CXQYYPE.%NR)+[BFXT*%&;=ESYCT>%#8?E/LLK\6
M2R-'$4+63R5F.I1I0OGLV)5X9'&Q/5?3ESGN549'&Q'22R.;'&USW-:N1Q&(
MR.>R=+#XBI+>R61L,K4ZL*(LDLLB^B<JJ-8QC4=)++(YL4,3'RRO9&QSDJ']
MYN]^\=N=N>K(#EAJ_"NOSW%:?I'O>V[9N,Y6TUM6X8CN*9G[!*;4I46'[C]?
MKD5U4&N4_)<LK:TH=U*ZFY+>[[H8G2TM=JRJM#&]W:LZMY1M[((U5;+:>G*Q
MQ\NBJ,=XXNYZS3S=-ND'1S$=,\8VQ.V#([9=A:F4RW9W-KM<B.=C<6KVH^&E
M&[A)9>&37Y&I-.C(VUZU?0$BTFDL5>"!P]\'KO+O/%A&\GKNP@\8ZP^M'H<3
M75#<78]K=:RK'F[&GSYNLQTN(SA&)-)*;SE:T*PW;+V<,!XZ>>V:5G#K,T6&
MI/7T<D-=&6[RI]:LEEDIM14].^L]/547BC7M<;1Y;^LZ=!)RRG!-L&08B\M6
M>TZ2CC6NX7ALD,$.0>K53N\=R-WHCD[M</&CYK_;#G34>&:R7[E3Q%K6+"[9
M;7]W]L]Y:AV;S3Z4YRAW,#5HNMKC+7]]ARUL6DI1ZW,N:C[0^Q>_[+0UZ&3F
M#!4_-8:B^GRADD9,YKD3T7Q4F4U8J^K5GF:B)RO.]^REJ?R7I^3VJQ'VV=FO
M^"HY4]?DK#NEKM<U53EOFR,E])$3T>VM Y57A$;#(5[+5&8. ^&ME[ <O:+Q
M'JJ%8L]QNV(4B=[67F:6E82N9?W\M&,I]46DIH\VR=;]25R/ATQF<J??:0K/
MZOK]S:<_C,#214FR%EL;Y>U7-K5VHLEJT]$^+*U=DDSDY17=B,:O<Y$75]SV
MJAI6L9C9LBJ+!BZCYHX>Y&OMVWJD5*E&J\\26[3XH&NX5&=ZR.X8QRI<RW'9
MN,^F_7&7<*CIJ^/N&M'AUM+4H=:;F6CE?'8JZ"E9>4C"7[O9;=R)#5+=1G,B
MRL'9\Q6$YD.XZ#9"YANG^I/L*Q(<5K^-CAKP(Y$DF6%C8:M=KE3A]FW.L<:O
M<GTII72R>G<IRNQ>/V#JEO455)%L9O:LO+/;LJUSHJZ3R/L7;;V(JJRG0K)+
M*D35X97@;#$G*,:4K.4^2MHYAY%W+D_=)GQNS;M>S;VT=3E?L,+DK\HU="0X
MI:F:VJA(C5=7&RM6(M=#BQDYREK!SNS>8NY_+9#,Y&3RW,C9DLS.Y7M:KU^A
M%&BJJMA@C1D,+.5[(HV-3T0ZOZY@,=JV"Q6O8J+Q8_$TXJ==J\=[TC3F2>54
M1$=/9F=)8L2<(LD\LDB^KE.AMMN/.-M--K===6EMIIM*EN..+5A*&VT)QE2U
MK5G"4I3C*E*SC&,9SG&#&(BN5&M17.<J(UJ(JJJJO"(B)ZJJKZ(B>JJ9ESFM
M:YSG(UK45SG.5$:UJ)RKG*O"(B(BJJJO")ZJ7 O#<ZBHZO<)L3]HKT,\N<G-
M0-BWM;J$YE4,-+2UZ_I"5^6,H^H8TIY^W2GSPO89]FW[TF)#KUMWWZ1:&FEZ
MXV6[$C<]F4BMY-7)].K&C56KC47ZO=6/<Z=$^-N69.Y\<<2IS!Z\=35ZA[:^
M''3J_6=?=-1PR-=^KN2JY$NY?CZ_?9(V,K*OPI0UW=L<DLZ+I=V0\6V=QCVN
MK]3X\A5^W\*<>.S-6Y-9CHBKG;E?2)3"+NPU>X7Y9BKTE455?2^EUNLO)_UZ
MF<N17RJ:SKX\V[KK)AMXAHXJ.*_KN)62EF6L1BR9"TZ1J6):4Z_L+CE9XJ_#
MDALR^\I(KHGUYHI6T3V:8=AZ;S9/-S3XS;,XV+(Z^YZR)#BZ;(WK4@R-5/\
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M=(,U^C_4[2,FK_'&W8*5*=_/",JY9RXJV]R_[+:UV5SD^MJ*GUGHI'+4[
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M78#,1[-#LTG+T&KC4EEFKIK2F/5[H-)J-6QLNJ26+V A57Y#'3KYKV(C5?\
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M*8@KVJ?[,:Q_CT_]/F+$>QU_:[;?Y<@_J=<M[E'3H.
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MG@,UI5Z=99-=EBR.(\CE5Z8O(R2-M5F?_=4[[$F;SZHN2[$7L8QK;%Q5@N$
M#S@^\G\ZW<'^])V!_P V=M.J_3O]W^B_R=K']$HG'#J?^\OJ'_/.V_U_($PO
MT<G^8?L!_8Q6?XXIB"O:I_LQK'^/3_T^8L1['7]KMM_ER#^IURWN4=.@X
M                                         !6(\:OEU[9^=='X@A2L
MJJ>+M/3<6<="\XQC;=[<;G/)?;3GTN9C:Q7:T]$6YCUM8M)J6\)0\I3M-?:)
MSSKFRXW 1O58,+02Q,Q%X3W[)JDCD<B?%64XJCF*[U;YI.U$1RJ[H)[)^L-Q
M^GY?9Y8^+.PY1:M>14Y5<9AVNB:K'+ZM23(3WV2HWT<M:)7*JL1&PO%>2U@
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M5>$3E5]$1/BJ_87U]!Z@8T3PG+'JR[68;VJVZR;MF]BY:PI]'*^Z:W<;C/\
M<SG'KDKI]ZM$PX:G/)?PE7#83AI#;;;?-G)[S\I=:HMR;-W4H-OQ_NS^51JX
M7'VX*,7'KPQ)\=#Y'HGIWS2.7E555ZK8KIY\E=!)M%6#MOV-)R?O4?;]-,_D
MJ5C(R]WQ5ZU\I.D4:KZ^."-J(U$1K:$YTF.5)?=\&SDS]Y?AZ<&J?D?$6FA-
M;3QG:8]?K^'_ &1V>S:H(_G_ !3Z-/EZVKT*QCTX7C"?-'ISGFOUXQ/R3U0V
M-&L[8<DZGEH?3CN]^IPNLO\ X\WF6TY3[/MY.K'LYYKY:Z1:NKW]\^*;>PL_
MKSV?)]Z=M1GVIQCGTEX7CCGT^CPJRAD/DX     _D\^Q'1[DAYIAOS\O6\XA
MI'GG^&/4M24^>?\ P\S]-:YZ\,:YR_'AJ*Y>/MX1%4_+G-8G+W-:GPY<J-3G
M[.55$,&=G>+JCG'KES7Q5:1V)T+?.,=NI8F5I2\B/;/4LI_7;:/_ %D9E4]\
MS6V\!SR5AN9"CNXQGT^6=BU#,3Z[M6OYJ%SHY,;EZ-A_"JU70-L,;:@=\%[)
MZSIH)6_6R1S?K-7W?!U]GT[9<#.QLL>5PF0K1\HCD98=6D=3G9SRGDKVFPV(
MG>J))$QWKP>:N=9#C"7(?H[FWR;;J9RMI\EY3R=/YVLYD#"E9S\-7;/I6GOX
MBMX_@EK%I5VLS'ECSR[->SG.?EC%#_:CHL@W;#7F-1JWM<A9+Q_?EIY"^SO7
M^/AEAC_[,;?X\]%_9!R+[&@9['/<KDQVTSR1<_W(;V-QS_&GU<>>">3_ +4C
MN?JXG_*SEL2O]](([(S..>NVC=?]=L%Q+GGK8Y4[:<QW,I>QQWQ\Y6V,RO=R
MWE+D=%[M=CK.$+RK#<R!2W<!;;K+S^$69]F35(\KM.1V:U$CZ^M561T^Y/H_
M*N326*.5.>4<M:E%;54XY9+/7D14<UO-3?:TW*3#:?B]3IRK'9VJY)+>['<.
M3#XE89I(G<<.:EJ_-21%YXDBK68E1S7.XIQ)2I:DH0E2UK5A*$)QE2E*5G&$
MI2G&,Y4I6<XQC&,9SG.<8QCS+WJJ(BJJHB(G*JOHB(GQ55^I$.=*(JJB(BJJ
MKPB)ZJJK\$1/K53T&?#0Z>4_3;J]ING2*MACE#=(-?O',5JII&+"3N-M"0^G
M779'EEQ5;H\)]&M5T=*DQE/QK.W;8:EW4]3O,7JUO<^^;A?OMF<[#T)),=@H
M$<OB90AD5JVFM^'ER,C5MRO5%?VOA@5SHZ\2-ZV]%>G=?ISH^.QSX&LSF2BA
MRFQ3JU/*_(V(D<E-7_%8,9$Y*4+$5(U>R>RUK9+,JND%(Q); !@SM!_+3V'_
M +#.6O\  .P&Q:A_:W5_YBPG]3JFK[Q_8O;_ .5]@_I-L\U(ZS'%\NB_1Y_Y
M']X_O)[U_EYQ,4%]J#]X>._E/'?U3-G2/V1?W8Y3^<\I_2, 3ME<2TI6@^DB
M_P"K_JK_ ,8\I?\ )--+:^RC_K3<_P#P&'_S%\I9[97^J=$_Q'._Y;&E3XNF
M4*/09\+_ *T5'5_IKQ)JS=>U%W+>*"NY2Y*FJ:2B=,W#=ZZ':K@35XQC*OV6
MIW*K4HZ$^37MTF9&,9>E2'7>8O5_;9]PWS-W5E5]#'V9</B8T7F-E#'RR0I+
M&G/I[Y.DUURK]+FQVKPUC6MZV=#]*KZ1TYP%%(6QY+)U(<YFI>U$EER&3ACG
M6*5>$5?<:RP4&(GT>VMWHBN>]SI!R,27     >?7XKW^T/[2?\>5_P#A#6CI
MQT6_==IW^&R_YZV<E.O7[WMY_P 5B_I](V[^C[_SU7O]@'('^*>/31_:<_=S
M6_F;&?Y/*$A>R3^]&W_*66_S^'+K)S_.E)7.^D;[;.@<#=>M'9=6BOV;EF_V
M6<VA64I>?TW47:Z"EWR\O6A&-TE.80KS3[B4.>7J;1E-I_96HQR;+L^1<U%D
MJ82M4C54Y5K;]YLLBI]BK\GL3E/7A53X*I3SVQ<A+%JNHXQKE2*[G[=V1J+Q
MW.QV/=#'S]J)\IR+POISPO'*)Q40+PG/H]*#JEQO4<0]:.!N-:.,S%@ZCQ1H
M]:YAE"48EVBM?@R[RT=PG&$JEW-W)L+::YC&/=F37W?+'K\CD[N>6GSNV[)E
MK#W/DO9K(S)W+RK(?>9&5H4Y_N05V101ISZ1QM3ZCLYH>&KZ]I6JX:JQK(L?
M@<7"O:B)Y)UJ126IW(B(GDLV7S6)5X3NDE>[A.38 UDVP %'KQX^.:C1._-O
M<U,9J+GE3BS0N1K1IA"6VE6_O7^A2Y.&T8PA+LU&B,3)2\8PJ1,?D2G<J>?<
M6KH;[-^5GR736&O.]7_(V9R6*A<Y55R0=M7),8JKZ\1KDG1L3X-C:QB<-:B)
MS&]JC#U\7U7L6:[&L7.X+$YB=K41&K8[K>*D?PGHCI$Q3))%3U?(][W<N<Y5
MTA\/_;9FD]WNJ%_"=6RO]_G&-'*6VK*%?56U[76ZI=H\\>7GAVGNIS2D9SA+
MB5J;5G"59R2%U-I1Y#IYNM:1J.3]&LO98B\<>>E2ENUU]?AVV*\3D7ZE3E/5
M",NDV0DQG4W0K<3E:OZ5X2K(J+PON]^_#0M)_P#BK696JGP5%X7T4]&,Y8'8
M8    '^9SA.,J5G&$XQG.<YSC&,8QCSSG.<_+&,8^><Y^6,#X_ ?#XG\F),>
M3A2HTAF0E.?2I3#K;N$J_CZ59;4K&,^7S\L^63].8]G'>US>4Y3N:K>4^U.4
M3E#\M>Q_/8YKN%X7M<CN%^Q>%7A3SZ/%/XKJ^'>_G9+4**(W"I9NY0MZK8S"
M$M16$<EZU2<@S8T-E&$H8B0K799\&/';2AJ.U&2RRE++;>#IQT;S,V=Z::G>
ML/=)8CH28Z5[U[GN7$V[&,C>]RJJN?)#4BD<Y55SE?W.7N53DGUTP4&N]6-S
MQ]6-L5:3(Q92%C$[8V)FJ57+RLC:G"-CCGNRQ-8U$:Q&=K41J(;1> EMTG7.
M_=72,NJ0QOW$O(^K2V\*SA+S<!BJWAK"D_PRI$C3VEISY>:<85Y9QA2O/3_:
M3HLM=-)K#D178S-XJXQ?K:LCIL<O"_Q;>5%^W_R-X]E3(/I]5X*S7*C<MK^9
MH2)]3FQ-KY1.?]S\<U47_P#Z7>SGJ=-@ ><'WD_G6[@_WI.P/^;.VG5?IW^[
M_1?Y.UC^B43CAU/_ 'E]0_YYVW^OY F%^CD_S#]@/[&*S_'%,05[5/\ 9C6/
M\>G_ *?,6(]CK^UVV_RY!_4ZY;W*.G0<
M                 I'=W]R=WWMUV'V)UW+Z4\I;-KT1[.<JPY6Z9+SIM4I.
M<_/V\UE#$]K'R]+?IQY8\O+'.7J1D'9/?-KMJY7(F:N5&.5>>8L?)\GPJB_[
M/AJL[?L;PAUKZ1XIN&Z9:/1:WL5==Q]Z1O'';/E8OE6RB_\ 6]XNR]W_ %N3
M5@TDD4YO6=<N-PV2@U+783EC?[1=5>O4E>SCS=G6]S.8KJZ(W_\ WR)DEEE.
M<_+&5XSGY'IIU+&0N5:%2-9K5VS!4K1-_:DGL2-AB8G\7R/:W_S/'D+]7%T+
MN3O2M@I8ZI8O6YG?LPUJL+YYY%_@R*-SE3Z^."VEV3W&FZ!]!8FH:C.;C;+6
MZ?5\2:%*CY^'DSMWV"!)Q>[<RG'WFID;'[2[PI6499S9,LQG$IQ)0DO1M^0K
M=+NF#*%"1&6X:$."Q;VIVOER5J)_O%Y$].V1J>^9)R\=OF:C53Z:(O-;0L5;
MZT=9I,GDX724)\I8V;-1O^FR'$4IH_<\8Y?@Z*1?<,0B<H_W=[I$55C52HE_
M'^)0XZ:DM?A/]1,\W\L?OEW2L]_C#A^SB2X;$MGUP]JY%:2U.I:GTK3[<F#K
M:%1]BNF\J4G+ZJ"!(8?AVDK#<Z]#M#_2/.?I!D8.[#8&9CXVO;S'>RS>V2O!
MPJ</BIHK;=A.>._W6)S71S/1*T^TCU-_1+6_T5Q-CLV#:*\L<SXG\2XW!.5T
M-NSRB]T<U]4?1JNX148EV9CV2UXU=N!XP7<?%16_Z*7'MIY6EPQ"M.8K*$]Y
M+@4[N&IU+HN'6\^I$FXQ\/=[ WC+:DU&*F I3\>YLH[6_=?.H'N\/Z$8J?\
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M.V5Q+2E:#Z2+_J_ZJ_\ &/*7_)--+:^RC_K3<_\ P&'_ ,Q?*6>V5_JG1/\
M$<[_ );&E4F PB3.A1G,YPB1+CL+RGY*PAUY#:LIS\_+.,*SY?\ O+H2N5D<
MCT^+6/<G^]K55/\ ]!0Z)J/EC8OP?(QJ_P"YSD1?_P!)ZA\>.Q$CL18S2&(T
M9EJ/'9;QZ6V6&4);::0G'R2AMM*4)QC^"<8P<?'.<]SGO57.>Y7.<J\JYSE5
M555^M55555^T[A,8V-C8V-1K&-:QC43A&M:B-:U$^I$1$1$^Q#^Q^3]
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M_I\Q8CV.O[7;;_+D']3KEO<HZ=!P
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M?_M:K_\ ,87_ ,RT7.G_ .0F_P"ZD_\ 0XHA7_YQ!_WT7_K:>H><?#N$
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M)_F'[ ?V,5G^.*8@KVJ?[,:Q_CT_]/F+$>QU_:[;?Y<@_J=<M[E'3H.
M                                        42.PU$[J_/O-VMO(RVY1
M<N<CU.4JQY?=@;A<1D*3\L>:'$-I6VK'W5H4E2<Y3G&3F?ME5U+:=DJ.3AU;
M/9>#C^$5^PQ%3^"HB*U?7E%14544[#Z/<;D=+U&^Q>YMS6<#9Y_C-BZLBHOV
M*USE:Y%]4<BHOJAB!"%NK0VVA3CCBDH;;0G*UK6O.$H0A*<94I2E9PE*4XSE
M6<XQC&<Y, B*Y4:U%5RJB(B(JJJJO"(B)ZJJKZ(B>JJ;0JHU%<Y4:UJ*KG*J
M(B(B<JJJOHB(GJJKZ(A:<U]<#PRO#G39SV8L3E_98.;#,*0AO+\[F;?X*<5]
M>^RK[LIC0J:''39,X7AJ5 U">IE>'IR/7=>JL71SI,DTK6,SUN)9?&[M[I=@
MRD?ZJ)S53A[<978Q)F_LOBH2JU>Z1.>==U)O: ZZ+7A?))K%&9(4E8YR,AU7
M"R_KYXW)ZQOS-J1ZP.5JNBFRD*/160KQ5LF2YMI.E3YTB1/L;&6_+F2Y+CDB
M7-FRWE/2)#[J\J=?D27W%NNN+4IQUU:E*SE2LYS2N222>5\LKWRS32.DDD>J
MODDDD<KGO<Y>5<][E5SE7E5555?53HC%%#6ACAA9'#!!$R**.-K6110Q,1C&
M,:G#61QL:C6M1$:UJ(B<(A:1\/KK+JO2;@39>Q7.KD36=ZV/5_K_ &F;;-^A
M_CSC]K#4^NU-MI2,RL;!<R,0YMY7L(^-EW*J76F8CLZJ2J9=/I9IM+ISJ]S;
M-E5E/)VZ7O5Z2=.'8K%M1LL-%$X5_O4[O')9B:GD?86O3:QTD"+)SOZU]0,C
MU9W.AH^GI+D,/0R/N6.BK+RS-YIRN@GR3G(OC6E59Y8J<[U\451+5]TK8;*I
M% AW&[2[1VSYDM^0+;XJNU6O]VDX[U5UW"F];U1A]:HZ7D-K6RN[MU_^D[^6
MA3GO3GL1&7<UM?7,1ZP=0-UN[UL$^4G[X:4/=6Q-%SN6U*37*K>Y$56K9L+^
MNM2)SW2*D;7+%%$UMS>EO3O']-=6K86MXY\C/VV\YD6MX=?R3V(C^Q7(CDJ5
M4_T>E$J-[86K*]OGGG>_D>F747<NW?*4;4ZC$JGT:B5$LN1]U2QZX^O4;CJL
M(APUNIS'D;+>>R_$H8"L+]3B)-E):S6UL]:/KT]T/(;YFV48.^OC*RLFR^11
MO+:M97+Q'&KD['7+/:YE:)>?5'S/:L4,G'PZJ]3<5TRUU^2L^.UF+B25\%B5
M?P^];:U.Z:5&JCV4*?>R2Y,G'".C@C<D]B%%L+]N>T7%_AX\&ZYQ%Q!5T['(
M+VNJJN,M*9PF3'UNLPIUF3OVVIRK+LEO,_,N6UF<I4W<-D5+4ZMUAF[FQ+6;
MWNF%Z4:U4P6!@KMRKJG@PV.;P]M.%.YKLI>3E7/;Y>]Z>5?)?MK(JJYK;,C*
M1=,^GFP];]OO;-L]BT_"-O>\[!EG*L<EZQPUT>&QJ\=K'>%(HG>%$AQ=!(T:
MC7NJ12U1-CV.^V^_N=IVBVG7VQ;#93+>[N;.0N586=G/?7(F3)<AS.5N//O.
M*6K.?+&//TIPE.$IQ1ZW;M7[5B[=GEM6[<TD]FQ,]7RS32N5\DDCU]5<YRJJ
M_P#R1$1$0Z04*%/%TJN.QU:&G1HP15:E6NQ(X:]>%B,BBC8WT:UC$1$^M?BJ
MJJJI*%X<'A]V'9+8(G*_*5=*@<$ZW8^;,5[#L61R?=0'O)RCKG,>VZC5X+Z,
MM[+<L*3F0XE=!5.XG*LIM'-'2/I7+MUJ/.9N%\6LU)>61N[F/S-B)WK7B7T<
ME*-R<7)VJG>O-:!WD\TE>O77;K7!H=*76]=GCFW"_!P^1JMD9KU29GT;D[?I
M-=D9F+W4*KT5&-5+MEOA2O#;FC[U=X=*Z:Z!%U#38]-8\OW-(B'H.DQ6F$5.
MHTS+68$/9M@@1/:;@T%8EGV*.F;3'7>2HOP43#%=$LIL&PW4OJ1CNGV*90Q[
M*\N>L5VQXO&L:U(*-=K?$RY:BC[4CJPHWLK5T[5L/8D;$;$R:2.J71_I'ENJ
M>;DR>4?;@UBK;67-9>1SELY*TYR32X^E-+W.FNV%?WW+2^1*<<GFE[YY8(IJ
MD>V;7L^_;/=[AM]S8;)M6S6<BUNKFR>5)GV=C,<];KSJO+&,>><I;8890VQ'
M90U&C--,---(HI>O7,I=LY"_8EMWKLSY[-B5ROEFFD7ESE7ZOJ:UC41K&HUC
M&M:UK4Z7XW&X_"X^IB\75@H8W'UV5JE6!J1PUX(F\-:U/C\.7/>]7/>]722.
M<]SG+8A\,_PWLZ1BB[$\_P!%C]LUHCVO&G'EM'\\Z>A>$O0]NVB$\GRQM:TY
M0_1T[Z//6$Y18SD8V/,=C7K8='ND7R:E;;-IK?\ &+D9/A\5.S_5Z*B.CO7(
MW)_SY4X=6KO3_0TXED3WM6-JT=Z^]=_ECWS1]+N?\4HKZV>SE:3TRBHJLEQF
M/E8OKC47EENTQW&07F")?<?(Z[M/X@'B!ZUU3UY_2=*>KMCYXV"ORNIIUY1+
MK]&@2V\X8VC:VDYRE3RDY]ZAU]S*7K1>$3)B6JE.,S=UZI=4Z>D5'8['.AN;
M-:BY@KJJ/BQL3T7MNWFHO[7]ZM57ATZ\22=L"<R1WT6Z*7^H]YF6RS)Z&FTI
M^+5I.8Y\O-$Y._'8URISVHOT;EUJ*RNWF*)765XBJQ4DK9^7^8:!_9K:QV7;
M.1>0:*/:V]F^N78VMML=]#B./R'EYRI:W796$H0G"6VD80RRA#2$(32FM)=S
M^P57W9YKE[+96JV>>9RR33SV[4<:N<Y>557*]$1$3AJ<-:B-1$3HG<BQ^L:M
M=9CZT&/QN#PEQ]:M78D4%:M1I2RM8QJ<(B-;&JJJKW.7ESG*Y5<M\HZ;'' _
M#CC;+;CKJT---(4XZXXK"&VVT)RI:UK5G"4H0G&5*4K.,)3C.<YQC!_417*C
M6HJN541$1%5555X1$1/555?1$3U53^*J-17.5&M:BJYRJB(B(G*JJKZ(B)ZJ
MJ^B(>9QSOR"YRSS=S#RDXXMU7(W*&^[PE2_5YX:VG:;2[9;PE7EE"&F9K;33
M6,)2TVA#:4I2C"<=;=;QB877L%AT1$^2L/C<<J)_M4Z<-=R\_6JNC557ZU55
M^LXK;5EUS^S[%G%55^6,YE<HBK\>V]>GLM3CZD:V5&HGHB(B(B(B<%C[Z-[Q
MYY-=HN6)+']=SCGCRED^C^'MIV79-F8PYG'S]7NZDYE"<_+TX4O&?-ORJI[5
MN4^EIV%8[X)E<I89S\>5J5*;N.?J[;R<JGU^B_M%Q_8VQ'T=YSSV?%<-B*TG
M'V)=NWF<_P#GCUX3[/7ZBT84\+QFA/B;< ?Z2'2;G'0X4+XW::;67.1='0VW
MAV7G;./59V:'!KTYQG&)FPU\*SU5"L^6/:OGL>IOS]Q,D](]F_1/J#KN2DD\
M=.>VF+R*JO:SW+)I[I))*O\ L599(;JI_M5F_'X+%76S4_TRZ:;/BHHO+>KT
MES&+1$[I/?\ $+[['%"G_P!I;ACGH)SZ=MIR<I\4\^&NL)U380;6LE/P;*LF
M1K"OG17%-28<Z$\B3$E1W49PII^.^VV\TXG.%(<0E6,XSC!T\EBCGBDAF8V6
M*:-\4L;T1S)(Y&JQ['M7T<U[55KD7T5%5%.2$,TM>6*>"1\4T$C)H98W*V2.
M6-R/CD8Y.%:]CVHYKD7E%1%3U/XR)$B9(?ERGG9,J4\[(DR'W%.OR)#ZU.//
M/.KRI;CKKBE+<<7G*EK5E2LYSG.3^L8R-C6,:UC&-:QC6HC6L8U$1K6HG"(U
MJ(B(B>B(G"'Y>]\CW2/<Y\DCG/>]RJYSWN57.<Y5Y5SG.5555]55553T3O#W
MX$_T:NG/!'%,J'\%L4#2X>R;JTM'ID(W?=G'=MVF+)7G&%O+J;6X?HV'7,85
MB#5Q&L)0VTAM'+;J=LOZ6;WL>:9)Y*LN0?5Q[D7EJX_'HVE3>Q/@U)H8&V'(
MGIY)GNY5555Z_P#235/T+Z=:K@7Q>*Y%C8[F2:K>'ID\FKLA>9(OQ<M>>PZJ
MUSO7Q01M1$:U$3<PT(D<J6_2/..O@.5>MO++3'GC:N/]PX]F2$(^25Z'L4/8
MJ]IY>,?);R.1+!4?"L^:TQG_ $^>&E>5U_94RGDPVV857?\ ,\G0RD;57U5,
ME5DJRJU/L:N+B1W'P5[>?BG-!/;'P_BSVF9]K/\ G^)R.(D>B?!<5<CN0M<O
MP17)F)E9SZN1C^/1OI#GX?G)G[H>['6/?')'PD.!R]J=)<2LJ]&(VO[I-_8G
M8WUYSG&,H:H=AL7'$YSC"T)4C.<85YD[]3L1\N=/MOQJ-[Y),'=L0,XY5]K'
MQ_*%1J)]KK-6)$^Q51?4KKTES7Z/=2])RJO\<<6PX^M8DYX[*>2E^3;KE7[&
MU+DRJGUHBIRG)Z+QRQ.PIYSWB <BV?*G=CM!N5J^[(<>YHWG7JY3JLJ6WKND
MW,C2M6C9\_ZOPNN:_5Q_0G[J,MY2GSQCSSU/Z98J'#=/]/H0-1B-P&.M2HU$
M1'6LA79D+C_3X]]NU,[E?5>>5.//5G,3Y[J7O&1L/<]7;)E*D*N555M/&67X
MV@SU5>/'2J0,X3T3MX3T)%/ *X!UWE7MELO)^U0(]I"X#TIO9=<AR6D/,,[]
ML]EBEURV=:<PIIQ5+5Q]FGP,J1ER)=MU-G&<:DU[2R+/:6V:UAM*J8>G*Z&3
M9<@ZI:>Q5:YV,IP^\6X$<G"HD\SZ<<B(O#ZZS1.1S)'(3![*.IT\[OUW-WHF
M3QZIC$NTXWHCFMRMZ;W:G8<UW+7+6@9=EBY3F.RE>=BM?$U2Z:4#.DP /GE_
M]4E?_#O?_EJ/TS]MO_:;_P#I0_$G_)R?]AW_ *5/+G.PQPZ+;/T<'_4_V7_M
M)TG_  O8E)?:L_U[J7^$Y#_.1%_O8W_L[NG^-8W_ ",I9'*HERBFU](=XTE:
MYVPXSY,;CJ14<F<.0JWXG*,X3(V70=BN(=PVE?EZ5?#T-]I^5)\\K1[V/5]U
M2"^/LO9=EO2\OB%>BSXC.R2]G/JVIDJL$D"\?5W6:U[^"\?;R<Y_:\PKZ>^X
M7--8J5\WKL4/?QZ/NXJY9BL(B_!>RI:QWISRG=Z^BH0E</<B3^(>6N,.5JI"
MG;+C3D'3=]A,)7Z,R9.H[#77S47*LYPGT250,1W$J^XMMQ2%XRA2L9L%G<5%
MG,)F,+,J-BRV+OXV1RISV-O59:RO^WEB2=R<>J*B<>I6?7<Q+K^?PF>@:KIL
M+E\=E8F(O'>_'W(;;6*J^G#UB[%Y145%5%14Y0]+73-NU_D#4-6WO4[%FWU;
M<]=IMJURTCYQEFQH]@KH]K536\XSG[DF#*8>QC.?-/K].?GC)R7OT;6,O7,=
M=B=!<H6IZ=J%W[45BM*^&:-?XLD8YO/U\<IZ':/'9"IEL?1RE"9MBCDJE:]3
MG8O+9JMN%D\$C>/J?%(UW\.>%.RGD/: #!G:#^6GL/\ V&<M?X!V V+4/[6Z
MO_,6$_J=4U?>/[%[?_*^P?TFV>:D=9CB^71?H\_\C^\?WD]Z_P O.)B@OM0?
MO#QW\IX[^J9LZ1^R+^['*?SGE/Z1@"=LKB6E*T'TD7_5_P!5?^,>4O\ DFFE
MM?91_P!:;G_X##_YB^4L]LK_ %3HG^(YW_+8TJGT_P#VM5_^8PO_ )EHN=/_
M ,A-_P!U)_Z'%$*__.(/^^B_];3U#SCX=P@     #SZ_%>_VA_:3_CRO_P (
M:T=..BW[KM._PV7_ #ULY*=>OWO;S_BL7]/I&W?T??\ GJO?[ .0/\4\>FC^
MTY^[FM_,V,_R>4)"]DG]Z-O^4LM_G\.763G^=*0 0_>*OT8ZH]@]"<Y8Y:Y*
MT[KAR9K,#ZLH.:M@G5=957C3*'7H6G;E6S)<!W;HJ\^ZFF36/9VJI=7G-3\=
M"S*H["<NC/47=-7R:87"8F_M>)N2^6SK]:.:6:NYRM;)>H2QQRI1>GHLZS-]
MSG:G$_C?V6(J\]=^EVA[=B79_/YG':=FJ47AJ[+;D@A@LM:CG18[(PR21.R$
M:_22LD#O?H'+_H_EC[ZLM(';*2%K6RW=!7;/0;I"J+&1 C;5JV+O&NWS4=>4
M8L:;]HZ;7KS,!_.,Y8594M=(6G'K^'PA2%*Z&4;,ENI7M2T[./DGB;(^E=]W
M]ZK*Y.?%/[K/:KI(W^\D5B5J?#NYY1.9%^K'2NV:D-ZIDHJ\SXF7Z/O/N=MK
M%X2:M[Y6IVO$_P"+5FK0O5/7LX5%7KQZCR&0^.^(^5.7+9NBXLXWWKD:X==2
MUBNTG5;O9Y2%+SCRR^W3PIGPS2<*PMU^1EIEEOS==<0VE2L8O*9S#8.!;.9R
MV.Q4"(KO+D+E>HQ43ZFK/(SO<OP1K.YSEX1$551#+X?7\[L%A*N"PV4S%ASD
M;X<90M77HKO@KTKQ2=C?K5S^UK6HKG*C454L&=$? :WB_NZ3DGNFEK4-/@O1
M[&)PE3VS$W;=H4VI+[,?=KVFD/UVK4;V/;Q+JZ:PG;+-97(A2)&JR6L.N5BZ
MD>TCCJU>QB= 5UZ_(UT3]@G@='2IHJ=JOQ]:PQLMRRWZ79-8ACJ1N1LC&W&.
MX2VW2SV5LI;LULSU*1N.QT3F31ZS6L-DR%Y47N:S)VJSW0T*KD[?)!6FENR-
M<^-[Z$C>Y;7M)24VLTU3KNNU5?14%%70J>EI:F&Q7U=355T=N)7UM=!BMM1H
M<&%%9:CQ8L=MMEAEM#;:$H3C&*76+$]NQ/:M32V+-F62>Q8G>Z6:>:5ZR2RR
MR/57R22/<Y[WN57.<JJJJJE]*M6M2K5Z=."&K4J0Q5JM:O&R&"O7A8V.&"&*
M-&LCBBC:UD<;&HUC6HUJ(B(ARA\3[E2WZ1WR%9R^5NN7%&'W$4U!Q[L_(3D9
M"LI:DV>W;)G6VGWT8^ZZY!BZ0\W%4OSRPFPF8;].)#GJNO[*F+A9AMKS7:BV
M+.3IXM'KPKF0T:GO;FM7XM21^0:K^/1ZQ1\_L)Q03VQLO-)GM.P*/5*]3$7<
MNZ-%5&OFR-WW)KWI\'+&S%O;&J\JQ)943CO=S OUTXN3S=S[PMP^[(=AQN3>
M4=&TB?-8RG#T&LV39*ZKM)[/JPK'NP:Z3*EHQE*O4IG&,)5G.,9LEM6977M9
MS^=:ULC\1A\CD(HW<]LDU2I+-#$[A47MDE8QB^J<([GE"JNGX--FVO6]=<]T
M;,WG,7BY96<=\4%V[#!/,WE%3NBA>^1/1?5OP7X'I-ZKJVO:1K.OZ;J51"H-
M7U2EK-=UVDKFL,0*FEIX;-?65T-G'GAN/#AQV6&DYSE7I1C*E*5G.<\G[MRU
MD;=J_=GDLW+MB:U:L2N[I9[$\CI9I9'+\7/D<YRK]J^B(AV:H4:>+I5,;CZ\
M52C0K04Z=6%O9%7K5HVQ00QM3X,CC8UK4]5X3U55]3GSS'K !10\<7_:,\M_
M\+<4?Y;ZV=&?9W_=7A?_ !N:_JMHY;^T[^^+8/\ P. _HU(^#P1O]I#P?_Y+
MRY_E'NI]?:$_=3L/_B,)_6\>?#V9_P!\VJ_]QL'_ +<RI>^.<)U/ !YP?>3^
M=;N#_>D[ _YL[:=5^G?[O]%_D[6?Z+2..'4_]Y?4/^>=M_K^0)@OHY3B,=BN
M?FLK3AQ?"L!Q#><X]:D-;S1)<6E/\<I0IUI*LXQY)RXC&?FK'G!?M4HOZ+ZR
M[A>$S\R*OU(KL=85$5?M5&N5/MX7["P_L=*GZ7[8WE.Y=;A5$Y]51N4K(JHG
MV(KFHJ_5RGVH6^BCAT(
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M!5^WL>:IPW:MVGC_ &EAUK&R*GKPWPY++*BK]2JN):US?K;,U5^*%HLIZ7B
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M?WD]Z_R\XF*"^U!^\/'?RGCOZIFSI'[(O[L<I_.>4_I& )VRN):4K0?21?\
M5_U5_P",>4O^2::6U]E'_6FY_P#@,/\ YB^4L]LK_5.B?XCG?\MC2J?3_P#:
MU7_YC"_^9:+G3_\ (3?]U)_Z'%$*_P#SB#_OHO\ UM/4/./AW"      //K\
M5[_:']I/^/*__"&M'3CHM^Z[3O\ #9?\];.2G7K][V\_XK%_3Z1MW]'W_GJO
M?[ .0/\ %/'IH_M.?NYK?S-C/\GE"0O9)_>C;_E++?Y_#EUDY_G2DQES5QI
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M-G8ZW"QS9DK31)*U6JK5:_N16JJ*G"\'I2G)P[.@
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MA:Y%[MNPO(?3&0ZY\0_A*LRK:V?0ZS60K&=G#"J^ZUJNP;KE%I8BM+<L2/\
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MBIPJ<I014Y1?J]2/F^S/T<8YKVZU:1S'(YJ_+^>7U:J*GI\H^OJA*^0L3T
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M5R%6_0S^U0+5M06V06)L5:C5T$S9FQ]S<76D2-58C?I.<]$Y^FJ^I/45M+5
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MN16N8S+6I;=-'-7AS7_)[Z:R,<B.9(KVJB*A)41,30
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MU$1K41$1$1.$1$3T1$3T1$]$0_9_#^@
M                                    &OW83K!PSV?U=K6.7-5;M_J_
M$I6O[% >S6;7J\F6EM+\FANF4+=CX>RS'<E5\MJ;3V"XT;-E6S,1V4HU;:M,
MU[<Z3:6=HML>+O6K;B<L-VD^1$1SZUAOTFH[M8LD3TDKRJQGFAD[&\;KI/4'
M:NGV1=D-9R+JOG\:7:,S$L8[(QQ*Y61W:CE1K^U'O;'/$Z&U"DDGN]B)7N5=
M<>.NA?6+JCK<S=M2X5V+FW>->C8G19=UC7MRWZ?(94E25:S5[%,U?2:NP8SE
M;C+]5$J[53>%--29CV&F5ZCB>F.FZ/3DR-#7;>QY*HSR,DL>ZY#*2O:J*BTX
M;<E+'02M7ES701P3<<HCY'<(N]YWK+U!ZCWXL3D]LHZEB+TGADBJ>_8K#0L>
MBHJ9"Q1BR.7L0/1$:]EB6S71RHYT<3.YR1:]L?%9[3,6MEHFH<76G69K/OL*
MD;E23)7)TB/A665/L*V&K@TM(V^VK.?_ $?26,R*XI#D#8?4E#RH6WGK?NK)
MIL90PD^G)])JOR-:23,N8B]O<SWJ"*M71Z?_ &5>9[%5%BM<HCEL/TV]G'IT
M^M!F,GL5;?W_ $'HS%7(H]?8_P#:['I2L36[;F+PGZZW!%(B.;-1X56I"_L^
MU;/NUY/V;<=AN]JV*T=]^RO=BM)MS;SG?+RPN586#\B4_E*<82CW'580C&$(
MPE.,8Q7F[>N9&S+<R%NS=MS.[IK-N:2Q/([[7RRN>]WV)RY>$]$X0M9C\;C\
M33AQ^+HU,=1K-[(*=&O%5K0M^R."!C(V(J^J]K4Y555>555. /*>T '9]3TK
M<=]MV=?T;5-DW*]D9Q[%/JU)97]F[ZE81C*(-5&E2<I]6<8ROV_3CS^><'MH
M8[(92=M7&T;F0LN_9KTJTUJ9?JY2.!CW\?:O'"?6IC\GEL7AJK[N7R5#%TV<
M]]K(VZ]*NWA.>%FL21Q\\?5W<K]2$J?7SP>.?^2'H5QS'-@<*:DXIMYV#+5&
MV'?YT?.<+]$6AKY6:RFR\C"FENWUM'L(#JD.+H)B<*:)MU7H#M&7=%8V"2+7
M:"\.=$]66LI(SX\,K1/6&NKDY1769VRQ*J*M5_"M*Y[M[4.EX%DU75HIMLR3
M4<QLT:24<+#(G*=TER>-+%I&NX<C:=9\,S45&W8N4<6">N?4G@WJW1+JN*M2
M:BVTR.VQ>[M<J;M=UV+",I5Y6EXMEG+,/+B$O)IZF/64;+V,OLUK;ZW'5VGU
M+1=;TNJL&$HM9-(U&V<C85)\C;XX7]=95K5;'RB.2"!L-9KOI-A1RJJTHWKJ
M7M_4.XEG8\FZ2M$]SZ>)JHZMB://*<UZ:/<CI>U5:MJR^Q;<SZ#[#F(UJ;*F
MWFA        TK\1S^0_MI_87OW_)9!O_ $J_>1I/\QXS_,,(UZQ_NKW[^5\K
M_EG$:'@U=5^LW+?1?1=QY2Z^<+<B;9^W?)$9S9MUXRTW9KZ1%A;*^U#B2[:X
MIY<Z;$B-8]N+$EOO1X[?FAEM"<YQF6NO.Y;;A.HV2H8?9\_BZ7R=BGI4Q^7O
MU*S7R4VK(]D$%AD<;WJO+WL:U[E]7*JHA"WLYZ)I6P=+L5D<[J.MYB_\J9EC
MKN2PF.NVGQQ7GMCCDL6*TDLD<;?HLCD<YC$]&M1"=W4=*TW0*2/K6AZEK.DZ
MY$4I42@U&AJM;I(JEX3A:H]531(4!E2\(3A66V$Y5A*<9SGRQY5QO7[^3L/M
MY*[;R%N3A)+5ZS-;L/1.>$?-.^21W'*\<N7CE?M+38_&8W$UF4L5CZ6,IQ\K
M'4Q]2"E68JHB*K(*T<<3>41$7M8GHB)]2%=_QC?Y]O#!_M*H/\YN-"T70G]V
MG6#_  BU_0,N5"]HG]ZW1#_&JG_N3"ECZ7_U25_\.]_^6HJHS]MO_:;_ /I0
MN/)_R<G_ &'?^E2M#]'[V)S4>L';_;&8#MJ]K&U0]B:K&<YP]8N4O'MA9(@-
M92E2L.S%1L1V\I2K.%N8\DYS\LVU]INJE[<-&I.E;"VY2?569W[,26,I'$LK
MOA]&-']R^J>B%+?9,N+C]'ZA7VQ+.ZC?CN-@;Z.F6MB)9DB:J(JHLBL[$]%]
M5^"G3_"LZP\=^(Q9<X=SNYTEWG/??WHO:93Z1>VUDQK6NLQJ&EV7ZQ>HH$^/
MEZAPULC6O:=K;[G[-5$.BM4_5T^4J.]7>[K+M^4Z61:]H.A,37<;\C-OSY&M
M!$ZW:<^S8J>)MF2-W;9YJ.M7[;4][GDLPJDL;4<V7'="M(Q'6&?9^I'4=Z[1
ME?EQ^.KXRU8F;2IM94K7?,ZK%*SNJHVXVICJ;G>YP1U9T\,KU8Z+K/<7B/KU
MP=XNW0+2^!M0T/0&<;IPK8[QK6DIBPVH>Q6/+RT5:[FMC/N(K+.=2)K78T9Q
MJ,])@NPI>&5MRF'G?7HF<VC8>A_4R_LE[)9-WN&?BQUO(J^1TE6+!HLR5YGM
M19H8["RM>Y'/:R5LD?<CF.:W']1]?U'6/:!Z3XW5<?BL2U,IJ\V4I8Q&1MCM
MS;'Q MF%CE;#/+62%S6*UCGQ.BD[5:]CG;.?2-/Y;>!O[<)'^ ME-1]E?^UN
MR?RZW^ITS>?;$_L9JO\ ,[_Z5=)^],_^I^I_\-47_*XI6B__ ,^N_P#B[/\
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MS'I27(NJ5WV)D65+V/EMV'/L2SS*J5ZR.<JR*UK(DX1K6G8O!AV.EO\ PY.
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M\QF(59O-EN.^JPW;U\=]UJJNY>L9U61\!EN*ZNND54S,?T36GGO?J^8V;/\
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M1&1+0
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M#EV6KW7+_P":KS]9C;/A2]%,N^YCAR;A'GY^QCDOE/VOX^?EZL[GE_R_W?\
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MY2ZF6ET](?GTNDMR;BA@9E.^])C:NJNV?2=BHJMYWS=Q4/;%:UT1><,UL>#
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M+,_S6;-B9ROL6[<W:WS69WKW/<C&1L:C(H8XH(XHF9Q-=-G
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      !YV'VC
M'>_\6O._YAWWZHZE?-9TX^Y.M_A57\AR ^>+JG]_]I_%[7YQ]HQWO_%KSO\
MF'??JA\UG3C[DZW^%5?R#YXNJ?W_ -I_%[7YQ]HQWO\ Q:\[_F'??JA\UG3C
M[DZW^%5?R#YXNJ?W_P!I_%[7YQ]HQWO_ !:\[_F'??JA\UG3C[DZW^%5?R#Y
MXNJ?W_VG\7M?G'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ
M]HQWO_%KSO\ F'??JA\UG3C[DZW^%5?R#YXNJ?W_ -I_%[7YQ]HQWO\ Q:\[
M_F'??JA\UG3C[DZW^%5?R#YXNJ?W_P!I_%[7YQ]HQWO_ !:\[_F'??JA\UG3
MC[DZW^%5?R#YXNJ?W_VG\7M?G'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+
MJG]_]I_%[7YQ]HQWO_%KSO\ F'??JA\UG3C[DZW^%5?R#YXNJ?W_ -I_%[7Y
MQ]HQWO\ Q:\[_F'??JA\UG3C[DZW^%5?R#YXNJ?W_P!I_%[7YQ]HQWO_ !:\
M[_F'??JA\UG3C[DZW^%5?R#YXNJ?W_VG\7M?G'VC'>_\6O._YAWWZH?-9TX^
MY.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\ F'??JA\UG3C[DZW^%5?R#YXN
MJ?W_ -I_%[7YQ]HQWO\ Q:\[_F'??JA\UG3C[DZW^%5?R#YXNJ?W_P!I_%[7
MYQ]HQWO_ !:\[_F'??JA\UG3C[DZW^%5?R#YXNJ?W_VG\7M?G'VC'>_\6O._
MYAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\ F'??JA\UG3C[
MDZW^%5?R#YXNJ?W_ -I_%[7YQ]HQWO\ Q:\[_F'??JA\UG3C[DZW^%5?R#YX
MNJ?W_P!I_%[7YQ]HQWO_ !:\[_F'??JA\UG3C[DZW^%5?R#YXNJ?W_VG\7M?
MG'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\
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MG'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\
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MG'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\
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MG'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\
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MG'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YQ]HQWO_%KSO\
MF'??JA\UG3C[DZW^%5?R#YXNJ?W_ -I_%[7YQ]HQWO\ Q:\[_F'??JA\UG3C
M[DZW^%5?R#YXNJ?W_P!I_%[7YQ]HQWO_ !:\[_F'??JA\UG3C[DZW^%5?R#Y
MXNJ?W_VG\7M?G'VC'>_\6O._YAWWZH?-9TX^Y.M_A57\@^>+JG]_]I_%[7YS
M2XWXC8
M
M
M
M
M
M
M
M
M
M
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M9WRLAE\M&S:AX>Z*1.U9?(G;])J<ISA0V$UD
M                         &7.O_\ KXX3_M<XW_QE2F#V?^S6P_X'EO\
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M^WM1"B269\IJ1%AIC<383$CO(=2XQ&3A:\88:4EK&%JQA'DK/GZ,K7KO]I+
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M.[45>$[GJJ\)]2<\(<<?8^(
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M1,R62E=5D\L/NMJ2G3]S['*]K7)'*^..65D#H5ED<[C>'_$7L-'ZJ3NH?*O
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M;4:<
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M;FDL6;$SUY?+//,Y\LLCU]722/<YR^JJJG$GW/.
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
&    #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g878734g41p15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734g41p15.jpg
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MBB;/F[$VHD:2J*EFLJ9F=&D)3-R5-!8<YN[<VI$*<!:<A$04UDI2$A!8"2B
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M!UEVJE<R6_/Z :H>AK*.$A)<&E\)DZ)0>I$QE"#T;Q\6CMKDO.=?K,Y-(?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g878734g44q12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734g44q12.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  6 &D# 1$
M A$! Q$!_\0 &P   @(# 0              " D&!P,%"@+_Q  N$  " @,!
M  $# P,"!P     $!0,& 0('" D $A41$Q06%R$9(R)66)&6U-7_Q  = 0 "
M P " P             '" 0%!@,)  $"_\0 -1$  @,!  $$ 0("!P@#
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MN2@Q-G8FAT_C7JN'Q0_WMP?(S&^_@6()9][-JC?+)\(C7%\Y$FHGY@Q,_'\
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M=_ \W^2-P7*]S/(\AUY!= K">GH;Q\"186!0USGA;/R]%O48@E/=0CCRRXP
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M(Z;0 IXVB>DBW(6!Q"'50MK"@=EL9*Z[&).$<")(EYZ1T(U"8X?S,KC\;<?
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(_L%?_%^?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g878734g63s72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734g63s72.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X5@[:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A
M=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^96QI;G,\+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @
M(" \9&,Z9&5S8W)I<'1I;VX^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @
M(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+7)E<&%I<B(^56YT:71L
M960M-R8C>$$[1G)I($UA>2 Q," R,#$Y(#$V.C$R.C U($=-5"TP-S P)B-X
M03M38W)I<'0@=C(N-"XR+"!);&QU<W1R871O<B!V,38N,"XP)B-X03M'<F%P
M:&EC('1Y<&4Z($%R='=O<FLF(WA!.R8C>$$[*BHJ5&AE(&1O8W5M96YT(&AA
M<R!P87-S960@<')E9FQI9VAT+BHJ*B8C>$$[)B-X03LM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*
M(" @(" @(" @/"]D8SID97-C<FEP=&EO;CX*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @
M(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX;7 Z365T861A
M=&%$871E/C(P,3DM,#4M,3!4,38Z,3(Z,C M,#<Z,# \+WAM<#I-971A9&%T
M841A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#$Y+3 U+3$P5#$V
M.C$R.C(P+3 W.C P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I#
M<F5A=&5$871E/C(P,3DM,#4M,3!4,38Z,3(Z,C M,#<Z,# \+WAM<#I#<F5A
M=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL;'5S
M=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @
M(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U-CPO>&UP1TEM
M9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:&5I9VAT/C4V
M/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @(" @(" @(" @
M(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%05-!0DE!040O
M-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!04)!05-!04%!
M045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!04%!04%F+V)!
M25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#=V]+)B-X03M$
M0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(>#AF2'@X9DAX
M.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&8O.$%!15%G04]!14%!=T52)B-X03M!04E205%-4D%F+T5!84E!04%!
M2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%04%G241!445"
M05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!0T%1341!9U%#
M0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC645537!':$)X5WA1
M:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#3E51;FLV3WI.
M:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT+U!%)B-X03LQ
M3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD-&58<#=F2#$K
M9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ8FY*,F5N-4MJ
M<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!341B445!06A%
M1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C133D-&5DII8W9%
M>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG6DIJ6D9':61K
M9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E75G!B6$8Q95@Q
M4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y
M3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+;7%Q-GET<G$K
M=B]A04%W1$%104-%44U2040X03E5-'%W+WIB*UIU:#9"23EP1T1F)B-X03MA
M:W5Z5SA2059$-%-0=E$K=T)/64=P-U%H:3)(<6LW5%(Y;%I-=S1J-EDY+S9K
M:2]-8GHW<BMJ>#9683)5<3)E;WIW0S1V=W%++TAL)B-X03M12V=%9V8X06%$
M6FDV-U<U26-)1S!Q<W5:,EHR9FEY;55P1&EI1%$O05-Z.'5V3F9N6%=D9$56
M>G%28E1,6D=U3#EP231Q0D9'=S4X)B-X03M14GE0=C!Q8W P3W!Z5&Y2;#92
M=6549C)N;SE0:7@R22MS-T1M;3EJ*V17;5!Q,#%T95=R4C9E6E-T=&5X,5DX
M2S!$4U(P<G8Q*T@W)B-X03MS>4ED<E(T:4-05#-U3FLW0VU)07A0<7)C9G%,
M,&M';T(X9F]Z8G5H9&EQ42MF9%9K,')Y6G)..44W4GI25W-I=WE)94Q,2DE0
M5&I9)B-X03M(>$1S1&U4;SAF2&QJ2'IC6%<U3T1$2U$R4$-722]K5#5S=DYA
M.'8S;&YQ3C%,9#,Y:%!5>E1U,&MH:&U&57%Z:W-A37)J-55Z3C=8)B-X03LP
M=WAZ0FE+:5(Y>F=D:39O-4U:16IC;VXW1"M#.4UZ574U94LV-RM91V]P*V1T
M;%I16'-Q851B5%$V9DYB3$EW9V0U459D;FIR=TI6)B-X03LU859)+UI'8B]$
M;S0O;$-34%515#4O:EHU>DYR<$180TE*-$)5879B9GDK4#)087,P1#!B<U9D
M:7)S5F1I<G-64U1Z>B]W06]4-6<O)B-X03LW6G0U+W=!;4AZ23!N.3E$*W-0
M=F-B5R\S12\V<W9U95-F.$%/3C,O04(P9&,O-'=W9CA!16YZ9&1U9E1(,VPP
M4',Y>FXX4#!V9',U)B-X03LQ-F0R2W5X5C1V.$%M25!Z62\U5T9%9$0K=69O
M+W=$9&9O+S9V>BMQ,#1R-FYR,"M$-V1A."LR8C=29FQV03ED8UA7*V9W+UDX
M-W(O)B-X03M!33,K64AH,W<Y2S5E9"]T93!#=$)8<C-P;6AE:61I<G-69&ER
M<U9D:7)S5EED*V-(+VMT.6$O,4EV.$%K+TAM9C):+VI%9G@P3'(K)B-X03LQ
M9CA!1G O:G%'2"]!4$].+W=$>'E.82\U:4EV*TE(33-T>C9O*S4Q+W,O+T%(
M8W9F*VAK;C5P*V0U3D9S,3!V5#,T-FQE25=E5619)B-X03MO96Y)9C541V](
M:'8W6G@O84]R3TUC369Q4#)"-VYS:E%$3$QJ;#E-9G1,>3=Y3'!2,69Z6EE1
M4T1N17-N,6DU3&1/15AX='E0*U93)B-X03MN,#5P=$AJ-#AO1#!084=B=SA-
M:4]D55!I;RMC=&(O5%AM5RMV,4Y96&LT5R]W1'AI:BM"4'9!<F<Q5UAX36AK
M>3!71'=S55DY979V)B-X03M:4'$W+W=#15!*35=I265'=#8T0E!Q3E!T4E%%
M545:*V8R9BM#>DQY2'=-4$(O2%!C*S=U+TAM-$=%9FUD46-N*U1X-U(X>C,O
M:GE1)B-X03M8-69A3%IX:69Z5')!-#94<%!X4G%F.$%D,7=0<TMO-SA34CE.
M4&9+.49I1RM79C!X*S!T=F%/95)R1&HK=68R0D\O25AN:GI,<79N)B-X03MA
M6E=6<#=054-Z5%<Q9F=T,%%55C!*-F-24E0O041F3VU:3VHQ;5-E8G9%=G-C
M5'1$45ES96Y(4U5E=F8K4'-E=C5V;FU(;3,U+V%I)B-X03MB6'E*.5=",W8W
M<4=%:78W2V-P:69V:D=B6'-A1C5R-V=F,4]N-V-Y8T]#=C5X02]4*V@U9"M2
M,G4O;W9Z,4)B>4YX9S%/3G)6=D1M)B-X03MF:FI0>C5,>$AZ>F-D<EEE4$-4
M,6IU-E1S6%!W6C8V4T90<$A5-RM$5'1.=711;C)G<S1:2C5F.5=.4W@O05IY
M=4]";$E22%5V65I*)B-X03MI151).&=,9DA%*W S:S)Q>6%O-S%V2DIZ9$Y*
M+W=!5W,O36XO9W,W;UEW23A04W%F4$1L:UHX9CA6,SA8,E196&MD-UDR,35&
M+V18)B-X03M-4U1*+W%Y2T=(-$A/16Y(:$I"-E!O:TI#44)(5C58-2LO4$<U
M,$A78G)2=$XP<TYD5VIC2F)I.$I#16M!9W)':$)+:T=O4$E:=61()B-X03LR
M4TUK0D]5=&HS3VHQ,V)*>%1-27@S2&5X:&8K8V<O3S!,;S$S<&1J-E1B9T-/
M94US06%F0WI3=5!W>DPO:UA#955P9EHK<'=2,CEM)B-X03M".559,3A2*VPV
M>#5!+TU,4W9/3VYY5%=Y1S)V8F5G=3=*>GE+8W9S<W)52$I45')19DQ.3').
M1DQ"2VIU1'E,=G1$<F]A:4YJ66IM)B-X03M'55-Y>%%X4$Y+-&II:E5V2DEX
M;W%Q;W%34V5G07I%07,P2$Y*<F-V1B].2"]/47-K9#@Q<C59<UDW:4I7-&DW
M=7<U16@V9D)%:&I9)B-X03M$=TIB-DTS,FXW1G-8:TYE42]7.#5Q93-Q;%=)
M6#5N.5-486XK9#-M<30P<E5.33$S4C19;W13=$HW94M32DIO1U5Y>$9!.4I7
M:T1!)B-X03M&:%AP;"M0<W)'2D-52D@P:TAO6$AY.7-:5$-58VM+-&]K9%(P
M.#!B+W=!-#-F.$%(4C%Z+VI$0B]W05-F2RLS4'!J-WDR*WHS3V9W)B-X03LO
M4WEV.#!0>E<Q3'EF<DYR65=T:D1D2E!B:61N;%IW45,W2E%C9CA!5GI$-U W
M3VIN9UI%:U584#=2-U1L<#5I26ID:3!L.'=F;C%E)B-X03LK=DA:*U=.3E,K
M=49J5G)M95):2DDK6E5&,6E337%X5E1T>4QF4E1C-4=(<V-695-60GAS+V):
M=FAX4C1J*T]69F5J4$QV-7 K8W(W)B-X03MY:'(S;4LY,#8P-&%7,&-.=$1%
M:WE'4U9N55-+,TM342]!<F<O5&QE9G,O1DA,1$=#9E8W;7I49'!:<%E:-4I2
M2' W<C4Y93E*.4PO)B-X03M!1"\Q-C<Q97IS2G1*=&]H8WIX475E56Y*4DDT
M5W1$.#AV>61J46I%>45J<T=J1C(W3U5X17A'-4%E,U1Z=S(X16QX3S9X45%Q
M,&MS)B-X03MJ;6EQ:6ER35-E9T%'8RM!4V%(3C9/56="6C501G1E+S5Y0G8U
M9%,K<"M63DU3-51K5FIM=59K9#5V9$E9;5)G4$-P<C=$3B]H-T=I)B-X03M)
M,VQL6'4V9D8U>E R-TEY-&--8CDO6#1"0G O>FM"-75S6G!99&$P4S-357AK
M>%)Q<S%U>7-2.$1-<VI31FQR-%4K951063)+475%)B-X03MJ.6AA>#(W;&=A
M>5%&+T5F97IJ.&YF369M+UAT1&UV3F1J5C=:<$=.:F9F0W)Y9D51-F5M;RMY
M:D-G8F)W-UIR*S X1TQ(34-(4'%()B-X03M:.6LV:DQL>#A75&PP4&8O04=*
M9BM9,S5Z>2M73E=L,&%Y,'-Z6'-3<7HS1GDS1T=J9TU#:7 X5&EH-CAL;V1S
M=#!06F9J4C1Z3&)Y)B-X03MA93!/,2]!;G=#3FYZ-69T65E0*V-G=E!-65-7
M9E1,2#!'3W@Y2S14;"]Q<UI337IV-4=W;EE3;&9W+U4V-RM88S1O;4UA.7@O
M5SE1)B-X03LO3'8X>G1,.#524WA*16)05DQ:43@Y;7I"=U5R5&Y',4)Y5W!!
M3S(R86I7-D-703-Z:65R=3E",FI$54-H=$ED1C,U=V8K4S,Q<B]5)B-X03MI
M+S50>#0Y;68T>$@X9$-N=%@O1G O:G%'2"\X-#,O.&-J5W8K66E,+VE">DXW
M8RMQ4'5D9C=0+T%.,TPS+V]95#5U,6545G9-;6]8)B-X03MZ:VQ:2FU724AT
M1V@T;U K0D%Z>E15-65025IE8C8Y;SA)>#1O>#AK-CAU>69O5'E:<3)T13AB
M=E5Z*VI,1'@T;C1P,TAT5&]F15IF)B-X03MG4&@T<%0V>3E)+U,T;7!(:34T
M62]W0T=(<5 V1DAY2'!6;C8X+VU(5E)44TY'06QC2"]D<R\X075Q2F$Y5'DS
M*S9V6$DV4$=,3U-8)B-X03LP=RLP.4%Z-U%Z4V]9;V984#=",4M(=')F5B]/
M+VUU4C-B:DIC<UI,:54O66=G6&)V,E9D:#0U1TU:-FI,-R]S1$]5;V%41#=U
M6&U5)B-X03M8-7<Q>4Q5-3=4>3,U9E)M,&5W26AS-# S8659-T=1,#9L:514
M-3$W-5!5-6A-:DA$-DDX=DTY-U9O=$]C64]83#EC='HU1'54>2MU)B-X03MO
M4$E(;# V5F%/<BMA9%-13F94;U%F<3A:1WEG*TER.% O0F5'6DTU1%19*T5F
M,VMU9FLT;4]",6U8:FPO8W@U1'8X07@K>G9E:"M1)B-X03M*9%-L.&]A83)O
M;WE826HT:FXY<&\Q2D5B2'9U;$]U8EA1;5)X4C1U8F\K,%)!6C5C2$LO-V9T
M95AF.$%/4T=O,75D13 Q5#EH2G)M)B-X03M19C8U5D4O-&<R9%HR2$1A579C
M2&I084A*=D-0=E T*S%J4&XO=T%S>F573&9Y:G)D;79P5%,R5G4P>D-V=S-K
M05=4:U0W.&="+W$U)B-X03MM85!/37AY45 X-"])=4AR.4]C07A:0GHT4B]P
M:"M0<V5K9FTW-79G9CAR-V4T=%=P+VE!44Q'061X1WDK=$HY=UAG9FYM<#=.
M,'@O)B-X03M-14@K0R\Q3S0W5C%1+TMG:B]+5BMV.$%9.'@Q8GEC3$PX;SE+
M,7@P+W="2W5R.3-9.7A"2VA2069A<T%99C8R8F9(<65,5E-H,$5F)B-X03MT
M+T)D3&PP;D1O-'IR8WDK=R\R0C=F.$%L2G%G,4@X=F1):TQC;G0T:F%U4$0P
M1TUA:B]G1EA/9C=3>#A/95AN=C@S<&5Y.&Y(<#1N)B-X03MU1F9,6D@V,FYK
M;E)R."M:9%E&<F$S>%)95G9:-F5O46Q30D=P<5,R+W=#>4]64%E:6&E/8DI(
M=S174C-.=6)W8V-V16Y1;'ES<U,Q)B-X03MR.#10>7,Q5S%N,'$O95<V<W!W
M561Z8G9W;V1U83AG2$)(54AJ55IM-'5Z3E1!:55D:5!.=TUV875L;41'4G5*
M.&DX-2])=3A.<BM9)B-X03MI,C!-:&5'-F=N:$Q!14(Q465Q<E5.0U W=DYP
M,G9'.$9N;U$V9G-39D1Q2T(R24Q0=CA!;DE,>DI06658<E12-V1Y:F%R235U
M0T1V)B-X03LV34A%;&8X05I--B]C8S%V63)!4VU:;BM(-WDW6'0S54='35%(
M.&8S0E8O23=Y4EEA9C5E:#AW6$5+>6%P<4%:-%I'1E1&0E5Q;U-V)B-X03M1
M=E1K4T]X07=D<F%U57!M02MM4#-S=7AT2$='35I#4%9,-VU7+VU.<#%J9F52
M.6)7-VA765%75GAC43AH57!,1D5Z;S9N<U%W>D(P)B-X03M->DA.1VHO14(Y
M<FYA*T%L9VY9=C!K+TE03% K8V)V*T]J<FXO1T=$+VE4-75/,U!P:C=Y-E0R
M935Z*T@V548O>FM8+T%-<%IP,R]-)B-X03M!=CA!>65K>7IS5"LV4#A!5R]1
M1W(R9R]V62\Q9C!L-G(K5C-L4W@X=BM58D99;S$K=3-S4UA..5!4-#-E4F51
M56XK5D$S140V97!/)B-X03MA8G1$54A,;$XX:'-(93EN85=/2$5!4'%)<R]J
M>5IA<4EP67%O0EDQ86=P53!P52]D;49B;G9N5#AY4"]!0V1S9B]-5' O.$%X
M1TQ/)B-X03MP,% K2V9#6#98:V1F+VIW.3AF,%!4=GIW=3=M,R],>3A%0DMI
M95='1UIL<E52<S1*,TA9.%%$.#@Q2%I-46,T=G!B=74R6D5A959E)B-X03M8
M,W-C+W=#8V1.2# W.41A:G)":E9T4DYY8E531VA:259J4C9,-&-M8S$X85IL
M9'0U6F-9:"]$5G5(,D)I:G=3;B]&9&9$6E!0>C,P)B-X03MI=W5V26LY+TUI
M+U<Y3VMI93%K,C5F=EI6:61+*T)6-C Y<W@K>4US:&U%4GEL>F-N='9&1U=!
M>5!/3E8X-E-R+VY(4S=N:SAT-FYA)B-X03MU4UE93'-.1EAS6DEX>4$O-$=U
M6&1T>$%Y4E!E1VYS0U)/2U$W<&9O6C=R,7 U4',W=5!Z2')I5W-6>&%2*VI$
M9EA.4&=5='E#;T<R)B-X03LU5G)39S5B;6Y5-7)S37-S:#1C3&\Y03=43D1$
M12M*3W)(57-6,5 X-F9Y>'59<&)'-6ML=G)36F5%;RMR3UDR53EI2D%P+T1-
M>D@R)B-X03M6<4%E26)(,W5$4'1F4WE&13)$-48U5BM6,7IB5V8U<U=I85I)
M,'5N>50S345$:T93.75Y4T--<T1U3F=R54]B;G1#2FQP:GAF5E$K)B-X03MB
M;W5Z2D-/<DA".4YY*U<Y4&$O>F<O.$%*8C8Q+W%29CAN-#@P2%IN*TU2+TA1
M=E-D<2\T=% X04A535 O=T-C8B\X06IK83$O=T%X)B-X03M%6"]%1&UB,C4Y
M569C-B\R9B]U-64O.$%1.#-T<E<T=6)Q2S!G479C5$]S56-9-FPR4$5$-S@X
M=6I%:S!/8C=,3UEI1$DX9WEV>D)")B-X03M,<6UT-F0U53!9*W1"<&E#,&E9
M9EEA62]&8WIN=TA+=%0T1$TS341/67A1,T5D=FHQ3')T3DE9.&-S,E19>C,K
M2#A)5V598G1B=5-Y)B-X03LX;RM89S%X63)B.$%51SDQ9'1S.'@Y=6]8=TAT
M9WIY-'%X63DT:C=4,W P,$]%4WHU9'!3+W=":DAU5F1A=C=8>3=P3"M73DIK
M13$O)B-X03MC52]4;"](=GEB+VQM:DDO6EAO,VHY-'<U6FI&2'<T.'HY4B]1
M>'=9>FYN-# Y;VHV0B]V:6HY371R5'E,<&$V=G%+3$PU;G9%+S-')B-X03LR
M1&EV,61',DUS;S=%+V8R+VUP8FII3E!(:FPO94AK3S=Z3%1L;$Q6>C1)+S-5
M9G%09C5$.&9O5V57=$1G36-V;EAZ:$EX<V<O<5<X)B-X03M-;GA09'EN8V9#
M97$W8D1O9CE564U'158T,EAL+W5I;E9:>EDP*T%E<G(O4D@T+T9V4F9Y.3AZ
M6"]M3WAV.5%U55=+15A::7195B]9)B-X03MJ5TY$>'(S*S%7=6)B439I5U5'
M4C58<S90=$Q3>'=3:D5C*TAF-6PT,RMB<G9R9C5S2G!32&QW3G!P.&1$6&57
M:FMB9C55>'IU3WI2)B-X03LT96TT=F5F>#AN>C-T6#DW<7A$*W)(-2\R=E8O
M>F@X=7)Q,VM'.%='365T<'9'.'0Q07!146=H=TMF.$%&4F)B3DPR6FXT37=V
M*TQB)B-X03LU+W1D.3)T9SA406$U>#,K6#=(>C1M;S9T-6EG.'8X06QH9FE&
M<$LY=EID>E<W;$)03#)8.5=D3UE2>$=E5'8S4'=$>5%Y5'I#1TQU)B-X03LR
M2'A,-D,O33-Y+T(O=T%Q='9T3G15+V0V8F)23F)J=7%7<%5K+SA!2714;DTV
M1$UF>DEK9C1J.3<Q=F%/069L6E)(.$DK-6I8+T]/)B-X03LK<G%F3&5R,E5J
M55=X=4)C13=M:512,"]80U1M6#(Q:B]E4E!E2RM8.7)H9&=:9C-5;R]Z5&9Z
M+T%,1T)A8D1Q,S5Q*V8R1C=C3D1B)B-X03MC6&U91&8P3%-.9T%K86YA<$Q+
M2RM*<6$U<UIM3VIW8D1F-WDV=D=*-C=58FUH.7<X;G1.<BM4+T%/6&1V8D-$
M.45*3E%585=74U)P)B-X03M$-SAU47 Y1DTP374P.#5..%0P8V5Y=$]"6$,X
M8B]+3T=/2#@R64E9>'AJ:F4X4D8S3D972U%!8C5V93!J96U*.3,V2&YE>31G
M875H)B-X03MY2$8K;&MN+T%$:VQ"24QN45HV9G4R4S13=CA!;$%X;F8W.'A/
M=WIT364W.4QM93!),V=F9BMH-E(K5F0U0F0O;"]O:G=T>45D=4E8)B-X03LX
M43A22TU$.4LU<2LP26U/958Y-W5/>EII5VYG4C-6.'1K9C4U+S51;GI"+S)Z
M8GHO:W<K5F%4*RMH+U=(,W1U="]U2B]W0E=8,U!*)B-X03M0*V-B=BM/:G)N
M+T='1"]I5#5U=3-0<&HW>39(,F4U>BM(-E5&+WIK6"]Y;&UN9CAW0R\X;G!-
M<S=%+W5J+U<O44=R,F<O=EDO=T)8)B-X03LY2F4V95@O*T]$<'8O34Q"+W=!
M;3%Z;G,S,7DY-65O>&914&-%9FQ462MC+WI)+SAN8D@O04UX3VXO.$%%67,V
M;E$O-' X2F9P95(Q)B-X03LO=T1J=SDX9C!09'9.;FPR,SAX95AB-U)P,C1,
M9%(P4U1R=VM5:&\S+W=":39G-7IU;7IN1FM%>#!E;C%705IS6F=E<C4Q.'9E
M879-)B-X03MF-5IE66(V=VMJ:'5K2D-8;&]*07E-57)W9$I%<G=B9G5/;E56
M-F12;C K4%9W171X,T8U1%0V;DIO<VAI85!E3"]&9FI:2"MA9E!F)B-X03MM
M,SAY;F<P6%-T2V%/,5=14T<R9TIL6FYP4E=L;$E25E)A;G%!4$AT;%=N,&5,
M4UA/570O>'E$9'%D8FTQ;%%H2&)U2#93.6\O3&9Y)B-X03M9=FQ,>7I&<'IS
M<VPW2WAN=G!&,U5Y=4%+3%@Y;%953"M09DY$<G16-#)4:39D2&]U>CE*-$=)
M4C8X>C<S:5=R>F%X*UI8-6QN5%!8)B-X03M-3FUS,&M6<W!Q56=T;V$X;C1D
M,UE,52M,1VQA9$]G>&E';# O1E<Y9DUL-79.>#9Z5F-&-U=F9T$Y:# W.&TO
M>3ES-U)91S!S6%1G)B-X03M5931U2&1P1U!I84962"MX07I2>C=4>GE..%9E
M-39(2#)4<#1I=4<O93AD.&]79'19+VYC=&QA<#9D<F$V<&1W=U(Q2C1X>&U6
M5E=P)B-X03M*2F]",WIE86U2;&\W4$UX2#9(;G1(05(Q,T-/46Q,.4PR8C@T
M4#A!>5<K=&8V:U@O2BM03D8R6B]J169X,$PP6&%V*TQ4+TA535 O)B-X03M!
M3V-B+W=$:FMA,2]Z15)F.%%/6G9B;C%2.7IR+UHO*S=L-R]!3D-!,5126F9+
M971A<'%(02]7<$IN:#AV4F=66FUN1E1-;S<K:6MN)B-X03M%9C5:.7,X+WE9
M:F=N2UA7+U0X979W*SDY3WA:>'%C8UDY2W5F=S9F12]99T-K=6<R:#!7=U5Z
M*UHY54%J=FYI*TIR94XO.$%J,5%J)B-X03LO9&IF-W-08G!L5F5'3T-0.35,
M;C5E6'8W+VLS5TTP=D5L=&EH>3@O-EAU-W9M,CEX0C56=#)S3DUC6%!M935(
M<%AL-48X4711,GAG)B-X03MG239Y;F]Z:G P1T5Y1T5C360X:#5N=3AH-2MA
M:4HQ0C1P-UEH>4@X-WI0;#-"15=.<EEE5$EL,4Q6;S!U+TUS9T0R3VQS87)B
M.&A5)B-X03M46$90,BLV<C$K;F-3:$=/1#%3,WED0C-E6F$X:S5A;SA%3G-8
M5UAF-40Y9C1+,7)P155F3'I:-39K6GI/4SEP<'(W5#-,52M'<3=C)B-X03M9
M>#1D4&\V>6II02]E-75V2614*WAJ4$U4*S0P=S5C-61)+W19,S5P.#$V:C5H
M=E).8S!J=#1Q<F%7:6)2>$HT061Z-&Y-5%5A:5=5)B-X03LR95A19'IN8513
M47=2;V-Z>E!E.70O3&92<$Y*.&\R54UQ.%HU=V)M6E0Q0FPS54@S0V-18S9,
M45EU1$5,-6YD-5!T5$]-;6-K8VAT)B-X03LX;FI(;%-'8EAV>G0K=79'-&=.
M+V,S66-Q4T%K260T="]M<6I/,S%"1U!35C$T45 Q=D$V84IY83=I23(T:69L
M>2]1*VI:23!K:F%/)B-X03M247E/0W)Q9'=19&E$;DQ!,#EC43A(+TQ$>4DY
M;BMA,G!X5$E48BM8:DDP5$U/<&UQ='546'AI6750;&Y2-B]6.%=M:5)Z;BM$
M.7)Y)B-X03LO6G5I-&182RM74#E03#=(="MQ,DMA:'!D-5E0.6DW9VMG8793
M:W%&1"MV3V5X>C1:0UAC6'!C:T)/2FEE;W T2BM18VLQ<C5S=CA!)B-X03M4
M3'%*,6EV8E(P6E-#05I);D)O5"]Q;#@V5'1G031H261#.'0R1U1(3$M*2$UF
M9"M#;%0R+VUJ.'%03U0S85<O<C)J0C196G!!9E)U)B-X03MB9'E'-#@Q<'AC
M8U%33WA(8V1B9V-E<WA692\S1GAZ2$QO33$Q8V9S22]8*T]42G)N.#=03UAM
M6E P6#57,%$R,3E0.$Q44G5B;5)1)B-X03MD=5,O0D=K9BMS,6%::5(W2WA9
M=E9K;%DK5&UY-UEZ6G94:6A5=FXK9U8X5TDV1W5R+VPW*UEL;%!R='$U84IY
M2E-P-4-33V1#:&MJ)B-X03MC-U!4;EAR,49->F-V1'%C0D5$*T$T1T54,&UP
M0GE$.71V969Z23AL4BMB9DQC;&=R3$AF470V.6A-,U%3<4-/3$AR>&-':"LO
M96UC)B-X03LU;V16-$]4:39D6'%/,$Y(-"M,:"]I-6HS=D-D0C@S965V>3)V
M2CE.;G1E14UJ.#5B0S=6:D=71D%:26Y5:G%"5&MP25!V;E(U=$YH)B-X03LQ
M445G9FE0,'9-64Y6;C!:-%-.=30O;U0S5W9Z9#@V*V).2'9T3S!N4T9G=%=T
M-68P:E!%2&U:64%H36YX:TMI07!58FEV:'9M3FDW)B-X03M.=S1:0U5P5V(R
M-F)U5FTW5GI:-$=-255+3CED=C!F:6MF.$$X-#1W>7@V:')H9$=11T=#;DE%
M9G10-#58,C1167@K3&(W4'A)33<X)B-X03MV,&],+VY):4-:+TYE;D9),EEF
M559&5D))<C8P;FAL;EEH2&AN*W0K9TY88CA38W-F-G8V4SEX,$%%841P;T]X
M1G)$568X.#%Z;F,S)B-X03LQ>3DU96YX9E%08VHX<F)(>G0K63!%-V9N5D4V
M>'-5*W,V9CA10G!S<UAF3V\P2D@U5#13+U,X;'(T;C@V4&9(.40S6'I61'%S
M,VQV)B-X03M5-'1*8FIQ5#(P<3)H1W@Y47%A0E0R63EJ-#5Z=6Y-4FMI6F94
M93<P*W!%:FIL=V964G X,2M7=DU'=F55,VUS;#AT5W1Z<4QY8W95)B-X03MV
M-U-74S13;$%56#1K25@T83!!-C4Q969$1$Y2-'E)*U(R94XP,F9,<#=I35E-
M=D]*=&MD>"M:;C5Y5T5(,7EF5%AS.5!102](<#=X)B-X03MW044Q2'A-;S8O
M-C)9;S!';&MA17)L+U<S8S)885=S:4Q-86HO5DY04R]Y=B]->5!Z:F%Z=S--
M2S)U<E=G1%1X4FLK;39-84(T*U93)B-X03M..6E#5%1X>E4Y;V%$=T-#1&-3
M-VIS,W1%86E*<U9-8S-K,VUB4V9-9C5C9697,3)Z9TUL:3 P:S%N8TUP848T
M-7%H;UI#3VI!358O)B-X03LT65IU<T=42'%S4$%4=E<O=S9U:3%/3$QP3E(T
M9T9X<S$S8CE$*U!.:T4O-3@K861A:D=N95AD0SE,535H>%=26&$V658R-4I'
M23!!)B-X03MP-'1594]9=S=(>#0O5FML-F9K-5(W8GDU9E1J:#9J.&8P34QA
M,#AZ95$O3W5N-G1R='4X:S9Y<&1Y>3$U:5E3:7-Y:5$W1U0T;41B)B-X03LO
M83ET.'HK3$AQ34IJ03=C=F0S9D(Q=D)L,'5E33AG."]F9E!F=F926&UB4V\O
M3E!K-C=S65<T1%5R54YB32MW1&M#4TET4W4S24-U)B-X03MC=F=Y941L0E X
M2F5V,4],>'-2:5 T:"]9*V1V3'9M9GIH*U<R<C-6=DI:*VU:<4QD5TXP<D)(
M2U8T=6I+4C!R<WEK9V<Y.7,V:E!P)B-X03LX5W%I1&9X1'E';C%/8E)Z24DU
M.'=8,$HU=CA!3%4R<'=,96%A<U-A-V))57-R<5=V=T(R2$EI;E)G2SA7;V50
M8F9F3T0Q5VY->'A2)B-X03LK<V-N,&)286]9>G=Z=G=Z>D@T*S$U4&)7=#5B
M=&171V=2=70P:&%05B]-1C,K-$5D9&Y21VMP-DLK2E W>'9B<&UJ:D5I-'<U
M+WA3)B-X03M/,SEN,VPV4U4T>7%753=F=W='+S-C+W5#+U)K4WIL83$X<#(U
M,6)82V9V.6%D2U%7-$]Z1T%0<W8O1U-4-D)H>$1H3EEH>%0O;F1")B-X03LW
M=C%L1V,X431S>#1-9CA!3C9N,R]Q0WHV-6](;'%:-W%35E!-6&U::5A-<D5V
M6G=32&-S5T\X,&QE+U0V8TA&1$5B*W9*.6<O5U4X)B-X03M'6$]+03A,1B]S
M:BMO35@Q6%8Y4S%A.64Y,4-D<FDT9G$W9$%/>7%"<V](9TUW.&U757IC:EID
M:&AW=WAX-%EI9WI$.',O24TR<S-S)B-X03ME<6%H158P:3-B:V=953ED,4]Y
M:78W05 R:CE(:E10,$=I3U$X579O2#)U<S=5-U)'2U!"12MS+UHK,3=L;E-0
M24]X5C1X;R]N6'IT)B-X03M"-6,P4'I,9&$O1'%",4LX1G),;V-L=$)'-TM:
M,FA*:65%2S5A:3AT>%1F-D1V<W5L=VY*3$=)1U!#3#1R4&1F5C4W1'$X-'AW
M>6U9)B-X03ML>%-R:&]D.6)5;G5I9FU48C9F9&$V=7526&IW46%Z9%=P,59,
M9FQA,CA+>4-/1T]75F%D3VY1;F-E3UDK6%%M46IW5EIG1%8W:SEA)B-X03M$
M:S1E,%)%>C0K2VA-:FER641P6EI$<B]!3UEE;6%&9E17.3=P,G!.8E<S1#8Q
M<556<UAT26A)05%7;'%++V%&94E/675(4E-Y0W=9)B-X03LR96PW=59N,3AC
M57%L1U9$;6$R2'AD<68U:6%66F$T*VE25U8Y<4]O<$A(3C96:D-*9UEP4#(K
M6$Y11E=O<50T-#0Y1DM53TUM35DK)B-X03M:5&LQ,$EZ-$ML2UA064E#.2].
M:GEV1VI'97IV-4Q&3&PW2S5U>&%L-V5/94YY=D(R<CA286Q2=T1D4C!/5W@W
M3WE(:UDS5C%E.4Y5)B-X03LK,#A9-6E66%).8D$O:G5T2#9B-34P95=Z,4YO
M.4]V8D]B4U535S8P,E,R-%A00U=P4FMI56YL>30K4'IY<DIP2F=X,VEE3&MB
M,F)S)B-X03ME<V=23&%13659<F0R;BMF+TPK;U)8-C,Y=&,V52MN46DV=7)B
M5DE04FM%2&%52E8K47%+8F(Q-UEZ,&,T:V-*175),$]%.559.61#)B-X03M9
M4$5$1&A&:U-&8F0W5VQF;4QP5B](3&-066%J66%F2$$Y,$Y2=DQ9>%=Z=W@P
M2EI81$XQ0C(R,S=9-4Y&2T\Q>&Q+-F](9&-7=6I/)B-X03MZ56]X<3=);U5P
M5VXU:V589%%V27)#87IV8F5+.5(U9%!U3#(R359V9')%=G%(,%=C-R]$.%$U
M061V15I+5VAY4DA%1$4Q>F\W:C-S)B-X03M99&]9-7E%86M,-45J85AU4G1V
M-3 P3390;W5O>%)Y<&%A,V-2,F1I9U)15FMM-3AE86AQ2W8W<S%P6$LU85=F
M2$M*-7=&;'1'<FAW)B-X03M1;#!M44(X56TX=2]M3F0V;"MN=G)/;%AQ3'!T
M>&-R0DI&8D5G4E%+;$DS-4]F.$%32W-4>#A-=GHV15(T2VQ(,4%D92]W1%$T
M,FXQ)B-X03LU;G@S1UAP2C9D,RLK6#)(-6A71FPU8S!35S=M=3EB,5!6:V1R
M84\R=%57-FY#<V%U64DR.4Y!;S(K,2](0E!24VQK;%%%27@W>G-0)B-X03MI
M;4=U:DA(0WE:>6YY;V)N-&-G;48Q-3EH9W-B3S9':#9X3DIE1U5*6GA76DTV
M96EW5G9547-!=EAB9F9T;&-D1U1):FEH=#%V6G1N)B-X03MR44EI6$)-,S T
M9"]I;#DS-7HO4U8Y-4]U=$=U6%A4=%=U<#0W;4YL0W-W:6EA<V)G9VQ3:G(R
M+U9L<V1,=T1)2FHQ4D%A>G$K331Z)B-X03M!*VU24#-(.4MA858U-S!Z5F1A
M;#!U>71,,E9)6G!B6CE314@K:&EA045U;G%G-TAB86\S-UI4:S!C;U$T:5DX
M<G$Y.2]*='AA,DTU)B-X03MM15),66M85S%J>E14>D1R;&YO5VDS;7(S;&9Q
M.6Y'6D=69G1-83!64C=S>$%'531C4GE415)Z3&9N>E)X44TU8V<X,SAS+S@U
M0C9")B-X03MD;TET9G0S,#(T<68S.%%A84%I=3)Y,6M5*S-%+U!.<FXW1FY(
M-D1X1#5&,"MN-V5X>3)Y1&A0>D@V,%0U<"]02'E-;6M834=N3RMQ)B-X03LS
M1GA%.%-W:4HT-#9U<%@Y-%IL5#1F:T1K3E R5&TT9UIE:T0X9$=E;S=A=T-"
M-&955#5F9F)'4"MC9$Y$=G8P<'%/=4UJ3%EI,RMP)B-X03MX=61G.&IY2DDS
M2'@T0U!F-35M9'0U4G=I2%<W8TAS1$),:6QK-E94,U9L5FQ+<T%Y<TM-<#-"
M0C=(3V-E;U=X45%W<59H:E=.4V%L)B-X03M50556.&1S2DI03D%&3GE2>'E)
M56M53V@V<7="0BMG-&<P:VAC04%!04M!8D%$07$R5T=+5F5%<4Q);EAI=T)(
M,TA#0U)Y45)A-T%L)B-X03M+3F4X<6%*<C-O1%5O5VQ&=7AD1D1U:6MN<GE#
M:U8O6&U0;3 P371C435/5G Y6FMW,W='<EE.-6HO3'9Z<F129E9,1R]T1C!P
M5#A&)B-X03MH07)7:68W2D9$:'HW=35/83-0;TUX1E))-&4T8F9J-74S,#-A
M96YI94M56F-F9696*U!G1T]7+S5-*V(U5W!),7)!=&1Y.'!/,RMW)B-X03M6
M<WA9.6Q:5'IO3V1,='I!3UA%9F=Y+WDW*U17:C)5:5A'<E1N54I6,T5!2$-%
M2#-&4WHO04E$,GI/=V1L4FIV33A8,T]S,5!B8S5I)B-X03MO1&A(,G91;S0T
M-&\Q:FI52D=G0V]I9T)10C!!07IA9T%B0C!H2DIS<G-+2%EQ=T0X<W9Y-# W
M4CE",#8U,6)325EV36M";$TP>D9:)B-X03M856U:>D=1>7,V5CE0:E%J3FQR
M.61+8WE)>5!H+W-D5C)D;TDT.&-43TDX45@Y+S9K2G%(:R]Z1DXU1S@T85I(
M86-R-U9D5W5B=7=H)B-X03LY4TEE<$1*8U)U:CAI,T9A<7!.1TE/5U$Q3TU:
M<V-R,FI!02LK:3$U3DIK3T1,1W962UI)-6-R0U<K9E!*,VUV5V16,7!$<$PV
M;S$P)B-X03MS63!7*RMU0T,S=%E5448Q.4%S2WE&.71X43%R<TLU8F\Y5FIX
M>&HV=4=V<4975#AE-7$Q,FMY-4I32$1X6#E*-'%!*TAF8DMV2S)H)B-X03LV
M>$(U<G9T6'8W4#9T2&1A8EE1;U,X8FQ:63!0<E(O07A0=W115C9(=&U(<4US
M1&E%66TV;$PY:FXV9D9-6E1/47$T>"ME.6A*2F9*)B-X03LS;5)V2DXY<&]S
M+SE.;3%S,W-C6'%28C(U=6QK-3AU6$@W07)3=&9B36=A<D@T=VQE,T)8>'!O
M3VQY94-9,78T;"]$:78W:U8U=#AT)B-X03ME8TQN5W9-1CEO82MJ2F5A5F(R
M=&YC:5)%6G!%;C53;W U0FM9>&LP66EN=FM.3FYX0T5"4'!):R]*3W%W6FI+
M6G@W17=!0BM*=C=')B-X03M-,G8U8S8O979Q:V-7:&Y1<E153DE.<$=:<C%B
M<'ID4GIP3TAL4$IM06Q+.&1H<T)7;3E->35A-D5E1S5C6FI/+W!R87$K>'=O
M-D1*)B-X03M)>3E(04I1<F56-S-E+W9:4$]N;E1Z3#5C=E!,5V\V0BMI4%5S
M>D5D46$U:6MI33AF2#!W<V-F>#A(2S=N.6XS>D1">%ES9WE2;GAB)B-X03LX
M<39/8V9'>EEZ:FQ$9W503WA6.45(-5@X;WE3,U9T2'%8;$$V6DQA4DU"<6(V
M:6)L1FY#8U9A2T0Q1S)A=&9B<&QM;S%.03A/5&EV)B-X03MP=S%T-S)V5&%9
M:VII>#A.1&YX6'8U0S!,<"MG965H<"]L5%%R:E%X1F)A0G%51GAD86E,<49L
M9$EI+WA2>#%$,#1Y8C$S.$(Q<$]E)B-X03MB1'A:2FE7.#1K0557=4=$4'<T
M-$=',D]12DYJ<&9*4#E$,#=Z3'!E<BM99$YF4WI0<'5R,VQZ9G=A<6LP4590
M6&A!16)2<W=E=DI!)B-X03MU=S<Q-EIJ6EHT-7AH3&DY55%"5F1X8W)":GE9
M-7IJ=S-'56I,:7-D4C-C,&LP;GDS-7<X='AE6&19=#E+1V\S5FQP<C9:<5=L
M:6%*)B-X03M*27<P,W),2D<Y5U)J-&=(.64R4FMZ-'-P;D%Y-%%:8U%.959/
M4&HP*V)%251%94EI2$-263<W<V1%5C5Q<V9/3W4O;VTW=F1!;6TP)B-X03LK
M351I-SAV43,P8U)-,TML=DI,36I+<DIX-T0W2G(Q>4=N;FEX.%%%>'AB5DQH
M-F1A1%!5=WI:3T5M0G)E-&-11R]3>C-F8VQU:RM5)B-X03LO3T]L84YO16<P
M9U-83V@V<F144U=+6$5236QT8TMA4U)U5TEO=DML1RM,8G!L=515-'!Z;C9T
M<'A'.611,#1T3FQX=V@V9#143S%J)B-X03MK8C-(>CDV86%D;TAM:4PX>&PQ
M2W@P;'1%,'%34S1B5TI&=6\U<F4Y0G(V36]T,4Y5;%DW='0O2&Q44$YJ3T1H
M375/5S-$='9(=C,W)B-X03MM-TAG>6I5.%59.$5.*TQE>$QU3F1$*U!F,&0P
M4U)'4C%$27=+<W)#;TE/>$)">E9!=3-94G)0-4PO;"]Q8VI3+U5'<UI73E=A
M>F-X)B-X03M$9G=J4$M-9E%U8DA&,G!N:'1D*SDQ;5AS:E1Z+VAR,V)F<U%U
M;F9K5"M8.7!-2EI)3&DY-&UO4S1M4$=V>6I%9&9P>54K,3@X:'I!)B-X03LY
M=UE9*WAD4$4S4E!V3%!B5S!T8E,S:G1R5T9)3&5)8UEO66Q#27%J<W%I9T=A
M-E5J23)D>3=335)%54)15F-I>61I<G-69&ER<U9F)B-X03LO.6L]/"]X;7!'
M26UG.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T
M4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R
M8V52968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @
M(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#I%03(W1$,W1#<X-S-%.3$Q
M0C5%0CDU,T1#-44T,#,W03PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @
M/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#I%03(W1$,W1#<X-S-%.3$Q0C5%
M0CDU,T1#-44T,#,W03PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM
M<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y
M,31!.#4Y,$0S,34P.$,X/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @
M(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I2
M96YD:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN
M<W1A;F-E240^>&UP+FEI9#I%.3(W1$,W1#<X-S-%.3$Q0C5%0CDU,T1#-44T
M,#,W03PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O
M8W5M96YT240^>&UP+F1I9#I%.3(W1$,W1#<X-S-%.3$Q0C5%0CDU,T1#-44T
M,#,W03PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R
M:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y
M,$0S,34P.$,X/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD
M:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @
M(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)
M1#YX;7 N:6ED.D4Y,C=$0S=$-S@W,T4Y,3%"-45".34S1$,U130P,S=!/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#$Y+3 U+3$P5#$V.C$R.C$V+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU
M<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I%03(W
M1$,W1#<X-S-%.3$Q0C5%0CDU,T1#-44T,#,W03PO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q.2TP-2TQ,%0Q
M-CHQ,CHR,"TP-SHP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7
M:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @
M(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z:6QL=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL
M=7-T<F%T;W(O,2XP+R(^"B @(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P
M4')O9FEL93Y0<FEN=#PO:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL
M;G,Z<W1$:6T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$
M:6UE;G-I;VYS(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P
M<FEN=#X*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y
M/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @
M(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E<SX*(" @(" @(" @
M/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(#QS=$1I;3IW/C8S,"XP,# P,# \+W-T1&EM.G<^"B @
M(" @(" @(" @(#QS=$1I;3IH/C@Q,"XP,# P,# \+W-T1&EM.F@^"B @(" @
M(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*(" @(" @
M(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!44&<Z4&QA
M=&5.86UE<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D^4$%.5$].12 Q-3D@0SPO<F1F.FQI/@H@(" @(" @(" @(" @
M(" \<F1F.FQI/E!!3E1/3D4@,S P-2!#/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @
M(" @(" @/'AM<%109SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @(#QR9&8Z
M4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D1E
M9F%U;'0@4W=A=&-H($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @
M(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4>7!E/@H@
M(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y004Y43TY%(#$U.2!#
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4U!/5#PO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT:6YT/C$P,"XP,# P,# \+WAM<$<Z=&EN=#X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y,04(\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z3#XU
M-"XU,#DX,# \+WAM<$<Z3#X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z03XT-#PO>&UP1SI!/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SI"/C4Y/"]X;7!'.D(^"B @(" @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y004Y43TY%(#,P,#4@0SPO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E-03U0\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z=&EN=#XQ,# N,# P,# P/"]X;7!'.G1I;G0^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^3$%"/"]X;7!'.FUO9&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.DP^-#,N.3(Q-C P
M/"]X;7!'.DP^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.D$^
M+3(Q/"]X;7!'.D$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.D(^+34X/"]X;7!'.D(^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(" @(" @(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP
M5%!G.E-W871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @
M(" @(" @(#QP9&8Z4')O9'5C97(^061O8F4@4$1&(&QI8G)A<GD@,3 N,#$\
M+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO
M<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" *
M/#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_;
M $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( #T!(0,!$0 "$0$#$0'_Q  >
M   " P$!  ,!           )"@ '" 8% P0+ O_$ $00  $$ @$# P("! H(
M!@,   0" P4& 0<("1$2 !,4"A46(2(C,3D7&"0R-D)U=K:W,S<X05%W>+49
M-#5$4WE6E];_Q  = 0 " P$! 0$!           '"  &"04$ P(!_\0 3Q$
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MZIA(F,R)1,L]C<EC\Q0JY3%7*^0QUY(V*ERHT'5["3_ UL"9&8YB1*/U@."
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MKC8P@4 +&2*9F8 !&/R&(ZSCIXK'X/ZC\?A\56&GC<;W3Q].C5 V,&O61GT
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M&3XJQKD!I(;+S:E,%J8.'4C7.\O<' 9=&2;LF7S->'"5S&9>_8OT[=>2B6I
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M?8<>HBF8K,AX4,GZ<3,\!8E^..1'@1-1'QY-*9+3UA_W;O)K^QM?_P";NO\
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MB/F?0KV6-\8^2\.(CF>M .ZNM6=O[=[;KU,?4NW\2PJ*N8CUKU%BLA21$SQ
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M2YFSV"0<P+!UB#8>6VV]*3!RT,H6XM P(J2Y0]QB. +(:1/4-4RFZ;!0U[$
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MB5K^C_9\/C[^V:W>N)J9+,_9%S$K>P5Q?]C&05;KH(Y$3M+&TAH5QDFM5Z[
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MY^8^.>#B_I7[G7X50V'<L70P@D'G7KY',9@A$)CB48UM>C1F1B/N2=M?C/'
M\=7?4>@;L#6/)_76TJ!N*D/:JUOMG6UYC(>TXL)%^D(2E3]>G)-F0?C:Z/ ?
M>Y5Z+/6PD9;$<RLIAK"FF6\Y37KOU*XS+ZAE,-D\%D!S.5PN6QSGT_:CC56,
MA6M5TDH6VBL^W2+E04G!-* *?DI^;1C_ *4LMA-WP^=Q.QXPL%AL_ALHBO>B
MV>5=6QMNI:>+B14"I[EY(;(P$@D9,1Y$8^&/M@A#6:K6J@,2T6#8;E2K9&1
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MY(?4QNDE;/8X><6D;*M6YF;G,5]5@CE7MDEF(@:$9!''O6&P+D77Y9V="$A
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MX^)!CMH6BM<O^#/(6';A<8YG\18K6=PIDB"86U4DU6KS>_(N=K\^/)@/$O\
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2U.IZG4ZGJ=3J>IU.IZG4Z__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g878734g75q32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734g75q32.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1=P4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T
M!UAWZSA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
M    3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT
M<F)O;VP      $)C:V=/8FIC     0       %)'0D,    #     %)D("!D
M;W5B0&_@            1W)N(&1O=6) ;^            !";" @9&]U8D!O
MX            $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L
M=                %)S;'15;G1&(U!X;$!S'XU0        "G9E8W1O<D1A
M=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N
M=$8C4FQT                5&]P(%5N=$8C4FQT                4V-L
M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 \     !  $#P     $  3A"24T$)@
M#@             _@   .$))300-       $    'CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]       $@ U     0 M    !@       3A"24T#]P      '
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #-0    8
M         *8   *:          $                          0
M       "F@   *8                      0
M   0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   *8     4F=H=&QO;F<   *:    !G-L:6-E<U9L3',    !
M3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M!V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I
M;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M    26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   "F
M %)G:'1L;VYG   "F@    -U<FQ415A4     0       &YU;&Q415A4
M 0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .
M8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       )
M:&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=
M  EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.
M;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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MLR.A]8K^LC6/NZ8^@8O5ZZQN=4RMS[L3J3:FM]2UF-ZV17E^_P!F/9ZOHO\
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M &\ 8@!E "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %
M: !O '0 ;P!S &@ ;P!P "  0P!3 #8    ! #A"24T$(@     !?DU- "H
M   (  P!   #     0*:   ! 0 #     0"F   ! @ #     P   )X!!@ #
M     0 "   !$@ #     0 !   !%0 #     0 #   !&@ %     0   *0!
M&P %     0   *P!*  #     0 "   !,0 "    '@   +0!,@ "    %
M -*':0 $     0   .@   $@  @ "  ( "ZP"   )Q  +K (   G$$%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z,#@Z,3,@,#DZ,C<Z-#4
M    !)    <    $,#(R,: !  ,    !__\  * "  0    !   "FJ #  0
M   !    I@         & 0,  P    $ !@   1H !0    $   %N 1L !0
M  $   %V 2@  P    $  @   @$ !     $   %^ @( !     $
M     $@    !    2     $X0DE- _T       @          /_A 8!-30 J
M    "  , 0   P    $"F@   0$  P    $ I@   0(  P    ,   "> 08
M P    $  @   1(  P    $      14  P    $  P   1H !0    $   "D
M 1L !0    $   "L 2@  P    $  @   3$  @   !X   "T 3(  @   !0
M  #2AVD !     $   #H   !(  (  @ "    \     !   #P     %!9&]B
M92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X.C X.C$S(# Y.C(W.C0U
M      20   '    !# R,C&@ 0 #     ?__  "@ @ $     0   IJ@ P $
M     0   *8         !@$#  ,    !  8   $:  4    !   !;@$;  4
M   !   !=@$H  ,    !  (   (!  0    !   !?@("  0    !
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M    !0,$!@<! @@)  H1$A,4%187&"$Q05-5DI;1U?_$ !0! 0
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M7-9"J'/_ +&V56+B[+4$ 85$W2B:C?0J&6T>:80=);;!H&_92_\ $G_[-?\
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MX9Y[5 _]=*=(],JM[SZ!X&HFR/2_U@Z4>(%B4>L7H.S4(\;YVH:, G:NK +
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M8LMRFR*;QZDJ04=NW(/;^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
$^#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g878734g97q10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734g97q10.jpg
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MA(HGR\L$05-D5TR >1G&<X]MV$KX"VT]\^#>4I_[>M3NV6+^QNWVGX_Q\##
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M*>8&LR6P2 P(@,#&1,#&9$A(2B)$AF)@AF(F)B8F.>N)VE=A-9ZRV+L>0\,
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MJ@):3Q)//(;#CRF)A$D++@!S YP[;&:;M.O;GB(V'73 T7&>%T22";R+J5+
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MDS:FS95AYJ6W+-H*8:WL$V03%K,H/D@&>8A.#RU&SW)G.X%3JF.L;M&6Q"'
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MZOG7V2. D9QMI*U3,\<V'O6JO6")]B98:I8_XBCIYLKW$T3"43R.3V_7J]0
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MY;?\AK.O8S7D:;:V+$T69*_9SUJVJLBS4C()"NJE1HWT$^R"U6+5RNOT$O\
M%Q,\*NN?4%YBZ]I>C-]V+BIJV0TAR(G*#4M>U""W.=^<XD_M.$<D-=$VHN1J
MC%#C@+.^EAQ0H!$F] BEMCS)PYC3O?L4.V.B93(;%K57<\RK8=6KY*[E+]G
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M_2W*G6^@XV,WM.3%/J]DT/M27N,C0;V!$O3,95-DUVQ1$>:AZ=;8<CQ).*\
M&S4*<\GF4NI9MUW0-4R6L9W/Z;EME:[7*Z+URILF&105D\<UXUW7<3:JO:OQ
MK24--+N62N8C[I2,E2\?W)W'%;=KVM[UAM42C:;5G'4;NJYVQD78G*IKE910
MS52Y72R"M"!)6ZOPJ&Q,_>&"@?Y7'2RL4OFOU@[B2!(2HU3=XQV4B,B6/DRL
MDQ!<>IR4= C!LJ3@B0,;%4.$QY)]TEQMORQY=_7]]JJ%?[?=BZ(-4DKL;?4%
MSR\$J*SL]5,-<?$^*ER<$PN)\0B9X]NO-IUT<;W,^(?(FISPH3I%TT5Q\WN&
MKJ5MY*0',>;F0N06/,>1R,<QSUWG"SE)RLY2 4+;\QJC0,3QRV6S9B CJ7MN
MP6#:FO/HZ9-F+!ND,;51:Y,R<C*A"QAH,)(QYD.V;D^1%'6,J.7S-_T[2].;
MD\$C-[*_:L0506*OX.K6PV4]>4DUE"PNZ=JNI2&&Y;+"FKL2N%*,H.&QU^VV
M\[YO*<3L5C :G7T[-#>-;<;L%NWG<1\M#Q0K(UF8]=.RYUA0(8JLY+*XLESE
MA(>B1+?0EZ-'2D74CZHG,O2G.4P#6R+5J*@ZG&(J]<IEXK;W[+;C!=*9=G;Y
M-0\@VTQ/0L\8*@*HS$.<P=$U\-LB)DH66F9YI;M]J.SVA;!VZ6S*S2S>2S1A
M<MY#'6Q^=P+8 HK8U#US)5K%5;).]7>LEOM,D7JL(16*$ [R]\>XVM=T&*PL
M7M?Q.  Z-/&Y2D7R.Q*)@S;RMFNV!&W6MM7"\?9KM%M>HH3KNK6+-L9O36'X
MCNF.PC#6Y^.-G L;+*4%2&L+1%2\))$83CS(8B+7B$.A&5K[X2(Y.6!;2<8S
MDYW.>V*YF/A4OC8(L!M=-M4BF05F*;D6%!S["3Z7S"[!1'U9%>K$S]%CU:<)
M\8V-*L([)IUY5P1B#;A+R+%9Q<>YC7O_ "K:PS/M"YLVYB/?U9^G5(<H/Q"5
MPO=+GJ1QMU*5J\V?CRXMW9ESL(TS:(<0YE8[[]8KD.&S%1,XTVM60IH^;G&Q
M'%>ZS%)):9);L.G_  PT<;D*V0VS-AF%UF@X<10JG7IO-900C<MO83GURF.&
M5U5ZQ'$<$^0(@FL;Q\7&1RN-M8S3, >#9;2Q!9K)6PLWJX-&0,J-*NL:Z+(C
M/ZJRZS:$)GR&O!B)QQ_0PX)["N&[*_R_O5?D*]JK6P\T_KLJ7&=$7L6[2T4=
M7FS(0=]*'3*U5Q)*0D"9YOL$_8V(N-CW#UBSB(WW_$5W'Q='7[6C8ZRJUFLL
M=<<H"#$XQ6/0Y=J0L$,S"[=QBE+"M/+!JDYK85!UI=SOA>[6Y?([-4[A92HZ
MG@<*%D\0RP!+G,9.PAE065@.()E&BI[G';'A97!KI23I"W"'"/2+]:'=3U.I
MU/4ZG4]3J=3U.IU/4ZG4]3J=3U.IU]!0HQHQ 1@[)89;#HI8I+2'QR1B&U-/
MCD,NI4V\R\TM3;K3B5(<;4I"TY3G./7Y, 8!+8(FLQ(# Q@@,"B1(2$HD2$A
MF8(9B8F)F)CCK]K8Q3 :HS6U9BQ;%E(,6P)@@,#&8(# H@A(9B1F(F)B8ZQK
M_8SUUJR)L<UQ4I&I-3[;EBB#0+S;Z5*[#Q$K+P[DH:!0=9A2JJVXI:/C(B5/
MP8:&_;<K)[>4(:'L=O<1A$6[&CXW X+.O,V+R=_&ORWH>?E)A5AEU9TAF9CP
M%$S6"(X*FV.(@J?^*N=V.S0J=R,OLVRZS66"G8?&9:M@_F87X^FRY*<>U>2(
M8&?.;,!<;)<CD$%S)!:Y&]/+J5;3L[L_?;+"[Y*:<>5'/QNQ8R,BH]EY7=34
M-6[8S2(>O-NXPG+PD0 ,-ESOG*WL_O5+KMW:?O%G+I6LI=K;.<$4I).62A"1
M+\J].\.-KU(G_$%=0AS]9+\4MCHG?'L%KF/&EA<?;TU9"$/&Q@GV++R".(*W
M?QIY>U>(>9\&VG&?C](#\,9WANE!SDE"$,E:IB8%E2_%1LMLC7#PS?W[94M$
M%:)HW*4_?.?;$6K.,9\4JSVQFIU^Q?<MQP+,)7JCSQZC\QB2"/WS,5;EEG$?
MP"9_=$]7BU\2G9^N$FK9+5XHCF%5<#G09/YQ$3=QU-7,_P 61'O[S'OUMK37
M1!GGBQ)'?NV8L"/0I#A%7U:,3(R!3><X5EARVV6/ $C7$XQX._'K$RA>5*PR
M2CQ2XHC:]\-MDC6W:<\E2HF).EA -K3CZR,W[BE DORGQI6(_P I_GT)=K^+
MNF*FHTK6;#GS$BO([&Q:$++Z><8S'O<RP,_4?/(U9CB/)<\R,&^TEQ]U!QWJ
MV*CJ*E1=4C7?:<DS&4N%SL^4RE24FV">-6_*RY*?-SV<%DK'"0XIB/8$%\6$
MLGKFJX#4Z44,#CD44SXRY@Q)V;1C'$,M6F23[!QS/CZAR*XF14(!P,*)MV[;
M1O.1G)[/EK&2>/D-=1S"Z=)93S*:5-4!7JKG@?+TEP;9&#<;&<G-S>K#U5.I
MZG4ZGJ=3H37.36L'L[G=TP86XTVN7NAXD.7[=LKUNB82PUTUE_4U0>BVY.OS
MK10<JVF3"8)90H$I(Q0S!6<-+::<P:^W>6LXCMQW?L4+]O&Y+TM&FE:HOL5;
M2R'-WA=*;58@8F92P@*88'F!D'WH*8Z ?<_"U<WW3[(5LCC:>5Q7J]PXOU,A
M7K6Z;!+ 8XT0ZI:$UOB'J%@Q*F>#  _NR(ST0U.MZ!K;6=MK.LZ)3=?P*Z_8
M'D0%'K,'4H;)3L02WE[$9!!1X&'EI2A"GLLX7E*4X4KQ3CL+IRN3RV6I6\MD
MK^3LQ:JC-G(W+%U_A#PGQ]:RQK/&)F9@?+CF9]O?HN_8V)PV$R%'"8K'8FK-
M.X45,72JX^MZA5SCR]&JI*H*?:)+QYXB.9XCH.M$K,VUT#CJPL+QG,\=]BB8
M!^2)G^\.WJSN-M_)P1D/]2%I5Y_(\,=^RE8SC.,'7)6Z\_$HNW#/^'_2K%'Z
MG@?X8Q],9GP\?/ZQ,<>//\.EWQ5*R/PI-I2KBU^A^97Z7FO\99.\0QYP?I^\
M3$\^?$?G//53\E['KW4VSN%5UYJ4.>VQQ+5Q I54UKKZ+Q V:NQW)AAJ&<FY
MJX:[E[%# V/WJ,^'%1<Q(XDX4-Y]EO :'6B3FNWJ53*9O$=P,?H&2K83=OTY
MR%W+Y-WS-2TW4B*Q%>O0RB*EAE3QR(L>Y"O1L,$2GU)&045?W6YB,!F^VF2[
ME8JUG] CMYC:.&Q"/E+M-&ZB-:;-K(XBQ<K*NP6+)==%AWKUED8Q"HD3</(:
M^B?HG'/K!ZQC]1(TN3=:PWNS76KPR*6J+AM7[*H#B*:(T[2I0^J0YZ& $.24
M&,6D>+>-2,*0:RRX3Z]V3?\ ,[5V+S#,Y.?#'W)U[*YA@WX<_,X?)C.0,HR"
M57'JDF\)LD$F\5R9BLB@.N?B$?+:?\0^$5KT:TS)41V;#X)9XV45L'FL40XT
M!+&/;0KN@4P3ZH,@$$V  VB)'T4;>D1(%=)ZZP; _G*.<(QXY ONL)\C/RC"
M8]GWENI'Q^]QE/N9=PU_Y>?C]_0?UQZ@[U8^P1<)CN";9/Q*?N?;;"\O&(DO
MI[\>//\ #GHY;17<?83)UA#EY=LQ3 >0QRS]'UCX^4E ?B]N?+Q_/GCK-W(R
MNS!G!/IAQHX?N&P^ZNG\1(L_(%1\=F+K B#E^XM]++WL*QG'BPXZIW_%E+F/
MOZM>K6ZX=Q^[[B9PNQ@.YPJ+Q.?,G7&2N.(&2'RC\R@8C_%QU3-PIV3[6=D$
M"OEM;9.TIN'S7'@***X;/E)0)>$_D$E)?X8GJ_-\PTJ5U/."<P&PG(,;J3E$
M.26MQGP')-K,2@/"Q\O-DO)6XG]7L(5A.,9\UM]\9]5G6["0[0]QT&4^HW-Z
M<0!$%R0!;?)\'XR S$?3RG_TB?IU;-IKO/O;VML+")6G7]X$SF1X VTZT+Y#
MR@RB9CW\(GC\YCH(>1M=V[2W)?C/L+C5+;GZI!&-MRVTMLV\O6DV%%$14M,S
MPUUI^R[3;LO5Z#@*$$ '#52I1,><Y)C8CEAB"$.2(["^>5HY_4=NQFVHP'9P
M?L1.&PE ,M78X'I36+'WL13HP-JQ:R9M.Q=O/:L4GZT&Q@PDECD,/D-;W72<
MMI=C9.^ASGWYS/Y \+94@T67V0R>.S5[(>5.K4Q*TKK4,>A+2>$)]):S)P;U
MG+U)<>I7AUU-(RHRM\T:[PAJ/&G=L+$FP %YHT:U(Q]PA;9 Q%AEXD"R.?M4
M.1!R<?'RK;F!0?DCN/,&I(;&U?&JV=.]]HW74XW8Q[A7MLU^P\+3<;D6RIE"
MQ2LOJH>RI'R9#92UB)CS;X' DN0DK6<H[4G]NN]B,?8RNKEVRQ^E[+6KLJ*R
MF+3#DY&K?J5[EBNFX7SXG5>I5B)\%>8$0,@QLO;VQ!.KOPVW=!<>:#9X=-+G
MM=6G79NV'*=%0^T[+6I9VQ2U2<B8>USI4,"_&QKL,DVSNQ )1\Y'/*=9!$DG
MA^3@\4?8[?->L[3DJ;YOULI3RB\+%]S\-4MH&JB]#WTJX6&"UPV)73BPP%5F
MC DTTB7:V#,K^(+MSL]74,3>K1C;6'OX=N?G&HKYV[1LE<L8^:]>_:964:4%
M7AEZ:RC;;24D*EOD**XS;%Z:/(3;--TY3.G/&PNWV)-3>QAC:CJ-%:U<5"AD
ME24HQ9$W7)-P!"EQ6& ?H4)F1+!=7(*CV"!TQA%BV[$]VM7PE_/9#NHZQ@R3
M$XHUWLY-O,!88()252:'A18Q!D3/F;'I R(5ZI"4N"K:5F.RVW9_':YC>SJ:
MVP@Z8S(,Q^OQ2P;*RS-SQN1D_4R*EV0$%?*U?68J9=*1,(0=HS'(T'I^\\.5
M06T]>7>X <R9;4=WT*9KTBE&/SDM6::]3IJK6 :RVZLXK+WU_*QP)60=^GNC
M,.%.K;;<9PKD(U5G<WMOIC,-E,?19H2,YC]D#*#D%C73;OC?1<JG4HV_FQ^5
MB#8E4>J)E 1$S!<=RSN2NTO=3>U9W$9/(J[C6->R>J,Q!XQA6K%+'%C;-&V%
MW(4HHE\W/@I[B](@$F%(Q(\U+K[3VU]Q]+'J%T-NJB0&S[ER<WM=,4]VQ0YP
MXAT)>-?WZ7K[-C;(9AR74-P$G$@R#SP0A1*&'W<BCO>:.WD\[A<!WD[7Y*;I
MVL10U#7,?\\-5ZR-=G'93&(M%4D2> S-I+V*&&& 20CYF/$U_$Z[GMC[%=W<
M5%!=3-Y'=MHR?V<5RNT%MJ93$9:Q4&X)C7,HBF^NIQ$M;#@#*5@7,:.<YMZY
MYT]/?F:'JZL7B#G=>\:K# 6N/MX< "+FS677MQ%^F0)\=8I7$B,";7#VG9$Y
MB(9=9? >90K+I30=4CM[ENW/<_0F9FYCK%;*;96LTFT666'\I4R=$_6LJ;53
MZ1,"VN14LGE!"T2F(@"9<_\ Q-PW=+M'W'#!T<I5M8C2[E2^K(KJ*7\[=P^1
M"$U&IN/]8%-IM$G-"N)"2B&)DF"NNKF%=.,D'T]^?8U1)OFO=2\.*9I+?U4B
M): !ML!4+'2:O)0]QJ+4]*1<3/%QED6\-*134DR46Q@%@56!2S9.)ZE!F/V^
MSW0[:%>'&Y3-[Y?V'6+KT664;-ZID+JK%&\59+GU@=4@32Z5$"R]0CCS6M+^
M-D%9/2*G:+NL../*XC7^W&-UC;:%>Q45D*>/MXNBZOD<>-IZ*]MB+LFNP@7"
M; A0K^XUCZ_?[&YH6;GOPLY:D\,*QLNDRU6I=<^@7NU2E*ITE8QGYS$ALZ$K
M:8VXS$E6Y,37T3," 34NJ-06;+X;CGA"!&RE\S%:#3[:[_I([]<Q.01<OV_F
ML;23D+ZJIC6]/#V+<MHH5;2>4?78VNB'2M:.6BP#((Z^9[D7>ZW;;?R[;TLU
MC+%'&TOE,K??C<<ZX!VO5S5:G"<C8?3>&)KV5JLV/1AC+'"368"R1]1UZXC6
M6>X7;DXC<5Y/6^L./_)#6X.\MOS49KR+N^2+4T77HVO2CPEKF]A;((9E,%3,
M[,OY?$:>%&5%ID5G.XCR>W&[O4K[_@MWW-.6S&S:IEF:[@Z[LJW'0-,@LNM)
M$Z5?%XD23XHK5Q\3D2.'2J%CZHC3ENWUVUVVV/M]HK\-@M2W+"IVC8;",0C)
M^=^"J5Z;R"_9R^9*'R=BU9+S6,@$HATL*%$EH=[D..74XY?U.XTN;E&N6].U
MKM?34U 2%;?"D!M":9G ;C SXYLT%(0)YIH$@'"$DB+"(?&0X4Z*$2@Q GR6
M.5M7:'1KM'(5TSI%_+87/5[*K8L4>RYZLRA9K$NNQ5E:UL4RP '# $Y@(-@2
MN3/BLHW3N]O<.AD<;9>/<#&X7/:Y9J-I$IP:IKEI61J6P;96VJYK%.76,URH
MR"),EK.&1CCC3M?5F[^>FH;'P4U3L/CW*BEW60YT4TV7JT!J::@/HRAX]+5-
M@+A,0UFL[%H>=Q&3U8K\1E!!8$O(C(<7(OQU[VW"YG7NVV<J]Q\UB]G288]7
M;J^M%VUFZ]J'P;9F_9H5[%2F5,8]:M<M/B16U"BF(4+ASI>?P6S]U=>N=K<#
ME]2>MF2=W0QS;%"I@+%3Y>05 XZKD;-:[>&])>C:HU*\P3%/<,3+B2RCZ4[I
MS^JYV;J#5>Z*\NJ;;UU3-DUQ2EN(B+I7(JQ!C/K3X9+!1)BD*CSDXQCVC@5#
MF,J2E33Z%)3G'5Q&<S. M1=PF5OXFU$1$OQ]IU4S&)Y\&2DQAJY_-;()9<S!
M#,3/7'S>O8+9*DT-@P^-S-.>9BODJ:+BP*8X]14/ Y4V/\+52#!F(D2B8B>A
MJ6_H?=/"U2+DB'J^TTM3SF77@ZALBX,1RUJSW5[84](V!H-O.?\ !@# H[>/
MTLM-IQV]%FC\0W=&DJ%,S%/(0,<"=[$T2;$1].65E529/^IGF4_XBGH+Y#X8
M^T-]Q.7@[V-DIDB7C\SD13,S/,^*[3K8KC]P*],!CV$8CJQ]3=(GI^Z@E!9V
M'T)$VV<"<;='D-F3=@V".AQK/DVY^SECDBZCEUM>,.(>S7O>0M*5)<QE*>W*
MS7?#N;G$G6?LKZ5=D2)*Q%>KBSF)CB8^:J)7>B)CVD8M>,Q,Q,==C ?#[VEU
MYX6J^J5\A:64$#LW9MY<(F)Y&?D[CF8_R&?<2FGYQ/$P7M'1)!QQQ!V!!&&1
M1166AQAAVD,CCCLH2VRPPRVE+;3+3:4MM--I2AM"4I2G"<8QZ%!$1D1F1&9E
M)&93)$1%/)$13S)$4S,S,S,S,\S[]&8 !8"M8B  (@  ,"  ,0(B(C$0(C$1
F C$1$1$1$<=?=Z_/7ZZGJ=3J>IU.IZG4ZGJ=3J>IU.IZG4Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g878734mm.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734mm.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1"N17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0?NH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QA:&ER=2!(
M87!U87)A8VAC:&D   'J'  '   (#   "'      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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MN8XY)O+C,)=D4S(F1@9!*$D#T4FFR-J-U;W4MQH%N9KB,+<*UL[><5\S;]0
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=110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g878734pc01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734pc01a.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X
M#D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$"
M 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,#_\  $0@!V@ / P$1  (1 0,1 ?_$ '\   (#  (# 0
M          8'! 4( @,  0D* 0$! 0                   0(0  $% 0$
M 00# 0$! 0    4" P0&!P$($P 2% D1%187(Q@D$0 " @(! @0& P$
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M:%1@ ^$W'26G.J:=4H5I2HCS#WW=%E7 12:5#R7>;>4K-C':Q6+KFN7XUK-
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M2_QZ(TA85;3P _FNB%0'DWT>PS(VN%<K="O<PA)MOG*;G!9-F:QX%5XQW-,
M39Y,D^X7X&8G2FDF>R+)979JER6G'_\ S%;_ &1?^VO,]\W&]8Z<IF(XQK$
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M5Q$4AU3\_P#B!U'?H'OCS&CZ?E8A7@0 KJN <W\M<K.&HE7I87)JMJ-ML)>
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M)/E_TT^+M'F\M2X[M]0[(S;V9M^O9L$BMY,%<-,:-ZEO#'^JH;J5*<D3Y8"
MRBM"W&Y+:'9J75K%>UN?#T-"^PJP:L%8RL@%PVR>@/\ )[&).&Z73[72JG9H
ME7(470*=9"PY[1;93:2<A2A-J=%%!<Z9S\T.3EI8^.5QA]D2O\"VP/(4U;SK
MO=<DYIZJ"3KRU;43JYJFDXH8V>T0V\K!4<"/SFU9SH!'.J^MFM X@@1+*DH$
MWI&-V83DK6M<YP&\\ !^Q_1LD_"R_%='-%J^5L5T$7:LP;9YRV7>L!U)86MZ
M1V;GFGBLI3 49@#F1G2W1RR++T8DR)FJCRHR'F_H6L[.'EZNY\'\G^EWZ^;H
MI^JV%6BE3%(C^:-HSWS]0T\R4(**5"M>>[M)F:+9*&6C#NE#<(7([P[.)3FH
M;;#SO6D@Y[EU&C^PR_N9CD5*NP_1M/S6Q@-2BE:V0RD%FMC-6"2)SK2"Y^KE
MQ>QV>G9@]79])@%7W>%2#*ER(K"(/%$EPD]$HI<$3 MG*W#!?09LGO5FN![.
M7+,TYI9C-LE R:9'?R2MZ#7BX4+1SYG/+5#AA+'&+MMSYC4A+SRH1%J,II;:
M0:R@K]X%+S$QD2$IM"F7T==-" 53061N%,>DB=:HDD582LJSP,>GEP@:SN1[
M&(&Q'')SKT>!'FN2N1I;S+49T*Q)G/S3=;04P[T1A-JP?0*4!JU0T56>FW/$
M2,NK-^HQ*D"TRV5X9P@9H=MO+]M,DXK==9_&18X,1OKL1GYW.*%>T_4US[!T
MC=LLR%^U>?*)'O=S:*NL3H[U,LVE.! S=:LA*.3B9Q3+'4K7=)!.U#Q8?X(,
M]IR$V540<2\S#=9<&:I-Y!G(-WVJWX=L&IWK(++72E3C6$SF=:=S>[UB[7@2
M+S@-9^#G<D,S2M]2?A7A\C7V&T\9>/J@HE1(K*)33?T*TIA&8?V::;#"E</R
M^S[%YDS2G6ZT]L;];VW?=EQ([ITZM@+G^56')N0!_P ]JB0(S[)7\R24BQO[
MT=#CO-/I<0P^+3KF2[\LG,R(^2_3;%8/>?9U;")T2)9S=#]"[[?,7CN/9*')
MS5V?<M!@QK77(,(/,;47DUMV2V%B_P NMJ3/2\V@+3W+9K+?=GLF76;*AP+R
MKM/H=JP'RJG[+ED++)<+,'(E4LSB"Q)W0M"I<B$1*I1T<TXU\,;K,]Q"Y?'5
MM1)0RE/*024#7[O<*?H=N/\ G?5<Z>J+T_E6S^SELIGZ5HL0=5X)KKHD55=%
M/TT#++FWWQ0Y@F>C<?=8X^^N,PZE? :74@>E?.E=]-4^MT.WE)$:J"[M"L]C
M!<9E21=T#HK]EK<ZMF&(90.^CK+5EZ3%RN.K_K#XZ!.^%_\ &^%8)P(S!O#K
M6+>>MYPGMQI\Y&W(MD=9&KY-&J%7 ,V#+066MS95)E7&T+LA:<P!X6,=<)QX
M4XA+?1&C0(O4,H%=I:9U>[CD<M7:UF'_ ":\7J;++B[JS:!GG78=PKE10+_N
M1O)H:7D-RSHU7]*CN/\ /PG$G(*F8CSJ^]7Q?$*"O47.%T_2V,:U,FC:O8YV
MJ*SK6J\:J&]Y(<%ZJ+MC]:#3:G8_/L1INN[&\.#0G2$:/!F6$Y-)$'&$19\:
M1'4MP5Q.D'7O_.*P2IX#2'WS\.UC3 NH1YD:3[5L(+@&>DT3DLR,Z\<76NV!
M\FN:TGJ"\V,Y'CM\^%UWGWL)^HR5?QCU%CY._O7/)WJB"8!DPPN+,TB)6;+)
M"^Y&6+@$=Q^OOOV 76MMMA+U,VV-,2)8YV-6'H3[\F YT,M4U?S=%?N7X_PF
M_LR%-4.L5#T=!OOHRKE:42<!D V4;Y-Q7,2XF)2]/,PY>M$Y-/T4*"A,R9DB
M$.(,AG),T[/&0'E?&XT[&HIG&"S\U:]5K)Y/]'WAO2-D-4>J1+V21K]KV$==
M9CM;:Q\#;I)_,]4;IU='"?\ )1"+D>7SL"4T$LT*:WUV2EG[N@UE#L]Q7&;0
M\TIMH#[7<L2L C2X1$.0H^/V;>REW0+H]\*V2CSLHJTAB=9@/:7!)&9BW/Y;
M'-!OS4];?CLNMB5RP,P/=[5=_/.^7 SJ-ML5BSMJU]C6\YY1LV3V"LH:RP'>
M LJ!@I2RDK??V(\0RR2A\XJ%T\EY,>+]R.H?6#68&]ZOB7==2SHO2<KB:U_D
M]CI5NM02/7:G:KP'J@&,;ERSV7![O<:%7%7CI3D,?\[I-#T000G/,,2WVVXC
MPB$EYCS:/3L']'BCGEA%"S.VVO1355QB-4:@-TG2,W+4(/#>K-TJ0W3KO49%
M@D*8EU<0RZ;@,20D* EZ,.1WJ."MY6<CD]CV[T-3<A63\S@XIW0GS#T9]GE<
M$74_%#LU.U%6'JG23N@9D+M)F7:1@R'(9<+MJB"94R<VQ*<BHCN!6)SH%L:U
MKT;8<.V6^:1F!41=:]'L1?*Z)VO@A>DG(47.1)^$!L%(&:#:QD4^J_ND!8SC
MQ2 X5@,Q9+L>)\_WK!I3"T+K]A.(5G1A>07!O $;KI]=T!=<H7"FB;%0JA2W
MK)3;JTHU<7\@CEB?1)N<AD S*D0OQ8)$U&D2Y4:&U(7]!5QB80G?(,F$[X_]
M=3!_GRO4E/S:-\]1K\/TJVWI\^/AE8Y/AE3ND5X9NIPY$F\75Y?1 KKD%X8J
M*,[*>9XM4X+;W+)I/WX9C LVS2?&);P,NS6SAEYDOSN=R.M7LC=(]#T66L ^
M6W$>4SA8>Q5&.5@\@2V'9!<@_%@14+DR6D]I*[%#YD]'/W[RGZ<T"7H>QG',
MSBW21RUV_1O)=GOX6*SB5;T6#+JMOR2EB//85V' /-R8:3R2?(,[J^E_C82J
M*W."M19#U]VG-1KN/ 2V;3C8L?&TFM?]1*56YX=G=P&YLH<?_)G52[^B'.9C
M72\:X\#*4[(0N:Y%^9J&J/)<;E,4E8G(B/,1;?49?Z0I5QRG41=/1%T<SE5^
M[HOBR?H!!^14Q$$O4")S(S<?.T:K)OJC$Z(5/!VQT9I3"2\V0XAQ2A7$I_</
M_P!E#>&R,.JT+?3)VIT\EI;0J%>Q*\WX.H)(IFVECRMJLK&N"+%0R0Z-1I)B
M/"A/CIQ&<<DP(XEKA=R XV)69P)/R>D0]Y%]>P1%>W.+HK,>X0=$@D'\3.:N
M2M?/.-(158E8%T&J <;&Z8Q0.A8DP/-%*>B6AM]DLN:K[I+XU;W+H;C]4^C*
M9YCS-N^W6JF[I#GFU!1=<"2:2-=G%!M:LE[=7*-:/:*92@[,,)2ICS*YI%E<
MB8VQ%BI>FR([#@PEW."JR;U)DVC9SKND56 ^&KF2$#<RY.K?J#@^=_%$":L[
M81QZLV Q69K9:K6>-)D*?F,S(<I3K,]J.\VOGT^8::*7V\2OPC'8!*E#LN/C
M(EX!+T.IZZ?H-6I]QICD TS%K,ZP::(-U 9!GWQT(HFI;']@L&W.0,6@FJ(K
M@M8D1/F<18I'E?TEG4[9<0L((*U>ZC2]&&#?/I//ZW$)Y&$D62PW.DY4%'9.
M+H#.@%"Q4>",1%D$5-R*T94\XMQ717M/(5?LN-4"K836KEHN=?\ 3 M.T?AY
MD"6L%?JE XMO,],@%VM/L5HI>@B!-0LU3GD0,=S@MR8H\7'(A/PIBV)L<2DS
M@0_D56+->+_7<\'8K;,RJ3'T&?8M#E&LG=K92I<\]U!"R]!-4O,J9FJ':Q26
M&(!V1,"3G4VH>141?GJXM2G!;3W+J6/OW:+-1],F1JW?=1J +)<&B;3KC--]
M!Y3CG'*"0N-K$M2Z'5+]B.IR]/TEB%3#,A<-PG7!R8T*-'Y)[)EM_:%5CZFZ
M,[I@H-E5\!1?3.E:5"+-6'\G7+)=,V,VS/\ DRNLPW7J^?KE*"U,3VMM(X2C
M=GCY:69*^N/<<9[QO@R]Z"#7,G\WVY#5WWG-,1LZ*]#8%,V[7*;0S2 8^<20
MW&&M'[D-D\&0YA><GC;/'4(<DO<YSG5KY_()O@(JUBV.4RI6"@T_)LSJE$MB
M"2+52JU1*L"J5F;,C4!BZ+!7!8J*&,H*AVDQ9/)++G'XR>-+^Y'.)^@E[Y/E
MA^R+%_4MN]">6M7JMVC$_+>>E%1+5FL;S[)] R,XW(P7CQL[]+VC+H%VJ<[5
M:I2FG^PT\:_*D4:6[P^Q!D_8[,%C576&GL^B] HWHT'G%Z :)Z!IM^TLRP91
M0=%#X0W1@E&?E@4P@CY:@)TZS)NB U@YV>ZCI4=^6SW\;^6OX^;Z&6U.%@T)
']"'GT!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g878734pc01b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734pc01b.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X
M#D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$"
M 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,#_\  $0@ &0 9 P$1  (1 0,1 ?_$ ((  0 # 0
M          H'" D+ 0$  P$                  0(#!!    8" 0(!!@\
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MRNDMB$+D]VHY1B5P>4U1KC.V>T(Y$K;M>XW&NY[6BRVEAAAC4\%)GA$DR0J
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$"#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g878734pc01c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734pc01c.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X
M#D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$"
M 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,#_\  $0@ '@ 4 P$1  (1 0,1 ?_$ ',   (# 0
M          4' @8("0$! 0$                   $"$   !0(& 0(' 0$
M       #! 4&!P(( 105%A<8$P 2(2(C)"8)&1$E$0$  @(" P$
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%XX_3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g878734pc01d.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734pc01d.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X
M#D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$"
M 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,#_\  $0@ %@ 9 P$1  (1 0,1 ?_$ 'L  0 # 0
M          H%!P@) 0$! 0$!               # @ $ 1   00" 0(% P4!
M        !@,$!0<! @@2"0 1$Q06(9,5X6+2(U47$0 ! P,"!04
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(IZ)7'@52_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g878734pc02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g878734pc02.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X
M#D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$"
M 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,#_\  $0@!VP / P$1  (1 0,1 ?_$ ($   (# 0$! 0
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MF62!M@%[/.KTDE-@A<CKEE7B7]C<;>'RH0SAI0PE/D_61F(D2)JD _+.B?\
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MI._R2/XZ/QVKG=?L]V ,5NY$+%5X&;85D_H:\GR(2@7,K8VP]#U[)=@KT2&
MH4,L5(%40H+D&!!=ZN8VVM33P5F<%+YE><,>$-1!DKL?O@\-#]$5*$]7O.]+
MJFLUH!&=LZ(="L/EQO'ZK0$[+3XDO\%^N*JLL2?G-MN]9F1I_P!*P?EW+#Y,
M':5$Q>JS+I)QT>RY=25>&D-;UC4<C6E5VS>^4RP#*44R*D:!:K*>.4TZ2BRA
M*QST%P4N5)>YSL5"DA39G/Q]:-93Y8]'KGC,/&8RY4M]M%3]!9AZ/]"V*[F+
MJR,6Y8K#KUWT'*1^O0K9+D2Y$S^TB(DN6-0,^W%%HXU!;<AJT<E[CZ^36S"J
M+GN-7YRX6+/;13]F9(TRZU/4L:R<\*)SL^O80I 29W#+==IYH2<KQ25'EC>"
MTR'D=XZEU'&>\524S@37F;VJ:T7(_0=4GWH@?L.88GHFGLZW/]!>9[;HT5*!
MY!4#O6\_PFEY948=;4E+D$L6K1& TMM/9S$Q'%H6#K#1JKTWY@WC3BA:T8#Z
M]TO!"-B@UT?<:/\ QX>T9[;8%6Z5[%BA9[T:+H>,ESK97K!(O52L20^VPPYU
MA3S7UK$32VI"'(<BT2J^7[QF!&J#Z?I)<9IL&.J%Z<WC2H]CLED'SV1UTD>@
M[5 '[U5Y%A(24/NR8Z7"]>5^ZH+KJV65]!M3/05'R71=D?R;/Y&.V$M79T+1
M9KIR7!]#!O,8YG[V::!&I)<]HY*='E%!U8TUX*2_KC4>=%L"HOXT^.N%]_O
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M3AD6[Q[B ?EW&U[4U3S_ ,-Y_AGH#RKMGH4?;;(&,T%JG8L]I-0FWH8,M1E
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E>OD]\W/^MS_A_P %?]G_ %_\>_\ 9_\ C_S_ .OT.9]_H#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
